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INTRODUCTION
Since 1983, the Space Biomedical
Research Institute (SBRI) at the NASA Johnson
Space Center has been conducting a program of
investigations into man's physiological
adaptation to spaceflight, with an emphasis on
delineating detrimental effects and their
operational impact. The primary vehicle for
inflight research has been the Detailed
Supplementary Objective (DSO), which provides
a means of gathering crucial inflight data
without interfering with primary mission
objectives.
Data from the Apollo and Skylab
programs pointed to a number of potential
problems resulting from adaptation to
microgravity. These included but were not
limited to space motion sickness (SMS),
cardiovascular deconditioning, and difficulty in
delivering health care in the remote space
environment. It became clear that an
understanding of these problems and their
operational impacts was essential to the success
of the Space Program. While a number of Space
Shuttle payloads dedicated to the Life Sciences
were planned, a method for obtaining more
immediate information was needed. The DSO
provided a means of obtaining this information.
At the beginning of the Shuttle Program,
the Space Transportation System (STS) Program
Office established a procedure for testing and
refining Orbiter and subsystem performance
capabilities, and for evaluating new hardware
and procedures. Procedures involving the
Orbiter, its subsystems, and its support
equipment were designated Development Test
Objectives (DTOs). All other operationally
relevant procedures were classified as DSOs.
DSOs were by definition "supplementary."
They were not to interfere with primary mission
objectives but were to demand less on crew
time, stowage volume, weight, and power
requirements than did other payloads. The DSO
seemed adaptable to inflight research into
biomedical problems with operational impact.
During the Orbital Flight Test period (STS-
1 through 4), postflight debriefings conducted
by the Flight Surgeons provided biomedical
information. STS-3 marked the first inflight use
of a biomedical DSO protocol (fluid loading as a
countermeasure to cardiovascular decon-
ditioning - see p. 41). Beginning with STS-5 in
1982, biomedical DSOs involving hardware were
manifested and flown on a regular basis. The
creation of the SBRI in 1983 formalized the
biomedical DSO program, providing direction
for a systematic approach to the study of
physiological adaptation to space flight. Since
that time, biomedical DSOs have been used to
study physiological adaptation as well as to test
hardware and procedures that are operationally
relevant to the Space Shuttle and Space Station
programs.
The inclusion of biomedical DSOs on
Shuttle missions has helped to fill the gap in
biomedical data. Serious decrements in
physiological function have been observed in
Space Shuttle crewmembers. Some have been
debilitated for several days early in the mission
with the repeated nausea and vomiting of SMS,
others have fainted postflight from the
orthostatic intolerance induced by
cardiovascular deconditioning, still others might
have been unable to perform an emergency
egress due to the combined physiological
changes which occurred during their adaptation
to microgravity. The DSO program has lent
insight into understanding each of these
problems as well as others. The study of altered
distribution of drugs in the human space
traveler has begun. Through the DSO program
a partial countermeasure to cardiovascular
deficiencies has been developed and applied in
a successful, practical approach. Additionally,
key hardware and procedures have been tested
and verified as DSOs prior to use in support of
more costly, complex life sciences investigations.
To varying degrees, biomedical DSOs
have been a part of each Shuttle flight to date.
Particular concentrations of these investigations
occurred on Shuttle flights STS-8, STS 51-D, and
STS 61-C. Over fifty biomedical DSOs have now
been flown. This document presents the most
significant scientific results of these
investigations. It must be cautioned that in most
cases the data are based on very small subject
populations, and as a result hard, dogmatic
conclusions cannot be made. Further
investigations must be performed to accomplish
this goal, and the SBRI will continue in this
direction.
_,= ........... _ .... resume, the future of
the SBRI DSO program is not easily assessed;
however, the work which has begun in these
endeavors is too essential to the health and
welfare of astronaut crews and the success of
the U.S. space program tobe given anything less
than critical priority.
This report represents the combined
efforts of many individuals. The investigators
and their teams of support personnel have
spent countless hours designing and developing
hardware and procedures; collecting, reducing,
and analyzing data; and reporting the results.
The editors have tried to present the material in
a manner that will concisely summarize their
findings without compromising medical
confidentiality for the individual subjects
involved. It has been a monumental task, and
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of many people. To all of them, the editors
extend their thanks.
This document is a reprint of TM 58280.
Michael W. Bungo, M.D.
Director, Space Biomedical Research Institute
National Aeronautics and Space Administration
DSO PROGRAM DESCRIPTION
Life Sciences DSOs are managed by the
SBRI Flight Projects (FP) office. When an
investigator wishes to participate in the DSO
program, he/she submits a proposal to the
Director of the Institute. The proposal is peer-
reviewed for scientific merit, and submitted to
the Life Sciences Directorate through the
Science Management Review Board (SMRB).
The board verifies that it is appropriate to
pursue the investigation as a DSO based on its
operational relevance. The SMRB then directs
the SBRI FP office to obtain the requested
number of subjects on Shuttle missions.
The Flight Projects office provides
assistance to the investigator in all aspects of
preparation for flight, and is essentially a "start
to finish" support system. Having received
authorization from the SMRB, the FP office
helps the investigator assess the hardware
requirements for the DSO. The FP Engineering
Support personnel work closely with the
investigator, manufacturing, modifying, and
readying the hardware as needed for flight
certification.
All hardware that is to be flown in the
Space Shuttle must undergo a strict certification
process to assure that it will pose no hazard to
the crew or to the vehicle. Since DSOs are not
critical to Shuttle mission accomplishment, they
are normally classified as "Class D" payloads. As
such, they must be certified for safety and
compatibility with the Orbiter and its
environment by personnel of NASA Safety,
Reliability and Quality Assurance organizations.
FP Experiment and Engineering Support
personnel ensure that all DSO hardware is
tested and analyzed for compliance with all
applicable requirements, including standards
for: Electromagnetic Interference (EMI);
Flammability/Odor/Offgassing (Toxicity); and
Shock/Acceleration/Crash Safety/Vibration. The
hardware is tested as necessary for functional
interfaces with the Orbiter and cleaned in
adherence to NASA standards for contamina-
tion control. FP Experiment Support personnel
then prepare a Safety Analysis Report for the
hardware, identifying potential hazards which
could result from its use and describing
measures taken to eliminate or minimize those
hazards.
All investigations involving human
subjects must be approved by the Human
Research Policy and Procedures Committee
(HRPPC). Concurrent to hardware certification,
FP Experiment Support Personnel assist the
investigator in preparing and submitting the
required protocol to this committee to secure
their evaluation and approval.
Having ascertained a feasible readiness
date for the hardware and procedures, FP
Experiment Support personnel examine the
Shuttle mission schedule to identify flights of
appropriate duration with adequate stowage
space and crew time to accommodate the DSO.
They then prepare a crew information package
summarizing the objectives of the DSO, the
scheduled pre-, post-, and inflight activities, and
the investigator's plans for the data obtained,
and send it to the crewmembers of the
candidate missions for review. The FP office
then arranges a science briefing for each
candidate crew, during which the investigator
can explain the DSO objectives and methods
and answer any questions. These meetings have
proven beneficial for all parties involved. By
soliciting participation in person, the
Investigator is better able to convey the
importance of the DSO. The crewmen, in turn,
are able to obtain better quality data when they
are knowledgeable about the scientific
objectives. They are often able to point out
relevent factors peculiar to the spacecraft
environment that the Investigator may not have
considered in preparing the study, and to
suggest appropriate changes in the protocol to
maximize data return.
The DSO is then presented to the Mission
Integration Control Board (MICB) for flight
assignment. This board is composed of
representatives from the Mission Operations
and Payloads communities, and is chaired by
Program Office personnel. They are tasked with
fitting the various flight objectives together and
planning a coherent, workable mission. These
objectives are outlined in the Flight Require-
ments Document (FRD) issued for each flight.
Oncethe MICBapprovesa DSOfor flight
and includesit in the FRDfor a givenmission,
the FPExperimentSupport personnel work to
see that all the requirements are met. They
contact the crew schedulers to reserve time for
training and data collection sessions; meet with
Flight Activities Office personnel to ensure that
the proper procedures are included in the Flight
Data File checklists and that DSO activities are
scheduled in the Crew Activity Plan, and support
mission simulations and crew training to allow
astronaut subjects to practice using the DSO
hardware in a flight-like setting. The FP office
also briefs Mission Control Center Flight
Directors and Flight Control personnel so that
DSO priorities and activities are understood
should real-time rescheduling of crew activities
be required during the mission.
Finally, critical hardware reviews and
laun¢h and landing activities are supported by
FP office personnel as necessary. These services
are provided for each DSO. After landing, FP
office personnel follow the DSO hardware and
data, and can be available for assistance with
data reduction and analysis. They obtain the
required Postflight reports from the
investigators and forward them to the Shuttle
Program Office so that D50 progress can be
monitored.
Section One 
Biochemistry and Pharmacology 
crewman collects a saliva sample as part of a DSO involving A study of the action of drugs administered inflight. The noninvasive 
technique demonstrated here has been successfully employed in 
support of several DSOs in biochemistry and pharmacology. 
COMBINED BLOOD INVESTIGATIONS
Investigators: C S. Leach-Huntoon, Ph.D., H. Schneider, Ph.D., IV. M. Cintron, Ph.D., and R. Landry
INTRODUCTION
A cephalad shift of fluid is thought to be
one of the first responses of the human body to
microgravity. Losses of body fluid and
electrolytes, which have consistently been
observed during space flight, may result from
the body's attempt to compensate for a
perceived increase in blood volume (Gauer and
Henry, 1963; Leach, 1981).
It has been proposed that the
redistribution of fluids initiates the following
immediate responses: reflex peripheral
vasodilation, suppression of the renin-
angiotensin-aldosterone system, suppression of
antidiuretic hormone (ADH), increased secretion
of humoral natriuretic substances, and reduced
thirst (Leach, 1981). To determine whether
these predicted responses occur, it is necessary
to measure key parameters that reflect the
status of fluid and electrolyte metabolism at
specific times after exposure to weightlessness.
In addition to angiotensin, aldosterone and
ADH, these parameters include cortisol, other
hormones such as catecholamines, and the
major electrolytes, sodium, potassium, chloride
and calcium. Although many of these variables
have been measured in blood samples obtained
during other space flights, estimation of early
changes has not been possible because of
inflight scheduling priorities and constraints.
Prior to Spacelab 1 and this investigation, the
earliest blood draws had been done at 3-4 days
inflight on Skylab. The most dramatic changes
in the adaptive response to weightlessness are
believed to occur in the first hours of a mission.
Early sampling would allow determination of
the sequence of changes, as well as whether
changes are due to a metabolic disturbance or
are adaptive. The primary objective of this
investigation was to measure these select
hormonal and electrolyte components of the
blood as early in flight as possible.
Circulating levels of several hormones
associated with the physiologic response to
stress are increased during space flight (Leach
and Rambaut, 1977). Among the key hormones
associated with the control and maintenance of
normal neuroendocrine processes and which are
thought to be indicators of the body's adaptive
response to space flight are adreno-
corticotrophic hormone (ACTH), cortisol, ADH,
and the catecholamines. Although measure-
ments of many of these hormones have been
made extensively in ground-based bedrest
studies, the only inflight data currently available
on the neuroendocrine changes during the
initial phases of space flight are from four
Spacelab crewmembers.
The primary objective of the
neuroendocrine part of this study was to
measure the changes in neuroendocrine
function evoked early in flight. The lack of such
information has precluded reliable evaluation
of the initiation of the endocrine and metabolic
effects observed in Shuttle crewmembers.
Information about integrated neuroendocrine
function has significance in formulating the
total picture of the crewmen's health status and
in delineating the effects of space flight on the
individual.
PROCEDURES
The general design of this DSO consisted
of blood sample collection at designated time
intervals followed by analysis of the specified
hormonal/biochemical variables using estab-
lished analytical procedures. A total of six
crewmembers on two missions participated in
the study. Blood was collected during preflight
and postflight phases of the missions in
conjunction with scheduled physical examina-
tions. For the first mission, three preflight
samples were collected, and for the second, one
sample was collected. Postflight samples were
collected as soon as possible after landing
(within 2 hours) and on the third day after
landing. Samples for the first mission were also
collected on the tenth day after landing.
Standard venipuncture techniques were
used inflight, with the Inflight Blood Collection
System (Fig. 1). Blood samples were drawn into
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plaintubesor tubescontaining EDTA or heparin
as anticoagulants. They were centrifuged in
Sarstedt separator tubes and stored frozen until
return to the laboratory. Inflight samples were
drawn twice during the first mission and three
times on the second. The crewmembers on the
first were on two different work/rest cycles, and
during flight they collected blood samples
during the postsleep activity period. This was
6:30 or 7:00 a.m. Houston time for two
crewmembers and 5:00 or 6:00 p.m. for the
other two. For two crewmembers, mission
elapsed time for the first inflight draw (MD2)
was 31 hours and for the other two it was 42
hours; mission elapsed times for the second
draw (MD6) were 175 and 185 hours. On the
second mission, blood was drawn inflight at the
end of the work shift, for sample collection
times of 35 (MD2), 82 (MD4), and 130 (MD6)
hours mission elapsed time.
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Figure 1. The inflight blood collection system.
MD2 MD4
Mean SE Mean
Table I
Two Shuttle Missions
Percent Change from Preflight
Mission Day
MD6 MD7
SE Mean SE Mean SE
Plasma hormones
Anglotensin I -50.0 12.5 70.1 18,1 131.4
ADH 719" 157,9 77.1 172.3
A1dosterone -15.0 8.5 -34.5 9.8 -23.9
ACTH 29.2 16.3 62.0 23.1 108,2
Cort_sol 41.2 16.9 -55.6 7.1 -43.7
Serum electrolytes
Na -I.0 1.0 -2.1 2.1 -.4
K -4.1 6.1 -10.8 8.4 2.6
CI -I.9 .9 -3,8 1.9 .5
Ca 1.9 1.5 -3.2 1.1 -5.8
Mg -2.9 1.9 -6.9 2.7 -7,2
CO 2 -6.7 3.7
Creatinlne 2.3 2.3
L+O
Mean SE
L+3
Mean
L+I0
SE Mean SE
18.7 43.5 9.3 201.0 77,7 73.9 26.I -35,1 20.2
70.0 9,6 9.6 .5t 4,3
15.9 -4.3 11.4 37.3 22.4 24,1 11.4 18.9 14.6
30,7 20.6 2.8 32.6 20.4 .3 6.6 32.8 4.3
10.1 27.4 15.4 65.4 25.4 21.2 17.5 82,5 3.2
1.1 -1,1 .9 -.4 .8 .6 .4
6.9 8.8 2.7 -4.9 3.4 -3.6 3,3
.5 -3.1 .7 -.3 1.4 .6 .3
2.6 -I.0 1.2 -1.0 1.0 -5.2 1.3
7.2 -2,3 1.3 -8.3 1.3 -1.3 2.9
1.8
2.8
-6.6
-2.8
-5.3
12.6
,05 3.2
-5.3 3.1
4.0
2.5
1,6 .2
3.1 2.3
2.2 .5
-2.8 .7
-3.4 1,1
-.I 1.9
9.8 4.1
*n=1
tn = 2
n 5 2 2 4 6 6 4
The following variables were measured
by standard clinical laboratory methods:
angiotensin I (Haber et al., 1969), aldosterone
(Ito et al., 1972), ACTH (Vague and Oliver, 1972),
cortisol (Foster and Dunn, 1974), sodium (Tietz,
1976), potassium (Tietz, 1976), chloride (Cotlove
et al., 1958), calcium (Trudeau and Freier, 1967),
magnesium (Trudeau and Freier, 1967), carbon
dioxide (Tietz, 1976), creatinine (Owen et al.,
1954), and ADH (LaRochelle et al., 1980).
RESULTS
The percent change from preflight to
each inflight or postflight time point was
calculated for each crewmember, using the
preflight mean for the first mission and the
single preflight value for the second mission.
Means of these percent changes are presented
in Table 1 and Figs. 2 and 3. Results for the two
flights are combined. Statistical tests were not
done because there were so few samples for
some time points. Some results were highly
consistent.
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Figure 2. Mean percent change in plasma
hormones measured inflight and postflight in
crewmembers. Bars represent standard error.
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Antidiuretic hormone, which unfortunately
could not be measured in some of the samples
because not enough sample was available, was
increased over preflight levels every time it was
measured in blood drawn inflight, but
immediately after landing it had returned to
preflight levels. Angiotensin I was slightly
decreased on MD2 but was increased on MD4
and MD6. Cortisol had an opposite response for
those days. Plasma aldosterone was decreased
on all inflight days, and ACTH was increased on
all inflight days. On landing day, angiotensin I,
cortisol, aldosterone and ACTH were at least
slightly increased. Levels of these four
hormones were lower on day L + 3, but cortisol
and ACTH levels had increased again by day
L+10.
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Figure 3. Mean percent change in serum
electrolytes measured inflight and postflight in
crewmembers. Bars represent standard error.
Serum sodium was decreased throughout the
flights. There was variability among
crewmembers, so that the decrease may not
have been significant on any day. At landing,
serum sodium was close to preflight levels.
Although serum chloride had a pattern similar
9
to that of sodium, it appeared to decrease more
on days MD2, MD4 and MD7. Serum potassium
decreased through day MD4 but increased on
MD6 and MD7 and decreased on L + 0. Levels of
all three electrolytes measured were higher on
day L + 10 than on any other postflight day.
DISCUSSION
Not all of the desired goals were
achieved. Although blood was drawn early, 31
hours still may not have been early enough. The
high levels of ADH were surprising because ADH
had been thought to be suppressed during
space flight, but an early transient suppression
may have been missed. Apparently it is not
effective in preserving blood volume. Secretion
of ADH can be stimulated by the emetic reflex
(Rowe et al., 1979), and this probably caused the
increase in plasma ADH in at least one subject
early in the flight. Another unexpected finding
was that angiotensin I levels increased while
aldosterone was suppressed inflight at the times
measured. The increases in most hormones at
landing were consistent with Apollo (Leach et
al., 1975) and Skylab findings (Leach and
Rambaut, 1977). Cortisol secretion appeared to
have been stimulated by the high levels of
ACTH, which decreased at the same time cortisol
increased above preflight levels.
The blood levels of electrolytes in
crewmembers of these two missions were
consistent with previous results (Leach and
Rambaut, 1977). Electrolyte concentrations
generally decrease early in flight because of the
loss of fluid. The suppression of aldosterone
may have contributed to the mild hyponatremia
observed during weightlessness, since aldo-
sterone generally stimulates sodium retention.
Serum potassium may be increased in space
flight, probably because of a breakdown of
muscle cells, and usually is excreted in urine
samples. The reversal of serum potassium
changes from the last mission day to landing
was quite rapid, and serum potassium remained
low for at least 3 days. Decreased serum
potassium on landing day is characteristic of
crewmembers who have ingested a
physiological saline solution as a counter-
measure against orthostatic intolerance, as the
subjects in these studies did (Leach and Johnson,
1985).
With respect to hormones associated with
the response to stress, the results of these
studies were somewhat different from Skylab
results. Plasma ACTH increased during flight in
the Spa¢elab crewrnembers whereas it
decreased in Skylab; plasma cortisol decreased
during part of the Spacelab flights, but in Skylab
it remained elevated throughout the missions.
The reasons for these differences are not
immediately obvious, but it appears likely that
either the Spacelab crewmembers were not as
stressed as the occupants of Skylab or other
factors were more important in determining the
levels of the hormones measured.
CONCLUSIONS
These results indicate that some of the
hypotheses put forward to explain physiologic
changes during space flight need to be
continually studied. They provide important
evidence that some of the other factors recently
found to participate in fluid and electrolyte
regulation should be measured inflight. Some
of these factors are prostaglandin E and the
atrial natriuretic factor (Leach, 1981; Leach et
al., 1985). The examination of renal clearance
factors and of plasma or serum endocrine/
electrolyte concentrations early (within hours of
weightlessness) will greatly enhance the
understanding of man's physical response to
space flight.
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INFLIGHT ASSESSMENT OF RENAL STONE RISK
FACTORS
Investigator: Nitza M. Cintron, Ph.D.
INTRODUCTION
Nephrolithiasis has been identified as a
potential complication of space flight. Despite
the limited available data, certain metabolic
changes which ensue during space flight
suggest an increased risk for the formation of
renal stones.
Hypercalciuria, believed to be skeletal in
origin, develops soon after space flight begins
(1). The progressive rise in urinary calcium
reaches a peak in 2 weeks and is sustained at
that level thereafter. Urinary phosphate
excretion is also increased during space flight,
probably by the same mechanism. Both of these
imbalances place an individual at an increased
risk for stone formation by increasing urinary
saturation of stone-forming calcium salts
(calcium oxalate and calcium phosphate).
Two other factors which may contribute
to stone formation during space flight are
potassium deficiency and high urinary uric acid
excretion (1,2). The exaggerated renal loss of
potassium may reduce renal excretion of citrate,
a well recognized inhibitor of the crystallization
of calcium salts. To date, no measures of urinary
citrate have been made during space flight.
Urinary uric acid, on the other hand, may be
high due to increased availability of purine
substrate (via muscle degradation or high
protein diet). The resulting hyperuricosuria may
cause a predisposition to uric acid lithiasis or to
calcium nephrolithiasis via monosodium urate-
induced crystallization of calcium salts. The
exaggerated renal loss of sodium may further
promote the latter mechanisms. Additional
factors which may aggravate the potential for
stone formation in astronauts include high
animal protein diets, high levels of exercise, and
varying degrees of dehydration. Substantive
clinical data exists suggesting that excessive con-
sumption of animal protein (high in sulfate and
purine) confers a significant risk for
nephrolithiasis by increasing urinary calcium
and uric acid and by lowering urinary citrate.
!3
Recently, preliminary data from Dr. C.Y.C. Pak
(UTHSC, Dallas) indicate that strenuous exercise
also accentuates this risk by reducing urine
volume, causing acidosis, lowering citrate
excretion, and increasing uric acid excretion.
The primary objective addressed by this
investigation was to evaluate the potential of
increased risk for the formation of renal stones
as a consequence of space flight. This was to be
accomplished by the analysis of 24-hour urine
samples for urinary risk factors such as
hypercalciuria, hyperuricosuria, hyperoxaluria,
and hypocitraturia (3). Where possible, the
urinary supersaturation with respect to stone-
forming salts was to be estimated.
A secondary goal was to compare the
stone-forming potential observed in normal
subjects during bedrest to that observed during
space flight. This would allow preliminary
evaluation of the validity of bedrest as a model
of weightlessness with respect to
nephrolithiasis.
The limited amount of data obtained to
date from a single crewmember (n=l)
precludes the appropriate assessment of the
risks for renal stone formation associated with
space flight. In this regard, the information
presented here must be considered strictly as
incomplete and preliminary.
PROCEDURES
STUDY DESIGN
The investigational design was comprised
of three phases, the preflight control phase,
inflight experimental phase, and postflight
recovery phase. The overall protocol was
identical for all phases and involved the
collection of void-by-void 24-hour urine samples
at designated times as summarized in Table 1.
Both the pre- and postflight urine collection
activities were scheduled in conjunction with
P CF.Di I'PAG : BLANK NOT FII.IM'3D M_tNT[NTIONALL¥ BLANK
the routine crew physicals. Inflight, the
procedure was repeated on a day early inflight
and a day late inflight.
TABLE |. STUDY PLAN AND SCHEDULE
Act|ritz Duration Time
_e:
Data Co]lection 24 hrs. F-]O phystca]
_o:
11ectlons 24 hrs. each Early FD
Late FD
_iect|on 24 hrs. L÷2 physical
The one subject for this investigation was
a male crewmember. Because of mission
operations and schedule constraints, the two
inflight collections were both obtained
relatively early inflight (FD2 and FD4 vs FD2 and
FD7) while the postflight collection was not
obtained at all. In addition, two 24-hour urine
specimens were collected during the preflight
phase as opposed to the scheduled single
collection.
The void-by-void 24-hour urine collection
entailed discarding the first morning specimen
on Day 1 and collecting all subsequent voids for
24 hours, including the first specimen on Day 2.
Because no provisions for inflight refrigeration
are available, all urine samples including pre-
and postflight specimens were stored at
ambient temperature in the presence of 1%
boric acid until time of analysis. Inflight samples
were collected using the Urine Collection
Devices (UCD) flown on every flight as backup to
the Shuttle Waste Collection System (WCS).
After specimen collection, the UCD was sealed
and placed in a ziplock bag. The time of
collection was annotated, and the bag was
subsequently discarded into the wet trash and
recovered during post-landing activities.
C_ pOOR QUALITY:
Figure 1. Urine collection device.
URINE BIOCHEMISTRY ANALYSIS
The specific laboratory assays and
procedures, methods of analyses, and normal
ranges for each parameter of relevance to renal
stone potential measured in the 24-hour urine
collections are detailed in Table 2.
TABLE 2, 24-HOUR URINE BIOCHEMISTRY
POPULATION ASTRONAUT
TEST METHOD REFERENCE NORMAL RANGE NORMAL RANGE
Volume (ml) Volumetric (4) 80D-1800 (M) 760-2500
600-1600 (P) 760-2500
Specific Gravity Refractometry (5) 1.003-1.030 1,010-1.024
Osmolality (mOsm) Freezing Point (6) 500-800 327-900
Depression
Na (mEq/vol) Ion Selective (7) 27-287 23-275
Electrode
K (mEq/vol) Ion Selective (7) 26-123 35-116
Electrode
C1 (mEq/vol) Amperometric Titration (8) 110-250 85-268
Ca (mEq/vol) Atomic Absorption (9) 5.0-40.0 4.0-16.9
Mg (mEq/vol) Atomic Absorption (9) 5-13 5-13
[P04 (mg/vol) Pbosphomolybdate (10) 300-1000 360-1200
Uric Acid (mg/vol) dricase (11) 250-700 375-1182
Creatinine (mg/vol) Alkaline Picrate (12) 1000-2000 700-1900
Oxalate (mg/day) Ion Chromatography (13) 30-60
Citrate (mg/day) Ion Chromatography {14,15) 300-900
Sulfate (mg/day) Ion Chromatography (16) 0-30
pH Bromothymol Blue (4) 4.6-8.0 4,6-8.0
M = Male
F = Female
Ground-based control studies were performed
to determine the effect of boric acid addition
and storage of samples under the conditions
anticipated during a mission. The results
indicated that borate affects certain variables
such as osmolality, creatinine, and pH.
Although these parameters were measured,
they were not considered for the overall
evaluation of results. In addition, due to
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ORIGINAL PAGE IS
OF POOR QUALITY
scheduling and procedural modifications during
urine sample collection and processing in the
preflight activities, the baseline control
measurements of oxalate and citrate were not
obtained. Inflight values were compared to the
established values for the general population.
mission phases, each set separated no more
than 2 days. When compared to their preflight
values, inflight data on a single void basis did
not exhibit the development of trends with
respect to changes in any parameter. As
expected, there was significant variation from
TABLE 3. PREFLIGHT URINARY BIOCHEMISTRY* VOID-BY-VOID SAMPLE ANALYSIS
Preflight
Osy
of
Sample Time
L-34 Days 8:15 8.m,
11:10 8.m,
1:30 p.m.
6:30 p.m.
10:05 p.m.
L-33 Days 3:45 8,m.
7:00 a.m.
L-31 Days 8:56 8.L
10:24 Lm.
12:41 p,m.
2:46 p.m,
4:37 p.m.
0:14 p.m.
8:32 p.m.
9:23 p.m.
10:08 p.m.
L-30 Days 5:48 8.m.
TV Specific Osmo *e No
ml Gravity mosm mEq/TV
41 1,030 1086 4
70 1.030 1105 9
51 1.031 1104 4
138 1.032 1215 25
57 1.030 1108 12
222 1.027 1007 29
142 1.025 1001 18
102 1.023 964 20
306 1.011 403 17
235 1.015 878 18
117 1.026 944 26
164 1.023 876 37
175 1.018 728 27
163 1.019 782 23
06 1.025 1050 16
12 1.026 1090 3
95 1.020 1041 18
eUrine contains 1% boric actd
eeAffactad by bortc 8cid addition and
L • Launch Date
storage
K C1 Ca Mg
mEq/TV mEq/TV mEq/TV mEq/TV
8 7 0.1 0.3
13 13 0.2 0.0
10 7 0.1 0.4
24 22 0.3 1.4
8 8 0.3 0.5
10 17 0.8 2.3
11 22 0.5 1.4
5 21 0.8 0.9
15 22 0.4 0.7
17 20 0.4 1.2
10 16 0.5 1.1
10 24 0.6 0.8
0 20 0.4 0.8
7 19 0.4 1.0
2 13 0.6 0.7
1 3 0.1 0.1
2 10 0,9 1,0
Uric
1P04 Acid
mg/TV q/TV
40 26
05 40
107 18
204 04
75 28
384 106
142 40
54 29
28 43
57 46
110 62
106 79
98 55
108 03
52 30
0 8
71 55
Crest oe
mg/TV
132
197
16B
304
108
390
224
9B
101
140
136
130
118
143
78
1R
144
TABLE 4. URINARY BIOCHEMISTRY • VOID-BY-VOID SAMPLE ANALYSIS
Inflight
METt
*'000
001
002
003
TV Specific
Timl ml Gravity
20:30 78 1.032
0 hr 44 mtn 328 1.016
2 hr 22 min 256 1.011
4 hr 22 min 278 1.010
7 hr Ol mln 303 1.010
11 hr Ol mln 305 1.015
19 hr 11 min 200 1.022
18 hr 11 aim 67 1.025
22 hr 40 mtn 390 1.020
0 hr 30 mtn 250 1.013
O hr 54 min 204 1.021
13 hr 20 min 104 1.014
17 hr 30 min 343 1.011
*Each urine collection bag contained 1 Gram boric acid
**This votd collection after arising at 20:30
Urtc
Osmot? N8 K C1 Ca M0 IP04 Acid
mosm mEq/TV mEq/TV mEq/TV mEq/TV mEq/TV mg/TV qlTV
1202 12 7 13 0.1 0.9 11 1
476 22 13 27 0.9 2.5 177 129
435 20 8 24 0.0 1.3 54 79
385 22 9 25 0.4 0.9 76 51
380 25 5 25 0.8 1.6 133 60
004 45 10 45 1.4 2.0 205 108
044 20 11 30 0.8 2.1 306 38
1005 12 3 11 0.4 0.7 107 11
738 60 10 58 2.3 3.4 337 103
500 25 9 24 0.8 1.1 77 76
737 30 10 26 4.5 2.7 400 47
503 25 O 19 0.7 0.0 224 110
400 17 0 13 0.7 1.4 247 94
Craatt?
mg/TV
239
346
174
127
145
287
364
123
553
188
4S0
227
280
tHisston Elapsed Time
ttAffected by boric acid addition and storage
RESULTS
The values for urine chemistries determined
from single voids collected from one
crewmember during preflight and inflight
phases of one mission are presented in Tables 3,
4, and 5. As mentioned earlier, two 24-hour
collections were made during each of the
sample to sample in all parameters throughout
the collection period. The latter is principally a
consequence of the diurnal variation of
individual parameters and the fluctuations in
void volumes as a result of environmental
influences.
The results of the urine analyses as
standardized to a 24-hour specimen for both
preflight and inflight data are summarized in
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Table 6. Urine volume did not appear changed
in this individual from the preflight control on
TABLE 5. INFLIGHT URINARy BI0OHENISTNY*
VOID-BY-VOID SABLE ANALYSIS
MET'*
Inflight 0O0
001
0O2
0O3
*Each urine collection bac
**Mission Elapsed Time
TV
TIME m]
20:30 78
0 hr 44 min 326
2 hr 22 min 256
4 hr 22 min 276
7 hr 01 min 303
11 br Ol min 305
Ig hr 11 min 20O
18 hr ii min 67
22 hr 40 min 998
0 hr 30 min 250
g hr 54 min 294
13 hr 29 min 264
ll hr 30 min 348
contained I gram boric acid
CITRATE OXALATE
m_/TV mg/TV
71.3 3.8
176.5 8.4
79.9 6.8
59.4 6.7
67.3 5.5
123.0 6.8
66.8 Ii.4
35.3 2.0
204.5 12.8
48.7 5.3
175.4 9.4
117.4 8.0
66.8 7.6
either mission day. A trend to an increased
excretion of calcium, phosphate, magnesium
and uric acid was present. This is consistent with
previous observations made in both space flight
(1,2) and bedrest studies (Pak, personal
communication). Urinary citrate and oxalate
values early inflight were within the normal
range of the general population. Observations
made in bedrested subjects suggest that the
development of hypocitraturia during space
flight, if analogous to the ground-based model,
would develop during the later adaptive phases
of a mission when renal loss of potassium
becomes significant. As seen in Table 6,
potassium excretion did not appear elevated in
the early flight days measured. This observation
is tenuous at best in light of the limited data.
Meaningful evaluation of all other urine
parameters was equally limited due to the low
number of data points available on a subject
"n" of one in clinical parameters known to
exhibit large variations from individual to
individual.
Reliable assessment of the potential for
urinary calculi during weightlessness will
require the further analysis of urinary
parameters and variables in a statistically valid
population size over a wider range of mission
days. The careful measurement of urinary
n_ram_tt=r_ incla,ding ny_late ¢itrate and
r" ........... r ................ , ........
saturation levels with respect to stone-forming
salts, is warranted for inclusion in this
evaluation (3). The importance of identifying
pathogenic factors both of environmental and
metabolic origin to future manned space flights
of long duration are considered significant for
proper safeguard implementation and timely
institution of remedial measures when
necessary.
REFERENCES
1. Whedon, G. D., Lutwak, L., Rambaut, P. C.,
Whittle, M. W., Smith, M. C, Reid, J., Leach,
C, Stadler, C. R., and Sanford, D. D. Mineral
and nitrogen metabolic studies, exp. M071.
In: Johnston, R. S., Dietlein, L. F., eds.
Biomed. Results from Skylab. Wash. D.C.:
Sci. and Tech. Info. Off. NASA. pp. 164-174,
1977.
2. Lutwak, L., Whedon, G. D., Lachance, P. A.,
Reid, J. M., and Lipscomb, H. S. Mineral,
electrolyte and nitrogen balance studies of
the Gemini-VII fourteen day orbital space
flight. The Endocrine Society 29:1140-1154,
1969.
3. Pak, C. Y. C., Britton, F., Peterson, R., Ward,
D., Northcutt, C., Breslau, N. A., McGuire, J.,
Sakhaee, K., Bush, S., Nicar, M., Norman, D.
A, and Peters, P. Ambulatory evaluation of
nephrolithiasis. The Amer. J. of Med. 69: 19-
30, 1980.
IABLE 6. URINARY BIOCHEMISTRY 24 HOUR COLLECTION
M_ssion TV Speclfic Osmo Na K Cl Ca Mg
Phase m1/24 hr Gravlty mosm mEq/24 br mEq/24 Pr)mEq/24 hr mEq/24 hr mEq/24 hr
IP04
m9/24 hr
Uric
Acid
mR/Z4 hr
treat
m9/24 hr
Oxelate
mg/24 hr
Citrate
mg/24 hr
Preflight
F-30
f-33
721 1.02R 1090 101
1435 1.021 696 205
82 96 2.3 6.9 1127 363 1581
77 174 61 8.3 690 479 1115
Intllgnt
MD2
MU4
1666 1.014 505 164
1549 1016 885 166
56 177 4.8 11.0 952 453 1443 45.3 572.9
50 140 9.0 9.5 1294 490 1686 43.1 612.8
16
..
.
.
.
.
10.
Bradley, M., Schumann, G. B. and Ward, P.
C.J. Examination of Urine. In: Henry,
John Bernard. Clinical Diagnosis and
Management, 16th Ed., W. B. Saunders
Co., Philadelphia, Chapter 17, 1979.
Relman, A. S. and N. G. Levinsky. Clinical
Examination of Renal Function. In M. B.
Strauss and L. G. Welt (Eds.), Disease of
the Kidney. Little Brown and Company,
Boston 1972.
Johnson, R. B., Jr. and H. Hoch. Osmolality
of serum and urine. In: Standard
Methods of Clinical Chemistry, S. Meites,
Ed., New York, Academic Press, 5:159,
1965.
Tietz, Norbert W., Fundamentals of
Clinical Chemistry, Philadelphia, W. B.
Saunders Co., 1970.
Cotlove, E., H. V. Trantham and R. L.
Bowman. An Instrument and Method for
Automatic, Rapid,Accurate and Sensitive
Titration of Chloride in Biologic Samples.
J. Lab. and Clin. Med. 51:461-468, 1958.
Trudeau, D. L. and E. F. Freier.
Determination of Calcium in Urine and
Serum by Atomic Absorption
Spectrophotometry. Clin. Chem. 13:101,
1967.
Daly, J. A. and G. Ertingshausen. Direct
method for determining inorganic
phosphate in serum with the
Centrifichem. Clin. Chem. 18:263, 1972.
11. Haeckel, R. The Reliability of a
Mechanized Procedure for the Enzymatic
Determination of Uric Acid According to
Kageyama. J. Clin. Chem. Biochem. 3,
1976.
12. Owen, J. K., B. Iggo, F. J. Scandrett and C.
P. Stewart. The determination of
creatinine in plasma or serum and in
urine; a critical examination. Biochem. J.
58:426, 1954.
13. Robertson, W. G. and D. S. Scurr.
Prevention of ascorbic acid interference
in the measurement of oxalic acid in urine
by ion chromatography. Clin. Chim. Acta
140:97-99, 1984.
14. Tuftegaard-Nielson, T. A method for
enzymatic determination of citrate in
serum and urine. Scand. Clin. Lab. Invest.
36:513-519, 1976.
15. Carr, S. E., et al. Urine citrate by ion
chromatography. Submitted for
publication.
16. Cole, D. E. C. and C. R. Scriver. Microassay
of inorganic sulfate in biological fluids by
controlled flow anion chromatography.
J. Chrom. Biomed. Appl. 225:359-367,
1981.
17
INFLIGHT PHARMACOKINETICS OF ACETAMINOPHEN 
IN SALIVA 
Investigators: Nitza M. Cintron, Ph. D., Lakshmi Putcha, Ph.D., and 
James M. Vanderploeg, M. D., M.P. H. 
INTRODUCTION 
The observation that a wide range of 
physiological and biochemical changes occur 
during space flight suggests that these changes 
may alter t h e  pharmacodynamics of  drugs 
administered to  crewmembers during flight. 
Conventional methods of therapeutic and 
pharmacokinetic evaluation of drugs using 
concentration profiles in the blood are invasive 
and require special technical expertise. These 
methods, therefore, are not suitable for space 
flight applications. In the recent past, salivary 
concentrations of certain drugs were reported 
to  be useful for clinical drug monitoring and 
pharmacokinetic evaluations ( 1 ) .  Since saliva 
sampling is simple and noninvasive, this method 
may b e  successfully employed for 
pharmacok ine t ic  assessment o f  drugs 
administered to  crewmembers during space 
flight. 
The usefulness of salivary concentrations 
for predicting blood levels depends upon the 
detectability o f  drug concentrations in  saliva 
and the consistency of saliva/plasma ratios over 
a wide range of  plasma concentrations ( 2 ) .  
Earlier repor ts  o n  sa l ivary  leve ls  of 
acetaminophen, a commonly used pain relief 
medication, indicate that there is a positive 
cor re la t ion  between plasma and saliva 
concentrat ions,  and t h a t  t h e  saliva 
concentrations are higher than those in plasma 
(3). Preliminary studies conducted i n  the 
investigators' laboratory to  verify the feasibility 
of using salivary drug levels for predicting blood 
concentrations of acetaminophen following 
oral  administrat ion have ind icated that  
therapeutic concentrations of the drug can be 
successfully detected in saliva. The saliva/plasma 
ratio of the drug was consistent and remained 
close t o  1 over a w ide  range o f  plasma 
concentrations dur ing  the  pre- and post- 
absorptive phases of drug dynamics. These data 
suggested that  acetaminophen might b e  a 
suitable candidate for reliable pharmacokinetic 
evaluation and therapeutic drug monitoring 
using salivary drug concentration profiles. The 
widespread use of acetaminophen as a common 
pain medication and its relatively insignificant 
side effects encouraged the use of this drug for 
a preliminary investigation t o  assess the  
usefulness of salivary drug monitoring for space 
medical operations in the future. 
The present investigation constitutes the 
beginning of a comprehensive pharmacokinetic 
characterization of drugs administered t o  
crewmembers during space flight in  general, 
and of acetaminophen as a representative drug 
in particular, by using salivary concentrations. 
The limited inflight data obtained to  date 
precludes the  appropriate assessment o f  
pharmacokinetic alterations associated w i th  
space flight. In this regard, the information 
presented here must be considered strictly as 
incomplete and preliminary. 
Figure 7 .  A crewman poses w i th  the vial 
(floating, foreground) and k i t  used for saliva 
collection. 
PROCEDURES
The investigational design was comprised
of two phases, a preflight control phase and an
inflight experimental phase (Fig. 1). The overall
protocol for both phases was identical and
involved oral administration of the drug and
collection of saliva samples at regular time
intervals for 8 hours after dosing. The details of
this experiment are as follows.
The participating crewmember was
requested to collect preflight control samples
any time between L-30 and L-15 days. Before
initiating the study, the crewmember fasted
from at least one hour before the sleep period
until one hour post-dosing. No drinks were
allowed for one hour before and after dosing.
The crewmember ingested two 325-mg
tablets of acetaminophen with 100 ml of water
followed by a thorough rinsing of the mouth
with an additional 100 ml of water. Saliva
samples were collected at 0.25, 0.5, 1, 2, 3, 4, 5,
6, and 8 hours post-closing. Samples were
collected using a cotton ball placed at the back
of the mouth between the jaws for 5 minutes or
until the cotton ball was saturated with saliva,
whichever was earlier. Constant rolling of the
cotton ball in the mouth facilitated saturation.
Stimulation of saliva secretion was achieved by
chewing on a teflon square for 30-60 seconds
prior to sampling. Saliva samples were collected
and stored in designated sample collection
tubes until they were analyzed.
The concentration of acetaminophen in
each saliva sample was determined later using
an established HPLC analysis method (4).
RESULTS
The saliva concentration-time profiles of
acetaminophen following oral administration
during preflight and inflight conditions in five
crewmembers from three separate missions are
depicted in Figures 2 to 4. It appears from these
profiles that concentration-time profiles of
acetaminophen change significantly during
space flight when compared to their control
counterparts.
Tiible 1. Absorption Parameters of Acetmein_iten
SU6JECT PEAK CQNCEIITRATZON TIME TO REACH PEAK
No. (,uj/ml) (h)
Control [nflight Coatro] [nfllght
1* 9.6 6.4 O.S 1.1 (11)4)
Z 8.9 6.1 O.S 1.0 (11)4)
3 9.8 14.1 0.5 1.0 (1_3)
4 12.6 14.8 O.S <--0.25 (_2)
5 13.0 15.6 O.S <-0.25 (HDZ)
• 1_3 data (Fig. 2A) frem this subject mere inadequate to estimate these pare-
meters.
Preliminary evaluation of the data
collected from all five crewmembers suggests
that significant changes in the absorption phase
of drug disposition occurred, as shown in Table
1, while the elimination of the drug appeared to
be unaffected. The peak concentration of the
drug decreased in two subjects during space
flight and increased in the other three subjects,
when compared to the respective control
values. The time to reach peak concentration
increased in three subjects and decreased in the
other two during space flight. While
intersubject variability in peak concentration
and time to reach the peak concentration was
minimal during the ground-based control
phase, large variations in these two parameters
were noticed between the subjects during
fl ight.
DISCUSSION
Preliminary evaluation of the inflight
results indicated that the degree and
magnitude of the pharmacokinetic changes
observed in crewmembers during flight appear
to be dependent on a number of inflight
variables that could not be controlled or
documented in this study. Some of these
contributing parameters that are unique to
space flight are discussed below.
2O
SUSCEPTIBILITY TO SPACE
MOTION SICKNESS (SMS)
The limited pharmacokinetic data
collected in flight (during three missions)
suggest that there may be a correlation
between the pathophysiological condition of
the crewmember and the disposition changes of
acetaminophen during flight. In one crew-
member who experienced severe SMS
symptoms, the peak concentration of
acetaminophen and the overall disposition of
the drug appeared to be erratic, with an
unexpectedly high peak concentration and
faster than normal elimination. While
experimental artifacts such as contamination of
the first two saliva samples by a residual dose in
the mouth due to inadequate rinsing after
ingestion of the drug cannot be ruled out,
H PlqlFLIGMT
i
(^)
t|
i"
|.
i
|.
TIME CHOUnS)
H PR|FUGHT
\
i J i i
_ 4 e I
(B) Tlue (Nouns)
Figure 2. Salivary concentration-time profiles of
acetaminophen following oral administration
of 650 mg to crewmembers on mission day 2.
symptoms of SMS, such as regurgitation and
dehydration, may also have contributed to the
abnormal disposition of the drug in this
crewmember. Information regarding the
incidence of SMS in other crewmembers was not
available; therefore, a correlation between the
physiological responses to space flight and the
disposition kinetics of the drug could not be
investigated.
MISSION DAY
Among the studies completed so far
during the three missions, two crewmembers
implemented the study protocol on MD2, one
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Figure 3. Salivary concentration-time profiles of
acetaminophen following oral administration
of 650 rng dose to crewmembers on mission day
3.
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on MD3, one on MD4, and the other twice
during one mission on MD3 and 4. On MD2,
both crewmembers had a higher peak drug
concentration and a faster time to reach peak
concentration than during the preflight phase
(Fig. 2). On MD3, the crewmember who had
SMS manifestation showed an erratic
disposition profile of acetaminophen while the
other crewmember had aslower absorption but
a higher peak concentration (Fig. 3).
On MD4, when the physiological
adaptation to weightlessness may have reached
an equilibrium, both crewmembers had a
significant decrease in the absorption of
acetaminophen as indicated by smaller peak
concentrations reached later than during
preflight (Fig. 4). These preliminary evaluations
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Figure 4. Salivary concentration-time profiles of
acetarninophen following oral adrnlnlstration
of 650 rng dose to crewrnernbers on mission day
4.
of the inflight data indicate that conducting the
study on the same mission day may reduce the
large differences in the experimental results.
INTERSUBJECT VARIABILITY
While no significant differences in
pharmacokinetic parameters have been noticed
between crewmembers during preflight control
studies, large differences in the values of the
same parameters between the same
crewmembers have been observed during
missions. These results suggest that the inter-
individual differences in the physiological
response to space flight may cause intersubject
variability of drug disposition during space
flight. In addition, any flight-specific activities
such as exercise and ingestion of SMS
medications like scopolamine may also
contribute to the intersubject variability.
CONCLUSIONS
These limited results of an inflight drug
pharmacokinetics investigation that is still in
progress indicate that following oral
administration of acetaminophen to
crewmembers, the rate and extent of
absorption of the drug are altered significantly.
Earlier reports on acetaminophen absorption
from tablets in ground-based studies indicate
that delayed esophageal tablet transit caused
by either inadequate water wash or supine
position after dosing alters the absorption
profile of acetaminophen in three ways (5).
First, absorption rate is reduced in the first 60
minutes; second, peak plasma concentration is
significantly reduced; and third, the time of
peak plasma concentration is delayed. These
results are similar to the ones observed on MD4.
This suggests that changes in the absorption of
acetaminophen during the flight may have
been affected by the insufficient water intake
reported during the mission. More importantly,
dehydration and weightlessness, two conditions
that prevail during missions, may directly induce
changes in absorption similar to those described
above. Such absorption changes decrease the
effectiveness of acetaminophen as an analgesic
(5). Similar changes in disposition have also
been noticed with scopolamine, an anti-motion
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sickness drug, in crewmembers during missions.
These results are being reported separately.
Changes in absorption of drugs could render
them ineffective or lead to unfavorable
therapeutic consequences when the drugs are
administered by conventional dosing practices
to crewmembers during space flight.
The limited inflight data accumulated
thus far are inadequate for characterization of
the degree and magnitude of the space flight-
induced pharmacokinetic changes because of a
number of interfering variables influencing the
disposition profiles and kinetic parameter
estimates of drugs. While information on some
of these variables (such as mission day) is
available, information about such factors as the
incidence of space motion sickness, ingestion of
other medications during the flight, and the
overall physical and physiological responses of
each participating crewmember to rnicrogravity
are unavailable. A thorough and compre-
hensive evaluation of inflight pharmacokinetics
of drugs can only be accomplished under
controlled experimental conditions, where
some of the factors contributing to the
variability in data can be monitored if not
controlled. When a comprehensive
characterization of observed changes in drug
disposition and of the contributing physical,
physiological, and biochemical factors is
achieved in the future, this knowledge can be
applied to predict the therapeutic consequences
of operationally critical drugs administered to
crewmembers during space flight. This
information will assist in the design and
development of safe and effective dosage
regimens for optimum therapeutic efficiency
and avoidance of undesirable side effects from
drugs administered to crewmembers during
Space Shuttle flights and other manned space
missions of the future.
3. Aditham, C. and Thangam, J.: A
comparative study of saliva and serum
paracetamol levels using a simple
spectrophotometric method. Br. J.
Clin.Pharmac. 14, 107-109, 1982.
4. O'Connell, S. E. and Zurzola, F. J.: A rapid
quantitative determination of
acetaminophen in plasma. J. Pharm. Sci.,
71, 1291-1294, 1982.
5. Charmer, K. S. and Roberts, C. J. C.: Effect
of delayed esophageal transit on
acetaminophen absorption. Clin.
Pharmacol. Ther. 37, 72-76, 1985.
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INFLIGHT SALIVARY PHARMACOKINETICS OF
SCOPOLAMINE AND DEXTROAMPHETAMINE
Investigators: Nitza M. Cintron, Ph. D., Lakshmi Putcha, Ph.D., Yu-Ming Chen, Ph. D., and
James M. Vanderploeg, M.D., M.P.H.
INTRODUCTION
The need for elucidating the
pharmacokinetic changes occurring during
space flight has been widely recognized, but the
technical and operational constraints of
collecting multiple blood samples for such
studies limit their implementation during space
flight. The usefulness of salivary concentration
profiles as an alternate, noninvasive method for
clinical monitoring of certain drugs has been
established (1). The feasibility of such an
application for salivary drug monitoring
depends upon the distribution of detectable
levels of the drug into saliva and establishment
of a consistent saliva/plasma (S/P) ratio over the
entire disposition profile of the drug (2). To
determine the applicability of noninvasive
salivary drug monitoring for pharmacokinetic
evaluation of therapeutic agents during space
flight, three drugs that are frequently used by
crewmembers have been selected for inflight
study - acetaminophen, a relatively innocuous,
common pain relief medication whose dispo-
sition characteristics have been well established,
and a scopolamine/dextroamphetamine com-
bination, an operational medication used for
the treatment of space motion sickness during
missions.
Ground-based, in-house investigations to
establish the S/P ratios of scopolamine have
been conducted in normal subjects. Following
IV and oral administration, scopolamine readily
distributes into saliva with consistent S/P ratios
over the entire disposition profile. In this
preliminary investigation, the pharmacokinetics
of scopolamine/dextroamphetamine following
oral administration to crewmembers before and
during space flight are being evaluated using
salivary concentrations to estimate the
disposition parameter changes of anti-motion
sickness agents during missions.
The limited inflight data obtained to date
preclude the appropriate assessment of
pharmacokinetic alterations associated with
space flight. In this regard, the information
presented here must be considered strictly as
incomplete and preliminary.
PROCEDURES
Participating crewmembers received an
oral dose of 0.4 mg scopolamine and 5 rng
dextroamphetamine in combination as a
Days: Preflight and Onor Before 1402
SANPLENUMBER
TINE POST-DOSING
(.rs)
ake-Up Drug AdministrationI
I I I I I I I I I I I I
1 2 3 4 5 6 7 8 9 10 11 12
Pre O.S 1 1.5 2 4 6 8 10 12 24 30
13
36
I Scopo1antne I
I d-_et_ine l
Figure 1. Saliva sample collection schedule.
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capsule (SMS medication), twice on separate
occasions during ground-based studies and once
during space flight. Saliva samples were
collected at designated time periods for 36
Figure 2. Salivary sample collection kit.
hours as shown in Figure 1, using the cottonball
saliva collection kit designed and developed at
the JSC (Figure 2). The saliva samples collected
during the first 12 hours post-dosing were
divided into two aliquots. Scopolamine
concentrations were determined using the
RPLC-receptor binding assay (3) in one set of the
12-hour samplealiquots. The remainder of the
samples for the entire 36 hour duration of the
study were frozen for later analysis to
determine dextroamphetamine concentrations.
/ H PREFLIGHT
z 400 I O'"O INFLIGHT (MD 0-1)
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Figure 3. Salivary concentration-time profiles of
scopolamine following oral administration of
0.4 mg scopolamine and 5 mg dextro-
amphetamine to a crewmember.
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Figure 4. Salivary concentration-time profiles of
scopolamine following oral administration of
0.4 mg scopolamine and 5 mg dextro-
amphetamine to a crewmember.
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RESULTS
Preliminary results from three crew-
members who participated in the study on two
separate missions have been compiled and are
presented in Figures 3-5. Preliminary evaluation
of the salivary concentration-time profiles
indicated that large deviations in the
concentration-time profiles of scopolamine in
crewmembers occur during space flight when
compared to their ground-based control
profiles. In one crewmember, a significant
decrease in the peak concentration and an
increase in the time to reach peak concentration
were observed, while opposite results were
obtained for another crewmember.
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Figure 5. Salivary concentration-time profiles of
scopolamine following oral administration of
0.4 mg scopolamine and 5 mg dextro-
amphetamine to a crewmember.
The third crewmember repeated the study twice
during the mission, and the changes in both
instances were relatively small when compared
to the results from the other crewmembers.
These preliminary results are summarized in
Table 1. These data indicate that there was a
large intersubject variability during flight, while
preflight differences were minimal.
Table 1. Absorptloa Parameters
of
S¢ogolamlne In Cr_s
Subject No. Peak Saltva Concentration Time to Reach Peak
(pgl=l) Concentr*tton (h)
C0ffTROL IMFLI6HT CONTROL IfLlr_lT
t zz7 zl6 (too-l) 2.o 4.0 (too-l)
as3(mz-3) t.s(mz-3)
2 633 zlz l.o l.s (_o-1)
3 356 690 3.0 3.0 (NDI-2)
DISCUSSION
The limited number of results collected so
far indicate that the absorption of scopolamine,
when administered to crewmembers as a
combination SM5 medication, may be
influenced by the physical and physiological
changes caused by weightlessness during space
flight. However, the degree, nature, and
magnitude of the pharmacokinetic changes
could not be evaluated due to the limited
number of results obtained thus far.
Furthermore, large intersubject variability
caused by a number of experimental differences
such as mission day and concomitant ingestion
of other drugs, in addition to inadequate
sample size, make interpretation of the results
difficult. Some of the flight-specific factors that
may contribute to the variability are discussed
below.
INTERSUBJ ECT VARIABILITY
Scopolamine, being an amine, has a poor
absorption profile in humans when
administered orally (4). In a preliminary
investigation conducted in our laboratories to
evaluate the pharmacokinetics of scopolamine
in normal subjects, bioavailability of the drug
was less than 25 percent of the administered
oral dose. Peak saliva concentrations ranged
between 600 and 800 pg/ml and were attained
in less than 0.5 h after oral administration. The
5MS medication used in the present study is a
combination of scopolamine and dextro-
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amphetamine, both of which are poorly
absorbedfrom the gastrointestinal tract (4).
The less than normal peak concentrations (227
and 356 pg/ml) noticed in two crewmembers
during ground based control studies may be the
result of an absorption interaction between the
two drugs which should be evaluated in
ground-based studies before definite
conclusions can be drawn from inflight results.
The crewmember whose salivary concentrations
were in the normal range during the ground
control study had a significant decrease in the
peak saliva concentration during mission and an
increase in the time to reach peak
concentration. The results obtained from the
other two crewmembers were highly variable.
MISSION DAY
As noticed in a similar study with
acetaminophen, mission day may also influence
the inflight results. This may be due to the fact
that the physiological adaptation to space flight
conditions is a dynamic process, and the degree
and magnitude of these changes may influence
the dynamics of drug disposition differently
depending upon when the study was
performed. The preliminary results obtained so
far are from different mission days which makes
interpretation of the data difficult.
SAMPLE SIZE
Since scopolamine causes dryness of the
mouth in addition to the possible dehydration
caused by SAS, adequate samples were not
recovered for a large number of sampling times,
especially during the absorption and
distribution phases of the drug dynamics. This
sample inadequacy might have resulted in less
than efficient estimation of saliva
concentrations in a large number of samples
collected during the early phases of the study.
Therefore, these results were insufficient for a
comprehensive evaluation.
Preliminary evaluation of these limited
results indicate that while significant changes in
the disposition of scopolamine may occur
during space flight, the degree and magnitude
of these changes have to be evaluated in more
crewmembers before reliable conclusions can be
drawn.
CONCLUSIONS
The limited number of results obtained
with three crewmembers from two separate
missions suggests that scopolamine saliva
concentration-time profiles were significantly
different during space flight when compared to
their preflight counterparts. Absorption of the
drug during the flights appeared to be altered
as indicated by peak concentration levels and
time to reach the peak concentration. Large
intersubject variability, inadequate sample
volumes, and insufficient data make it very
difficult to reliably assess the pharmacokinetic
behavior of scopolamine in crewmembers
during space flight. These intersubject
variabilities may be due to a combination of
contributing factors, such as different physical
and physiological responses of the
crewmembers to space flight, simultaneous
ingestion of other medications, and the
physiological condition of the participating
crewmember on the day the study was
conducted. In addition, the pharmacokinetic
interaction of scopolamine and
dextroamphetamine when administered
concomitantly may influence the disposition of
scopolamine inflight as well as the preflight
study results. All of these factors need to be
evaluated in both ground-based and infiight
studies. These results, therefore, warrant a
comprehensive evaluation of the
pharmacokinetic behavior of SMS medications
with a minimum number of variables that
contribute to the disparity of inflight data. The
results of such a comprehensive evaluation of
SMS medications and other therapeutic agents
for the treatment of pathophysiological
disorders induced by space flight are important
for determining the therapeutic efficiency and
for predicting the incidence of undesirable side
effects of drugs administered to crewmembers
during missions. Furthermore, the results from
the pharmacokinetic and bioavailability studies
during space flight will provide information for
the successful design and development of
effective therapeutic regimens for both short
and long duration missions.
28
REFERENCES
1. Graham, G. C.: Noninvasive clinical
methods of estimating pharmacokinetic
parameters. Pharmac. Ther. 18, 333-349,
1982.
2. Danohof, M. and Breimer, D. D.:
Therapeutic drug monitoring in saliva.
Clin. Pharmacokinet. 3, 39-57, 1978.
3. Cintron, N. M. and Chen, Y.: Quantitation
of scopolamine in plasma and urine using a
combined reversed-phase liquid
chromatography and radioreceptor assay.
J. Pharmac. Sci., Submitted, 1986.
4. Goodman and Gilman: The
Pharmacological Basis of Therapeutics.
MacMillan Publishing Co. Inc., New York,
NY.
29
PRIgCEDINO PAGE BLANK NOT PILMED
SALIVARY CORTISOL LEVELS DURING THE ACUTE
PHASES OF SPACE FLIGHT
Investigator: Nitza M. Cintron, Ph.D.
INTRODUCTION
The complexity of the physiological
response to weightlessness has stimulated
research into identifying biochemical and
endocrine parameters which might provide
insight into the underlying mechanisms
operative in the overall adaptation process.
Available data from earlier inflight and ground-
based studies substantiate the value of
performing correlative studies to evaluate and
assess the neuro-endocrinologic mechanisms
associated with the various conditions of space
flight-induced stress (1-3). As expected, these
investigations clearly indicated the central
involvement of autonomic neurotransmission in
the etiology of stress-related imbalances (e.g.
immunosuppression, motion sickness) and
pointed to the potential of correlating early
changes to hormonal alterations.
Cortisol, under the direct influence of
adrenocorticotrophic hormone (ACTH), is one of
the key hormones associated with the control
and maintenance of normal neuroendocrine
processes and with the response and onset of
stress-related conditions. Plasma concentrations
of cortisol have been found to increase during
space flight (1). However, no data are currently
available on its changes immediately after the
achievement of weightlessness. It is during
these first hours of a mission that the most
dramatic changes are thought to occur as part
of the adaptive response to weightlessness.
The lipophilic and neutral chemical
nature of steroids have been shown to effect
their rapid equilibration into saliva from plasma
by passive diffusion (4). As a result, steroid
concentrations in saliva represent those of the
free fraction in the circulation and are
independent of variations in salivary flow rate.
For cortisol, salivary levels have been
demonstrated to correlate with the free steroid
fraction in both plasma (5) and serum (6).
Recent improvements in steroid immunoassay
and salivary extraction techniques have made
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feasible the routine assessment of adrenal
activity by monitoring cortisol levels in saliva
(7,8). For inflight application, collection of
saliva represents a stress-free, non-invasive
means of obtaining information about adrenal
activity during the early inflight period; many
samples can be collected with a minimum of
disturbance of crewmembers' activities.
The primary objectives of this
investigation were to determine the feasibility
under operational Shuttle conditions of
collecting saliva samples for cortisol analysis
and, more importantly, to examine the key
facets of endocrine function (i.e. adrenal
activity) during the acute and adaptive phases
of space flight as derived from the resultant
cortisol measurements. Information about
adrenal activity and about integrated
neuroendocrine function have significance in
formulating the total picture of the crewmen's
health status and in predicting, in conjunction
with all other available metabolic data, the
possible duration of man's stay in
weightlessness.
PROCEDURES
The general design of the overall
investigation involved the serial collection of
saliva samples throughout a specified 24-hour
period during pre- and inflight phases of a
mission (Figure 1). Saliva collection activities
consisted of collecting 4 samples throughout
each 24-hour period at approximately the same
times ( + 1 hour) during the sleep/activity cycle.
To avoid an interruption of the sleep period, the
first sample was collected soon after wake-up;
the second sample at wakeup plus 5 hours ( _+ 1
hour); the third sample at wake-up plus 10
hours ( + 1 hour); and the fourth sample, shortly
before the sleep period. These operations were
performed once preflight at approximately one
month prior to launch and twice inflight, once
early and once late in the mission. All inflight
P"A_JNTENTIONA[LT BLANI(
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data were compared to preflight baseline data.
A total of 6 subjects were required for
appropriate assessment and evaluation of
results.
Days: Preflight, MD2 and MD6
SAMPLE NUMBER
Waie-up Sleip
I I I I
1 2 3 4
Figure 1. Inflight salivary cortisol sample
collection schedule.
To date, two crewmembers have
participated in this investigation. As scheduled,
four samples were collected from each
participating crewmember at approximately 6-
hour intervals during a 24-hour period about a
month before launch. During flight the
crewmembers collected samples on mission days
1, 3 and 6.
Saliva samples were obtained using the
Salivary Collection Assembly which consisted of
a beta cloth pouch with foam inserts to retain
Sarstedt syringe tubes, each containing a dental
cotton roll (Figure 2). The syringe barrels had a
screw cap on one end and a sliding plug on the
other end into which the syringe plunger
screwed, so that the barrels functioned as tubes
for collection of samples as well as syringes for
retrieval of the samples. Squares of Teflon film
which could be chewed to stimulate salivation
were also stowed in the pouch. Samples were
collected by placing a roll of dental cotton
between the lower teeth and cheek toward the
back of the mouth. The cotton roll remained in
place until it was saturated or for 20 min,
whichever occurred first. The saliva samples
were then stored in the designated tubes for
subsequent analysis.
Figure 2. The saliva collection assembly with
the Sarstedt syringe tubes containing dental
cotton rolls and with the Teflon film squares
used for stimulating salivation. The kit
configuration shown is that used for saliva
collection in conjunction with the Salivary Ac-
etaminophen Pharmacokinetics investigation.
Samples were frozen at -70 ° C as soon as
possible after landing. They were thawed and a
plunger was inserted into each syringe. The
contents of the cotton roll were squeezed into a
50-ml tube which was centrifuged with the
syringe in a Beckman J-6B centrifuge. The roll
was squeezed again so that as much sample as
possible was transferred to the 50-ml tube.
Samples were analyzed for cortisol by the
radioimmunoassay described by Foster and
Dunn (9).
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Figure 3. Preflight diurnal variation of salivary
cortisol for Crewmembers 1 and 2. Samples
were collected throughout a 24-hour period 30
days before flight and cortisol was determined
by radioimmunoassay.
more cortisol than its preflight counterpart. For
this crewmember (Crewmember 1) cortisol
levels on day MD1 were higher than they were
on MD3 (Table), but for the other crewmember
the opposite was true (Table). Since the samples
taken early in the flight were not taken at the
same times of day as the preflight or MD6/7
samples (Table), cortisol levels in the samples
from MD1 and MD3 could not be strictly
compared to those from the other days.
Some of the samples collected by
Crewmember 2 did not contain enough saliva
for detection of cortisol.
CONCLUSION
Salivary cortisol is now considered by
some investigators to give a more accurate
picture of adrenal cortisol function than serum
RESULTS
For both crewmembers the sample taken
late at night (2030 hours) contained the highest
concentration of cortisol (Figure 3). The
concentration had dropped by at least two-
thirds by the next sampling time (0140 hours).
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Figure 4. Comparison of preflight and inflight
diurnal variation of salivary cortisol in
Crewmember 1. The inflight samples were
collected on mission day 6/7.
Only one complete set of inflight samples
in which cortisol could be measured was
obtained. It was collected on Mission Day 6/7.
The graph of cortisol levels in these samples was
almost parallel to the graph of cortisol in the
same crewman's preflight samples (Figure 4);
each of the samples taken on MD6/7 contained
Table. Uiurna| variation of saltv|ry cortts01 before and during
space Hight tn two Shuttle cre.M.embers
Corttsol
MissionUay Time Cre_ember'_E'_J--creM_ember 2
Preflight 2030 .60 2.04
0140 .18 .31
0600 .35 .18
1130 .11 .16
HOl 2245 .5b .31
0330 .28 .22
1'_3 2215 .37 .53
0345 .34 .42
0850 .29 NS*
2200 .16 re +
• )6 2110 .73 NS
0125 .38 N$
0725 .4U NS
1200 .13 N$
• rt$ : sal_ple size not sufficiently large
+NC : not collected
cortisol (7). Results show that saliva can be
collected in zero gravity in quantities sufficient
to measure cortisol. The noninvasive methods
used in this experiment are highly
advantageous for collecting samples frequently
and with minimum disruption of the
crewmembers' other work. The only problems
encountered were insufficient saturation of the
cotton rolls (possibly due to dryness of the
mouth, a common side effect of antimotion
sickness drugs), and ;nad_quate labeling of
some tubes. There mcy alsn he some difficulty
with collection of samples at the same time on
every day of the experiment, because of other
demands on the crewmembers' time. It should
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bepossibleto solvetheseproblemswith further
trainingandcreworientation.
Thepeakin plasmacortisolconcentration
generallyoccursabout0700hours(10),but for
the two crewmembersin our studythe peak
occurredmuchearlier, not later than 2030
hours. This might be due to the strenuous
preflight training schedule. There are not
enough inflight data to draw any conclusions
about the early effects of flight on cortisol levels
in the body or on their diurnal variation, but in
at least one crewmember the diurnal rhythm
was the same after about a week of flight as it
was preflight.
In conclusion, collection of saliva samples
for measurement of cortisol during space flight
appears to provide a feasible approach for
studying change in adrenal function during
adaptation of the body to weightlessness.
Specific information regarding the status of
adrenal activity in the initial phases of space
flight will require additional data for the
appropriate assessment of changes. In this
regard, the current limited data must be
considered strictly as preliminary.
.
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Section Two 
Cardiovascular Effects and Fluid Shifts 
I 
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crewman prepares containers of drinking water and salt tablets A to be consumed by his crewmates prior to reentry. DSO 402 
demonstrated that fluid loading is an effective countermeasure to 
orthostatic intolerance upon return to gravity. Fluid loading is now 
a standard procedure on all Shuttle flights. The device on the 
crewmember's right hip is recording his blood pressure and heart 
rate as part of another DSO. 
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BLOOD PRESSURE AND HEART RATE
DURING ORBIT AND ENTRY
Investigators: William E. Thornton, M.D., and Thomas P. Moore, M.D.
INTRODUCTION
Postflight orthostatic hypotension has
been noted since the Mercury flights and can be
expected after exposures to weightlessness. The
problem is thought to arise from fluid shift and
subsequent fluid loss, from decreased peak
physical loads, and probably from neurological
adaptation. There had been sufficient concern
over hypotension during STS entry to provide
the crew with anti-g suits (AGS). A commercial
blood pressure-heart rate recorder was used in
SMS studies on several missions, and by one
crewrnember during entry with anti-g suit
activation and deactivation.
Figure BP-I. Installation of commercial BP-HR
recorder showing conventional cuff (2), with
microphone (I), over brachial artery and EKG
electrodes (3), used to generate timing and rate
signals. K-sound signals and cuff pressure are
transmitted by cable and tubes (5), to recorder
(4].
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After several near-syncopal episodes on
Shuttle missions following seat egress,
presumed to be orthostatic hypotension, it was
agreed to make a series of blood pressure and
heart rate studies during entry and egress.
Figure BP-2. Record of digital data, generated
by recorder and stored in memory (time, HR,
SBP, and DBP). Other data shown are calculated
from this by the replay unit. The missing line
has been manually deleted for artifacts.
PROCEDURES
The BP-HR recorder was an extensively
tested and used, commercially available,
ambulatory unit modified only to the extent of
decreasing minimum automatic sample time to
35 minute intervals. It used a conventional cuff
_I_.I,_AG_ BLANK NOr FILMED PA_INTENIIONALLT 8LANK
and K-sounds (Rivi-Rocci technique), was
completely automatic, and was capable of
recording and storing up to 200 lines of data
(time, BP, and HR) internally. Equipment
placement is shown in Figure BP-I. Postflight;
these data were transferred to a standard
digital format (Figure BP-2) and plotted by a
companion data reduction unit. Accuracy of the
unit has been examined and reported by a
number of investigators who have used it in
both clinical and aerospace applications. Each
unit was repeatedly checked for accuracy by
simultaneous comparison of its results with
manual determinations made with a calibrated
sphygmomanometer. Mean errors were
typically less than 4 mmHg systolic and 3 mmHg
diastolic.
RESULTS
Blood pressure and heart rate were
obtained with this device pre- and postflight on
Launch -59 days and Return +2 days and
inflight on Mission Day 7 and through entry and
egress on one subject. The records were edited
and artifactual values removed. Results were
then plotted and are shown in Figures BP-3, BP-
4, BP-5 and BP-6.
symptoms which might have been characterized
as orthostatic hypotension had the individual's
BP and HR not been known. The most striking
record was obtained on R + 2, Figure BP-6, when
the HR is above 70 bpm and systolic BP is slightly
elevated except during the period of 1415 to
1520 when systolic BP and pulse pressure
(systolic BP minus diastolic BP) were decreasing
and HR increasing. While there was no diary for
this period, such a BP-HR signature is consistent
with orthostatic stress, possibly caused by
standing. All symptoms were denied during this
period.
In summary, there was little change in HR
and BP during an inflight record. During entry
and seat egress, BP was normal for the situation
with minimal HR changes in spite of being
symptomatic on seat egress. Two days later
there was a persistently elevated (for this
individual) HR and one period consistent with
orthostatic stress but without reported
symptoms.
CONCLUSIONS
The first record, Figure BP-3, was made
during a one-g simulation. BP was
approximately 120/80 and resting HR
approximately 55 beats per minute (bpm). The
inflight record, Figure BP-4, _s equally
unremarkable with lower systolic and diastolic
BP and a low HR in spite of personal
"acrobatics" performed during a portion of the
record. Essentially the same values are seen
during entry preparation with increase in BP
and HR during seat ingress and then an increase
in BP with onset of g-loads and an increase in
and an upward trend of HR, Figure BP-5.
Thirty-two ounces of fluid with 8 gm of
NaCl was ingested prior to entry and the AGS
was worn and inflated to 1 psi. Blood pressure
peaked during touchdown and egress and
systolic pressure remained slightly elevated
during the remainder of the record. It was
during this period that the subject had
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CARDIOVASCULAR DECONDITIONING DURING SPACE
FLIGHT AND THE USE OF SALINE AS A
COUNTERMEASURE TO ORTHOSTATIC INTOLERANCE
Investigators: Michael W. Bungo, M.D., John B. Charles, Ph.D., and Philip C Johnson, Jr., M.D.
INTRODUCTION
Early in the manned space flight program
it was noted that the cardiovascular system
undergoes several adaptive changes when
subjected to the microgravity environment.
Experimentation during NASA's Skylab missions
demonstrated that fluid was shifted from the
lower extremities to the more central and
cephalad portions of the circulation. The results
of this redistribution and of other alterations in
the controlling mechanisms of the circulation
which were not well defined were termed
"cardiovascular deconditioning." The term
deconditioning was felt to be appropriate
because those individuals who were tested
during or immediately after space flight
demonstrated less orthostatic tolerance when
provoked with lower body negative pressure
(LBNP), higher submaximal oxygen
consumptions at equivalent workloads, and
higher resting heart rates when compared to
their responses preflight (12). Numerous
ground-based studies were performed using
water immersion, bedrest, and headdown bed
rest in an attempt to duplicate the
cardiovascular adaptations observed in
microgravity (3,14). Fluid volume shifts had
been quantified, and the time course of events
had been characterized (1). Several methods of
reversing the deleterious effects of
deconditioning were also suggested, such as the
use of anti-G suits (including elastic leotards),
liquid cooling garments, lower body negative
pressure, electrical stimulation of the muscles,
and various pharmacologic agents,
mineralocorticoids being the most prominent
among them (2).
Originally Published in: Aviation, Space, and
Environmental Medicine, October, 1985: 56(10):
985-990.
With the advent of the Space Shuttle, it
was known that astronauts would receive the
effects of reentry deceleration in the + Gz axis
(head-to-toe), compared to earlier space flights
in which these forces were directed + Gx (chest-
to-back). The combination of this more stressful
acceleration loading with the deconditioned
state of the human cardiovascular system
following space flights increased efforts
directed at developing suitable
countermeasures. Most were rejected for actual
use in the Space Shuttle due to either complex
hardware requirements or objections by flight
crews. Even the anti-G suit, considered by many
as the only acceptable alternative at the
inception of the Shuttle program, was not
regarded favorably. Therefore, the
development of other, more suitable
countermeasures to post-space flight
orthostatic intolerance took on greater
importance.
Earlier bedrest studies had revealed the
usefulness of oral rehydration using normal
saline, in the more palatable form of bouillon,
in providing a degree of protection against the
loss of LBNP (10,11) and acceleration (4)
tolerance by expanding the circulating plasma
volume. In one study, six male volunteers
underwent 15 d of bed rest to "decondition"
their cardiovascular systems in a physiological
simulation of weightlessness (11). On each of
the last 3 d of bed rest, each subject was stressed
by LBNP at -50 mm Hg in one of three randomly-
assigned conditions: employing no candidate
countermeasures; having ingested 1 L of
bouillon alone as a countermeasure; or
following ingestion of the bouillon during 3 h
of LBNP at -30 mm Hg, as a combined
countermeasure. The results showed that the
combination of oral rehydration and prolonged
LBNP provided a more sustained increase in
plasma volume and reduction in stressed heart
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rateresponse.However,oral rehydration alone
provided a larger increase in plasma volume and
essentially the same reduction in stressed heart
rate response, but for a period of only a few
ho,ars. Considering the constraints of Space
Shuttle operations, especially the inconvenience
of providing for the appropriate LBNP
treatment of the entire crew during the last 24 h
of space flight, the relatively short-lived
protection of oral rehydration alone was
deemed the superior treatment. Accordingly,
the simple technique of oral rehydration shortly
before reentry into the earth's atmosphere was
evaluated during several Space Shuttle flights.
PROCEDURES
On the day prior to Shuttle landing, all 26
crewmembers were to consume at least 3 quarts
(2.7 L) of fluids as part of their usual meal and
snack routine. This was intended to offset any
dehydration due to low intake during the
period of adaptation to weightlessness, or to
high insensible loss; it was not expected that
this consumption would alter the physiological
adaptation to microgravity.
Preliminary testing revealed that Shuttle
crewmembers found isotonic saline unpalatable
even in bouillon form. Therefore, the crews
were provided with salt (sodium chloride)
tablets (1 g each) and advised to take one tablet
with each four ounces (114 ml) of water
consumed, to a total of 8 tablets and 912 ml of
water. This concentration approximated
isotonic saline. On the day of landing, starting 2
hours before entry into the earth's atmosphere,
the participating crewmember was to begin oral
intake of fluid and salt at a rate dictated by
personal comfort. It was stressed that
regardless of the total fluid volume consumed,
the tablet-to-volume ratio be kept constant as
prescribed. During the interval between 1 and 2
hours after landing, each crewmember's heart
rate and blood pressure responses to a Passive
Stand Test (9) were recorded, for comparison
with their preflight values. During the Stand
Test, the electrocardiogram was recorded
continuously, and blood pressures were
measured each minute for 5 minutes while the
crewmember was in the supine position, and for
5 additional minutes immediately thereafter
while the crewmember was standing The
individualstood with his/her feet six inches (15
cm) apart and nine inches (23 cm) from a wall,
and leaned slightly backwards against the wall
for support. Passive standing had previously
been validated as a test of orthostatic
intolerance (9).
Heart rate was determined from the
electrocardiographic record as the number of
QRS complexes occurring during each 1-minute
interval. Mean blood pressure was calculated as
one-third the sum of the systolic blood pressure
plus two times the diastolic blood pressure. The
average heart rate, systolic blood pressure, and
diastolic blood pressure during the equilibrated
portion of each 5-minute segment of this stand
test were used in all calculations. In addition,
the minute-by-minute group mean values for
heart rate and mean blood pressure were
plotted to illustrate the differences in the
dynamic adjustments of cardiovascular function
before and after space flight, and with and
without the countermeasure. The results were
similar to the averaged data.
A means of estimating the degree of
cardiovascular deconditioning was formulated
which standardizes each individual by his/her
preflight testing response. This Cardiovascular
Index of Deconditioning (ClD) is defined as: ClD
= AHR- ASBP + 6DBP, where AHR = heart
rate (bpm) standing postflight minus heart rate
standing preflight; ASBP = systolic blood
pressure (mm Hg) standing postflight minus
systolic blood pressure standing preflight; and
ADBP = diastolic blood pressure (ram Hg)
standing postflight minus diastolic blood
pressure standing preflight.
The ClD is a unitless index that reflects the
numerical increase in heart rate and decreases
in systolic and pulse pressures resulting from
cardiovascular deconditioning, as documented
in both space flight and bedrest experience (13).
Therefore, as the numeric value of ClD increases,
the response of the cardiovascular system is
greater, and the level of deconditioning (i.e.,
orthostatic susceptibility) more profound
The experiment results were analyzed
statistically using a two-factor mixed design
analysis of variance (one factor between groups,
and one within). The mean steady-state value
of each variable during each 5-minute phase of
the Stand Test, both preflight and postflight,
was analyzed as a separate treatment.
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RESULTS
All crewmembers from the first eight
Space Shuttle flights were considered as the
subjects of this investigation, for a total of 26
data sets from 24 individuals (two individuals
flew twice). Of these subjects, 17 utilized the
countermeasure and 9 did not. The space flights
lasted from 54 hours to 192 hours, and flight
length did not appear to correlate with the
deconditioning parameters examined in this
study.* Crewmembers participated in the study
on a voluntary basis. Those that did not take
the countermeasure did not use other
countermeasures for the Stand Test and were
considered the control population. The
astronauts using the countermeasure consumed
fluid and salt according to personal preference.
Some drank water while others preferred
various on-board beverages, especially fruit
juices. Salt tablets were taken as prescribed or
less than directed but not in excess. The
operational environment in which the space-
borne portion of this investigation took place
made it impossible to control these individual
variations. As a result, the amount of fluid
consumed ranged from 0.5 L of hypotonic
solution to 1 L of isotonic solution. Occasionally,
crewmembers who had used the
countermeasure prior to reentry consumed
additional fluids postflight before the Stand
Test was performed. Because of this pattern of
compliance, any attempt at volume loading
with salt and fluids prior to reentry was
considered a use of the countermeasure.
* Subsequent to this analysis, additional data
were collected which suggested an effect of
flight duration on crewmembers using the
countermeasure, but not on those who did not.
This will be treated in more detail in a future
publication.
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Figure I. Responses of heart rate to orthostasis
pre- and post-spaceflight, with or without
countermeasure (C. M.).
The postflight Stand Test usually took
place during the interval between 1 and 2 hours
after landing. The heart rate responses to the
orthostatic stress are summarized in Fig. 1. Both
groups had mean supine heart rates of 57 bpm
preflight, which upon standing increased to 70
bpm in the control group and 71 bpm in the
countermeasure group. These changes in heart
rate were statistically significant (p < 0.01), and
the responses of the groups were essentially
identical. Postflight, the control group's mean
supine heart rate of 75 bpm was significantly
elevated over the preflight supine value
(p<0.01). Their mean postflight standing heart
rate rose to 110 bpm, a significant increase over
both their postflight supine (p<0.01) and
preflight standing (p < 0.01) values.
In the group utilizing the
countermeasure, the postflight mean supine
heart rate of 64 bpm was only slightly elevated
and increased (p<0.01) to 89 bpm with
standing. The postflight heart rates were
significantly lower in the group using the
countermeasure than in the control group, in
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both the supine (p<0.05) and standing
(p< 0.01)positions.
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Figure 2. Responses of mean blood pressure to
orthostasis pre- and post-spaceflight, with or
without countermeasure.
Mean blood pressure responses to the
orthostatic stand test are summarized in Fig. 2.
The preflight response to assuming the upright
posture was a 6 to 10 mm Hg rise in mean blood
pressure. Postflight, the control group's mean
blood pressure dropped 7 mm Hg when the
astronaut assumed the standing position. In the
group which utilized the countermeasure, the
mean blood pressure rose 2 mm Hg when
changing from supine to upright posture. In
both the control and experimental groups, the
supine mean blood pressure was significantly
higher (p<0.0S) postflight than preflight.
The individual responses to orthostasis
before and after space flight are presented in
Table I. The Cardiovascular Index of
Deconditioning (ClD) was calculated for each
crewmernber and listed in Table II. For those
who did not use the countermeasure, the
average CID was 49.4 + 9.6 S.D. For those
crewmembers utilizing the countermeasure, the
average CID was 21.4 + 15.9 S.D., a significantly
(p<0.003) lower value than for the abstainers.
Of the two crewmembers who had more than
one Shuttle flight, one individual did not use
the countermeasure either time; his CID values
were 45 and 63. The other crewmember did not
use the countermeasure on his first flight (CID =
46), but did use a partial countermeasure on his
second flight(CID = 24).
Of the 26 crewmembers on the first eight
Shuttle flights, 1 suffered an episode of outright
postflight orthostatic syncope, and 2 had
episodes of presyncope. None of these three
individuals had utilized either the fluid loading
or any other countermeasures for the Stand
Test.
DISCUSSION
The use of orally consumed salt tablets
and water has been shown in these studies to
have a beneficial effect on orthostatic tolerance
as measured by heart rate and blood pressure
responses to a post-space flight stand test. The
cardiovascular adaptation to microgravity,
termed "deconditioning," therefore apparently
has fluid redistribution and subsequent
elimination as a significant component.
Nevertheless, employing the countermeasure
did not completely reverse the effects of space
flight. This might be due to inadequate
utilization of the volume loading protocol.
However, given the complexity of the
cardiovascular system's control mechanisms, and
their potential susceptibility to alteration by
space flight factors, it is probably also a result of
other such alterations which are not so readily
reversed. Future basic research will aid in
discriminat ing these factors.
Although not providing the fine
increments of orthostatic stress that a tilt table
or lower body negative pressure device might
generate, the stand test produced reproducible
provocation that was clinically simple to use and
easy to evaluate.
Since the countermeasure was utilized to
various degrees of adherence to the protocol,
the larger spread of CID values in the
experimental group is not surprising, yet the
statistical difference from the control group is
maintained.
The instance of the crewman who used
the countermeasure only after his second and
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longer space flight demonstrates its
effectiveness. The lower value of the CID after
his second flight clearly implies that his
orthostatic tolerance with the countermeasure
was improved over that without the
countermeasure.
The Cardiovascular Index of
Deconditioning is a simplistic reflection of a
complex, as yet unsolved, clinical research
problem. However, this index can be helpful to
those responsible for making operational
judgements with minimal facilities for data
acquisition. Certainly it can serve as an
indication of the obvious clinical effects of
deconditioning.
Oral rehydration using salt and fluids has
also been evaluated for use during Soviet space
flights (8), and is employed in the Salyut space
station program (5-7, 15-17). During the final 1-
3 weeks of their long-duration space flights, the
Salyut crewmen have spent time in their
"Chibis" LBNP garments (5-7, 15-17) to
reaccustom the vasculature of the lower limbs
to blood pooling. Some crewmembers also
drank "15 sips" of water about 20 min prior to
the later LBNP sessions (16), although they
apparently did not take salt, as was done in the
Americal bed rest study (11). On the last day of
flight, the cosmonauts consumed 30 g of salt (in
tablet form) and drank 300-400 ml of water at
each meal (6,7,16,17), in preparation for the
return to earth, sometimes before or during
LBNP exposure (6,7). However, the salt and
water countermeasure is apparently not used by
the visiting crews of the week-long Soyuz
resupply missions, who stay in space for periods
comparable to American Shuttle crews (Jean-
Loup Chretien, French spationaut on Soyuz T-
6/Salyut-7: personal communication).
The ability of an astronaut to perform his
duties during the +Gz forces of reentry is of
considerable concern to the NASA organization.
This is the first time a countermeasure to the
physiologic changes occurring during space
flight has been applied acutely in a successful
manner. In this instance, success is judged by the
Table 1
INDIVIDUAL STAND TEST RESULTS
Subject Time Counter- Preflight
number in flight measure Supine
(hours) yes/no HR SBP DBP HR
1 54 N 61 127 88 73
2 54 N 59 129 76 65
3 54 N 78 118 76 102
4 54 N 54 110 70 71
5 192 N 52 118 80 70
6 192 N 53 tO0 70 65
7 169 Y 57 lIO 68 65
8 169 Y 53 130 80 60
9 122 Y 58 103 65 68
10 122 Y 68 100 60 86
11 lZ2 Y 49 100 67 67
lZ 122 Y 57 tOZ 68 66
13 120 Y 69 109 68 gO
14 120 Y 65 108 63 82
15 120 Y 48 110 69 62
16 120 Y 49 95 50 60
17 146 Y 59 96 60 71
18 146 Y 53 tO0 60 72
19 146 Y 5t 96 60 66
20 146 Y 55 80 60 78
21 146 Y 71 lO0 60 83
22 145 N 52 IOO 60 64
23 145 Y 52 90 60 66
24 145 Y 53 100 58 73
25 145 N 54 98 60 59
26 145 N 52 lO0 60 64
Legend: SBP = systolic blood pressure
DBP = diastolic blood pressure
HR = heart rate
CID = Cardiovascular
Standing
SBP DBP HR
145 92 61
137 86 66
118 76 103
t05 68 80
105 80 77
100 72 77
g8 66 69
118 78 69
112 77 67
107 73 65
117 79 51
110 74 60
120 80 69
120 80 59
118 78 77
110 68 50
120 82 72
rig 76 72
ltO 70 57
90 65 64
120 72 61
112 72 79
113 72 47
110 75 75
110 72 68
118 78 61
Index of Deconditioning (see text)
Postflight
Supine
SBP DBP HR
t20 80 99
140 110 85
t17 75 126
118 82 111
140 84 120
118 82 137
108 78 93
128 84 97
120 88 89
119 75 92
106 60 71
114 56 82
119 80 79
137 88 90
106 62 120
ItZ 57 74
149 101 87
132 96 94
122 79 77
124 92 91
126 80 83
110 70 120
liD 72 82
tOO 73 107
109 78 105
122 83 89
Standing
SBP
110
135
90
118
120
104
100
126
110
110
116
122
109
129
114
113
136
125
116
96
114
105
112
116
112
84
DBP
80
110
82
86
98
70
68
82
9O
80
79
72
86
98
69
77
106
103
80
63
79
72
83
89
72
60
CID
49
46
38
45
53
66
Z8
33
36
10
5
2
8
15
53
ZO
Z4
43
15
5
13
63
28
42
44
41
45
Table Z
SPACE SHUTTLE
CARDIOVASCULAR INDEX OF DECONDITIONING -
INFLUENCE OF SALINE COUNTERMEASURE
With Countermeasure Without Countermeasure
28
33
33
10
5
2
6
15
53
20
24
43
15
5
I
28
42
Z1.4 ±SDIS.9
49
46
38
45
53
66
63
44
41
49.4 ±SD9.fi
Legend: Difference between two CID values is
significant to the p<O.O03 level
CID = AHR - ASP + AOBP (see text)
acceptance and regular utilization of a
technique by the crewmembers, and the
objective demonstration of statistically
significant beneficial physiological effects.
Indeed, this success has resulted in the official
adoption of oral fluid and salt loading as an
operational countermeasure for all Space
Shuttle (rewmembers.
In addition, a clinically useful index, the
ClD, has been developed to assist the flight
surgeon in his assessment of the degree of
deconditioning.
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CHANGES IN TOTAL BODY WATER DURING SPACE
FLIGHT
Investigators: Carolyn $. Leach, Ph.D., L. Daniel Inners, Ph.D., and John B. Charles, Ph.D.
INTRODUCTION
The objective of this experiment was to
measure the changes in total body water (TBW)
occurring in humans as a consequence of
exposure to microgravity.
It was hypothesized that total body water
decreases by about 1.0-2.0 liters within the first
three days of weightlessness and is maintained
at that level for the duration of a 7-10 day
flight.
Fluid shifts occurring during the first few
hours of weightlessness have been identified as
the probable cause of early adaptive responses
of the human cardiovascular and renal/
endocrine systems (3). Fluid shifts have also
been implicated as possible contributory factors
in altered vestibular function. Despite this role
in triggering the response of major pathways of
adaptation, the timing and extent of the
exchanges of water and electrolytes between
compartments is unknown.
TBW measurements are particularly
important to the goal of tracking fluid shifts.
Not only are the overall changes in total water
content of interest, but also changes in
intracellular fluid volume cannot be calculated
without reliable estimates of TBW.
Although exposure to weightlessness has
long been known to affect the distribution of
body fluids, previous measurements of total
body water have been confined to preflight and
postflight periods. Leach and Rambaut (4)
measured TBW pre- and postflight on Skylab
Missions 2, 3, and 4 on a total of nine subjects,
using tritiated water as the tracer. Comparison
of pre- and postflight measurements indicated a
mean decrease of 1.7 % in postflight TBW
relative to preflight. On the other hand, the
ratio of TBW to body mass was observed to
increase slightly in this comparison.
With the development of noninvasive
techniques employing stable isotopes (5), it was
possible to make direct, precise measurements
of TBW at almost any conceivable time during a
mission while making very minor demands on
crew and spacecraft resources. Moreover, these
newer methods are capable of a resolution of
events separated by only three to six hours.
PROCEDURE
SUBJECTS
The subjects for this experiment were
three male crewmembers. Height, age, percent
body fat, and preflight body mass are
summarized in Table 1.
Table 1. Height, body mass. percent body fat, and age for the
three subjects who participated in this experiment. All data
except body mass were recorded as part of the previous annual
physical exam for the crewman. Body mass waS taken from F-33
preflight data.
Subject Height (cm) Body Hass (kg) % Body Fat Age
.............................................
A 178.5 80,6 t4.7 39
B 170.0 68.5 14.2 35
C 177,7 71,9 14.4 43
Subject
A
B
C
Table 2. Body mass of subjects.
F-33 F-3O F-24 F-7 L+O L+3
........................
80.6 8t.2 83.9 B0.6 79.7
88,5 69.6 70.3 67.1 68.9
71.9 72.2 13.5 70.8 71.0
The proposed schedule of the experiment
is summarized in Figure 1. The design included
no special control group or control experiment.
Instead, all inflight and postflight data were
compared to preflight baseline data. Because of
a delay in the launch of the mission and the
unavailability of some crewmembers during the
immediate pre- and postflight periods, the first
preflight measurements were at F-34 to F-30,
while some measurements were missed entirely.
The actual schedule of measurements was as
indicated in Table 3.
I  |NG: BLANKNOT
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Preflight Inflight Postflight
I ........................... I .............. I .............. J
I I I I
F-IO F-5 FOZ FD5
Day Measurements
F-10 TBW and body mass
F-5 TBW and body mass
FD 2 TBN
FO 5 TBW
L+5 TBW and body mass
i
L+5
Figure I. Nominal schedule of experimental
sessions for measurement of total body water.
TBW was measured by the isotope
dilution technique utilizing oxygen-18-1abeled
water (H2180) as the tracer. Briefly, this
method requires the ingestion of a known mass
of 180 water followed by sampling of
representative body fluids such as urine or saliva
over a period of several hours following the
administration of the tracer. The protocol for a
typical measurement is shown in Figure 2. The
measurements were initiated immediately after
a sleep cycle with the crewman in a fasted state.
After the collection of background samples the
dose was consumed followed by at least S0 ml
of fruit juice or galley water. The subject was
allowed to consume a light breakfast 30 min
after dose administration and was requested to
abstain from caffeine-containing beverages for
the duration of the experiment. All food
consumed during the experiment was recorded
on a log sheet
Table 3, Taw Measurements. Total body water tn kg for three
_-em_e_be_, A, 9. and C, on the mission aays lnalcetea. Tnls
iS the unbalanced data matrix used for the general mixed model
analysis of variance.
F-3! FD 4
Hour F-34 F-30 F-3 F0 2 FD 5 L+6
................................
A 47.33 47.87 49.65 44.87 48.82 50.08
3 he 8 40,02 40.19 41.41 43.46 39,20 41.32
C 44.41 47.53 43.74 48.58
A 47.14 49.94 44.38
5 hr 8 40.83 42.01 42.79 41.80 43.4Z
C 41,t8 47.43 44.17 45.71
-10 m 0 h 3 h 5 h 7 h
I ..... I ....................... t .............. i .............. I
I _ I i I
8kg Tracer 1st 2nd 3rd
Semp I e Samp I e Samp I e Samp I •
W,U.&S S U&S U
Figure 2. Schematic representation of a typical
inflight experimental session (U = urine sample,
S = saliva sample, W = galley water sample).
A sample of galley water was collected on
FD 2. The experimental design called for galley
water sampling on all days on which TBW was
measured, since it had been observed on several
previous occasions, including STS 51-D, that
water sampled from the galley was enriched in
180 content. Urine samples collected during
inflight testing of the Urine Monitoring System
on Spacelab 3 also exhibited 180 enrichment.
Dental cotton rolls were used for saliva
collection. All cotton used in the experiment
was from one batch, and rolls were packaged
individually in vapor-tight, 10-ml glass
lyophilization vials (Wheaton) in a single
operation lasting about 30 min. Once closed,
the sample vials were opened only for sample
collection and sample removal. The sample
collection vials were packaged in a Nomex kit
(Figure 3) for inflight use.
5O
/Figure 3. The Nomex dose syringe kit, an
assembled dose syringe, the syringe cap, two
saliva sample vials, and two beverage containers
used to collect Shuttle galley water samples. A
similar, separate kit was used for stowing the
sample vials.
180 water (95-98 %) was purchased from
Mound Laboratories, Miamisburg, OH. The
dose was approximately 6 g. The labeled water
was filtered directly into a sealed, sterile syringe
vial through a nonsterile 13-mm Millipore Type
HA filter (0.45 micrometer pore) using a
disposable filter holder. The syringe used was a
two-piece disposable type manufactured by IMS
(El Monte, CA), consisting of a glass vial
containing the dose and a separate plastic
injector with a lavage tip (Figure 3). This syringe
was weighed three times: empty, filled with the
labeled water, and after use to determine the
dose delivered and the amount remaining in the
syringe (usually about 0.3 ml). Syringes were
stowed in a separate kit similar to that used for
the sample vials. To ingest the dose, a crewman
removed the protective caps, assembled the
syringe, and delivered the contents directly into
his mouth. Used dose syringes were left
assembled with the tips capped and stowed in
an empty food locker.
A test subject collected saliva by placing a
dental cotton roll under his tongue for several
minutes and then replacing the saturated
cotton in the vial. It was determined in
supporting studies that samples could be stored
for over a week at ambient temperature
without affecting isotope content, provided
they were protected from evaporation. Sample
vials were replaced in the original kit and
stowed in a different locker from the used dose
syringes. This precaution was taken to minimize
the possibility of accidental contamination of
the sample vial contents. The samples were
frozen at -70 ° C after being returned to the
laboratory.
The usefulness of the TBW measurement
is greatly enhanced if body mass can be
measured as well, since this enables the
calculation of the TBW to total body mass ratio.
Body mass measurements were obtained on
days F-33, F-30, F-24, F-7, L + 0, and L + 3 (Table
2). Since these measurements were obtained at
three different locations and presumably under
three different protocols, their interpretation is
difficult.
OXYGEN-18 ANALYSIS
Analyses of the samples were carried out
in ground-based facilities of the Stable Isotope
Laboratory at Baylor College of Medicine.
Frozen samples were thawed and
approximately 0.3-0.5 g aliquots were
transferred to preweighed 20-ml Vacutainer
serum tubes using disposable plastic tuberculin
syringes. The tubes were reweighed to
determine the mass of the sample. The tubes
were then filled with 5% carbon dioxide, 95%
nitrogen and equilibrated for 48-72 hours at 25 °
C. The cryogenically purified carbon dioxide
was analyzed using a Model 3-60 Gas Isotope
Ratio Mass Spectrometer (Nuclide Corp.,
University Park, PA). Details of the analytic
procedure and calculation are found in
Schoeller et al. (5,6).
RESULTS
The results of the experiment are
summarized in Table 3. The eight gaps in this
table represent five missing samples, one
sample collected late, and two values which
were spuriously high, perhaps owing to
inadvertent dilution of the sample during
collection. The values in the table are not
corrected for fluid intake during the period of
the experiment.
The data were analyzed according to the
general mixed model analysis of variance,
utilizing BMDP module BMDP3V (BMDP
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Statistical Software, Los Angeles, CA). Subject
was treated as a random variable, while mission
day and sample time were regarded as fixed
variables. Various null hypotheses were tested
to identify the source of the variance. These are
listed in Table 4. In addition, the multiple
comparisons test (1,2) was applied to test for
significantly different means of TBW for the
different phases of the mission. This test is
summarized in Table 5.
No attempt has been made at this time to
make a similar analysis using the ratio of TBW to
body mass.
In agreement with previous observations,
the galley water was found to be enriched in
180, i.e., the enrichment was approximately 40
parts per thousand. The actual ratio of 180 to
160 in galley water was 0.00216, which may be
compared with the ratio observed in normal
surface water, 0.00208. The source of this
enrichment has not been identified, although it
is possibly due to boil-off during ground storage
of the liquid oxygen used in the fuel cells.
Table 5. Wultlple comparisons test for arithmetic means of
test days.
Comparison F
Preflight vs. Inflight 5.145
Preflight vs. Postflight 0.254
InflJght vs. Postflight Z.073
FO Z vs. FD 4,5 1,852
Critical F
p=0.05 p=0.10
6.61 4.06
From Table 5 it is apparent that the
preflight values of TBW are significantly
different from the inflight values at the 0.10
level. The fact that the inflight vs. postflight
means are not significantly different can
possibly be traced to the limited number of
measurements conducted postflight.
It is clear from the foregoing discussion
that additional measurements under similar
conditions are highly desirable. Future
measurements would ideally be made on the
same schedule as was actually obtained on this
flight, even though this schedule departed from
the planned protocol.
Table 4. Results of analysis of variance using the general
mixed model.
Type of
Source of variation factor Chi-squared df p-value
..............................................
Subject random IO.7Zg 1 0.001
Hour fixed Z.538 1 0.111
Day fixed 10,g31 5 0,053
Hour * Day fixed 7.060 5 0.216
Hour * Subject random 0.0 1 0.998
Day * Subject random 9,514 1 0.002
Hour * Day * Subject random 0.0 1 0.998
The analysis summarized in Table 4 was
based on the assumption that the day of
measurement, i.e., the phase of the mission, was
a fixed treatment effect. Under the hypothesis
that this treatment had no effect, the resulting
ratio of variances would be observed with a
probability of 0.053, indicating that day of
observation was a significant factor in
explaining the observed variance. According to
the usual convention of rejecting a null
hypothesis for p-values smaller than 0.05, the
decision to reject was borderline at this level of
probability.
CONCLUSIONS
It was concluded that TBW probably
decreases by about 3% during exposure to
microgravity. On the other hand, the
differences between FD 2 and FD 4,5 were not
significant, suggesting that the decrease had
occurred by the second day inflight. These
tentative conclusions were based on a limited
number of observations on a small number of
subjects, and must therefore be accepted with a
degree of reservation until further
measurements can be made under closely
similar conditions.
1.
.
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HEIGHT CHANGES IN MICROGRAVlTY
Investigators: William E. Thornton, M.D., and Thomas P. Moore, M.D.
INTRODUCTION
Variations in height with position, from
supine to upright and vice versa, and slow
decreases in height from time of arising through
the course of the day have been noted for some
time. Difficulties were experienced by some
crewmen in donning their unyielding space suits
inflight and on the moon.
Changes in height during weightlessness
were first documented on Skylab Mission 4, and
again demonstrated on the Apollo Soyuz Test
Project. Supine and upright height variations
on Earth and the time course of these changes
with and without varying loads have been
investigated by Thornton and others. A series of
inflight studies was also performed on the
Shuttle missions. These studies and experiences
resulted in adding an inch to the spacesuit torso
length.
Results from the studies are consistent;
the intervertebral discs expand or compress with
changing load in a biphasic fashion. There is an
immediate change in height with load followed
by a slower change with a time constant of
hours.
While the magnitude of such changes is
fairly well established for weightlessness, their
time course was unknown; this was studied as
follows.
Table t. Height
PROCEDURES
The barefooted subject was positioned
standing fully erect, back against a wall and
exerting downward pressure with his hands to
ensure maintaining solid contact with the floor,
Figure 1. A square jig was placed against the
wall with its top just touching the subject's
vertex, and an index mark was made on the
wall. Pre- and postflight measurements were
made in a similar fashion and the changes were
measured to 1/16 of an inch.
RESULTS I CONCLUSIONS
The height data for one subject are
tabulated in Table 1 and plotted in Figure 2.
The model proposed by the investigator, and
independently by Kazarian, predicts an
exponential increase in height under flight
conditions. When plotted in semilogarithmic
fashion, all but one of the points follow such a
curve with a time constant (1/e point) of 10
hours.
of Subject CrewmembeP
Height. in,
Preflight Inflight* Postflight
02:40 04:20 08:00 23:30 29:30 50:32 73:30 R+1.5 h
71.5 72.00 72.50 72.50 72.75 73.00 73.00 73.00 71.5
.5 1.0 1.25 1.5 1.6 1.5 1.5 0
% (.70) (1.40) (1.75) (2.10) (2.10) (2.10) (2.10)
*MET - Mission Elapsed Time
 AG'E. NOT
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be statistically significant. Should it ever
become necessary to accurately allow for such
changes, as in equipment design, prediction
procedure might be developed by studying the
...... _,v,, v ...... ,_,,_ _v one-g _,,a,,_ ,,, _,,_
same subject from a suitable population; if a
consistent relationship were found, the flight
value could be predicted from one-g changes.
Figure 1. Sketch of inflight height
determination. Level of mark above floor was
measured and recorded.
COMMENTS
This was the first opportunity to follow
the time course of these changes in
weightlessness and the results were consistent
with the theory of the phenomenon. The
absolute value of observed change was 1.5
inches.
It would seem reasonable to extend this
measurement to a population large enough to
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73.5 - Launch Inflight Landing
J_
T
73.0
72.5
72.0
71.5 B
• Height
71o I I I
L-10 02:00 04:00
I I I I I J
06:00 08:00 20:00 50:00 80:00 R*0
Time
Figure 2. Pre-, in-, and postflight height changes for one subject. Note that time was truncated
between 08:00 and 20:00.
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INFLIGHT AND POSTFLIGHT FLUID SHIFTS MEASURED 
BY LEG VOLUME CHANGES 
Investigators: Thomas P. Moore, M. D., and William E. Thornton, M. D. 
Figure 1. Shuttle crewmembers taking plethysmograph measurements. 
INTRODUCTION 
Signs and symptoms secondary to  fluid 
shifts in weightlessness were among the first 
physiologic effects noted i n  the  manned 
spaceflight program. These effects included 
puffy faces, nasal congestion, inf l ight  and 
postflight weight loss, orthostatic hypotension, 
cardiovascular changes and the "bird legs of  
space"(1). The headward shift of body fluids, 
both intravascular and extravascular, results 
from the absence of  the  l-G hydrostatic 
gradient. 
Measurement of changes in leg volume 
were made pre- and postflight on Apollo 16 and 
17 and subsequently on Skylab 2, 3, and 4 by 
Hoffler et. al (3). The volume measurement was 
accomplished by using a modification of a 
measurement system fo r  f i t t i n g  support 
stockings. Single-point calf girth measurements 
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were also done inflight on Skylab 2, 3, and 4. 
The postflight leg volume measurements made 
on these missions were late in  the recovery 
period after the return of fluid was largely over. 
The inflight calf measurement was subsequently 
shown not to  be characteristic of the entire leg 
volume, and hence neither the time course nor 
magnitude of the changes were appreciated. 
On Skylab 4, inf l ight  changes in  leg 
volume were documented using a tape measure 
system. The results showed volume losses of  
several liters from the legs (5) .  This data 
provided the  i n i t i a l  g r o u n d w o r k  f o r  
formulation of  a basis of  understanding o f  
postflight weight loss, orthostatic hypotension 
and other observed space flight phenomena. 
A repeat of the leg volume study was 
performed on the Apollo-Soyuz Test Project 
(ASTP) which confirmed the volume changes but 
raised questions on the time course of the fluid 
shifts (2). While these studies answered a 
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fundamenta l  quest ion rega rd ing  t h e  
approximate magnitude of fluid shifts, many 
significant details remained unknown, including 
the time course during launch and recovery, the 
volume distribution as a function of time, and 
the volume and distribution during orthostatic 
stress. 
On the third Skylab mission, SL-4, the first 
infl ight volume measurement was made on 
Mission Day 3 (MD-3). From this data i t  was 
concluded that the major volume change had 
occurred prior to  the MD-3 measurement. On 
the ASTP one crewmember was able to  obtain a 
measurement at a Mission Elapsed Time (MET) 
of 06:OO hours. This value reflected only a 
portion of the shift observed to occur during the 
subsequent in f l ight  measurements which 
started at 32:OO hours MET. From the ASTP data 
the investigators hypothesized and concluded 
that the major shift o f  fluid volume from the 
legs did not occur in the first few hours of  
orbital exposure; rather, the time course of the 
fluid shift was likely t o  assume an exponential 
form with maximal rate of decrement within 
the first 24 hours and a distant plateau evident 
by 3 to  5 days. 
PROCEDURES 
The methodology used for these studies 
was tedious and time consuming. There was no 
opportunity for repeat studies until the Space 
Shuttle became operational. Other methods of 
vo lume determinat ion ,  such as w a t e r  
displacement, are impractical in the weightless 
environment of  space or are logistically difficult 
and time and equipment intensive. A simpler, 
much more rapid scheme for obtaining volumes 
was therefore devised and resulted in  the 
stocking plethysmograph used dur ing the  
Shuttle program (Fig. 2 ) .  This scheme was 
routinely used on several Shuttle flights (Fig. 1). 
lnflight data from early Shuttle missions was 
obtained at 11:OO and 13:OO hours MET (4). The 
conclusion from these data was that by the time 
of these measurements the fluid shift from the 
legs was essentially complete since later inflight 
measurements showed no further significant 
leg volume loss. Therefore, this experiment was 
designed to  obtain data during the critical early 
on-orbit time frame as well as throughout the 
mission, in order to define and delineate the 
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t i m e  course and h o p e f u l l y  t o  f u r t h e r  
understand the dynamics of the fluid shifts. 
Figure 2. The stocking plethysmograph. 
The measurement of  body segment 
volumes presents problems since they are 
irregular and compressible. The stocking 
plethysmograph employed the use of  direct 
girth-length measurements. From a series of 
circumferential measurements, volume was 
calculated under the  assumption t h a t  a 
truncated cone represents a reasonable 
approximation of a leg volume segment. Using 
the formula for the frustum of a cone, V =  
n L / 3 ( R 1 2 + R 1  R 2  + R z 2 ) ,  t h e  volumes o f  
individual leg segments were calculated. Leg 
girths were measured to  the nearest 5mm and 
the volume derived for each volume segment 
w i t h  t o t a l  vo lume d e t e r m i n e d  by t h e  
summation of these volume segments (Fig. 3) .  
This assumption represents the first source of  
error in  this method since the human leg is not 
shaped as a perfect cone. However, with the 
number and location of the volume segments 
used, this error was minimized. Another 
potential source of error existed in reproducing 
vertical location of the measuring tapes over 
successive measurements.  Nonelast ic 
longi tud ina l  tapes were used t o  ensure 
consistent ver t i ca l  l o c a t i o n  o f  t h e  
circumferential measuring tapes. 
V: : WVo VOLUmK _q_ROWIILtTIGN,
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Figure 3. Volume approximation, stocking
plethysmograph.
Physiological and anatomical factors
produce a series of potential errors. Changes in
relaxation or contraction of muscles and the
anatomical position of leg segments will
produce volume changes. Changes in body
position as one moves from the supine to the
standing position cause minor shifts in tissue
volume and subsequent volume changes.
Similar changes in tissue shapes and volumes are
induced when going from 1-G to the
weightlessness environment.
These potential sources of errors were
realized and, insofar as possible, were examined
or controlled. It was decided to anatomically
divide the leg into 7 volume segments, 3 above
the knee, 3 below the knee and 1 including the
knee. Therefore, the stocking plethysmograph
utilized 8 circumferential measuring tapes.
Specific anatomical landmarks and locations
were used for the determination of position of
the 8 circumferential tapes. Eight different
colored pens were used to mark the
circumferential tapes and record the mission
elapsed time (MET) directly onto the stocking.
Each circumferential tape was then measured
upon return from flight.
A large effort was put into the design,
selection of materials, and design testing of the
stocking plethysmograph. Due to limited
development time for the first flight of the
stocking, a plastic marking window was used. It
was found that it did not produce uniform
friction on the measuring tapes, introducing
significant errors in measurements, A uniform
and consistent metal marking window was then
designed and used on subsequent missions.
A series of repeatability and validity tests
was run, comparing the stockings to a tape
measure. For repeatability, multiple tests of 5
on and off repetitive measurements were made.
The standard deviation of the circumference
measurement of the stocking was .25 cm versus
.36 cm for the tape measure. The average
difference between the stocking measurement
and the tape measure was +.27 cm for the
stocking method. In looking at the vertical
variation of the location of the 8 circumferential
tapes, a standard deviation for repeated
measurements of .50 cm was found.
When comparing the stocking method
versus the water displacement method, a mean
difference of + 380 mls was found for the
stocking method. This was believed to be well
within acceptable limits taking into account the
compressive effects of hydrostatic pressure
associated with the water displacement
method.
RESULTS
The leg volume changes from the Shuttle
Program with comparison to Skylab and ASTP
are illustrated in Table 1. Volume
determinations were made on subjects on S
different Space Shuttle flights. Two of the
subjects made measurements on 2 separate
Shuttle missions as indicated. Over 140 inflight
measurements were made. The inflight
volumes, illustrated in the table, reflect the
mean of all measurements made during the
missions except for early-on-orbit
measurements (Mission Day 1) made on 3
subjects on two separate missions. These
measurements were not included because they
reflect volume determinations made during the
time periods of active shifting of fluids from the
legs (launch position). The data for these three
subjects are presented in Tables 2 to 4 and
Figures 4 to 6.
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Table 1. SUMMARY OF LEG VOLUME CHANGES FOR THE SPACE SHUTTLE PROGRAM, SKYLA8, AND ASTP
PREFLIGHT INFLIGHT INFLIGHT LANDING LANDING POSTFLIGHT
TOTAL VOLUME PERCENTAGE VOLUME PERCENTAGE VOLUME
VOLUME (mt) CHANGE (ml) CHANGE CHANGE CHANGE CHANGE
SHUTTLE CREWMAN A (1) 8,549 952
SHUTTLE CREWMAN B 7,735 962
SHUTTLE CREWMAN C 9,003 1,069
SHUTTLE CREWMAN D . 8,227 860
SHUTTLE CREWMAN E 9,028 1,116
SHUTTLE CREWMAN F (2) 10,612 1,790
SHUTTLE CREWMAN G 8,656 1,096
SHUTTLE CREWMAN H (1) 8,422 685
SHUTTLE CREWMAN J(2) 10,540 1,164
SHUTTLE CREWMAN K 8,011 855
SHUTTLE CREWMAN L 7,560 740
MEAN 8,758 1,026
SKY LAB 7,679 931
ASTP 7,957 803
POSTFLIGHT
PERCENTAGE
CHANGE
11.1 229 2.7
12.4 439 517
11.9 380 4.2 305 3.4
10.5 370 4.5 291 3.5
12.4 517 5.7 394 4.4
.16.9 951 8.0 714 7.0
12.7 326 3.8 337 3.9
8.3 200 2.4 88 1.0
11.4 + 89 + .8 43 .4
10.7 597 7.5 402 5.0
9.8 119 1.6 30 .4
11.6 381 4.3 283 3.2
12.2 574 6.6 312 3.2
10.0 477 6.0 387 4.9
(1) (2) - INDICATES THE SAME CREWMEMBER ON DIFFERENT MISSIONS
The volume change and percentage change are
all compared with the preflight volume
determinations. The landing measurements
were made within 1.5 hours of touchdown. The
postflight measurements were made during the
first week postlanding through recovery plus 6
days (R + 6). It should be noted that the 1-G leg
volume measurements for Skylab and ASTP
were made with the crewmembers in the supine
position, whereas the measurements in the
Shuttle program were made with the
crewmembers standing. When going from
standing to supine, there is a shift of
approximately 300ml of blood out of the legs.
Table 2 SEGMENTAL LEG VOLUME CHANGES FOR SHUTTLE CREWMAN G
INFLIGHT
PREFLIGHT MD I MD 2-7 FOSTFLIGHT
(='1=23) (n=)) (n=8) (n=3)
(Volume) S02S ml 4867 ml 5440 mt
5655 ml
ABOVE (v_ Change) -531 -7M o216
KNEE
65 3% {% Ch&ngc) 11 t % t4 0% 3 8%
OF TOTAL
(Volume) 2825 ml 2_93 ml 2579 ml
3OO0 m_
BELOW (Vol Change) - t75 - 317 - 121
KNEE
34 7% (% Char_le) 5 8% tO 6% 4 0%
8654S ml 78S0 ml 7560 ml 8319 mi
TOTALS (Total Volume
Chan9e) - II06 - 1096 - 337
(Tota_ %
Change) 9 3% 12 7% 3 9%
This should be recognized and taken into
account when comparing the data from these
different space flights. There was an average
inflight shifting of 1026ml, or 11.6% per leg.
This compares with the Skylab findings of 93 lml
and 12.2% and ASTP of 803ml and 10%.
Landing volume determinations showed a mean
decrease of 381ml or 4.3%. Postflight
measurements taken at various times from
recovery plus 1 day through 1 week post
recovery show a residual volume decrement as
compared to preflight of 283ml or 3.2%.
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Figure 4. Leg volume changes for Shuttle
crewman G.
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INFLIGHT
PREFLIGHT MD 1 MD 2-7
(..9) (n.S) ¢n.4)
(Volume) 4402 he; 4,N0 m4
5656 mi
(VOl Change) -442 -S44
605_ |_4_) 91",4 11.F,6
OF TOTAL
(v_ume) 2@57 ml ;qlS6 ml
(VOl Chlm_) -210 -31!
395% (Y, Change) 6.6'_ 9._
801 t ml ?3Hm_ 71S4m_
|ToU_ V_umQ
C.hJng4,) - 6S2 - IISS
(ToU¢ %
Ch4)nge) 8.'Y)4 10.7%
POSTFUGHT
(n .li)
4S75 nd
-;Nm
5 6_
)034 ml
- 133
4 2_I,
7SOB nd
- 402
50"4
Tables 2 to 4 and Figures 4 to 6 show the leg
volume changes in the 3 crewmembers who
wore the stocking plethysmograph during
launch and were able to make a series of
measurements during Mission Day 1 (MD1).
Figures 4 to 6 illustrate the time course of the
volume changes throughout the missions as
compared with the mean of preflight
measurements. The measurements represented
are: one taken 4 hours prior to launch, five
inflight volumes during MD1 (represented by
mission elapsed times [MET] on the graph),
those taken on MD2 through MD7, one taken at
recovery, and those made postflight through
the sixth day after landing.
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Figure 5. Leg volume changes for Shuttle
crewman K.
The leg volumes in Tables 2, 3 and 4 are broken
down into above- and below-knee values and
percentages along with the relative changes
inflight and postflight in these two regions of
the leg. The mean MD1 volume change ranged
from a decrease of 573ml (7.6%) in Subject L to
806ml (9.3%) in Subject G. MD2-7 volume
decreases were also greatest in Subject G of
1096ml or 12.7%, with the lowest being 740ml
or 9.8%. All of the crewmembers exhibited
significantly greater absolute volume changes
as well as relative percentage changes occurring
above the knee as opposed to below the knee.
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Figure 6. Leg volume changes for Shuttle
crewman L.
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The postflight residual volume decrement
ranged from 30ml (.4%) to 402ml (5.0%).
The mean data of the 3 crewmembers (G,
K, L) are presented in Table S. Again,
breakdowns of the total volumes above- and
below-knee are illustrated for the preflight,
inflight and postflight leg volumes. For these
two regions, the volume, volume change from
preflight, percentage of the total volume
change that comes from that region, and the
absolute percentage change along with the
total change are shown. There was an average
MD-1 volume change of 677ml or 8.4% and a
MD2 through MD7 change of 897ml or 11.1%.
An average 619ml or 69% of this volume change
came from above the knee or the thigh with
only 287ml or 31% arising from below the knee.
There was a postflight volume decrease of
257ml or 3.2% as recorded during the first week
postflight.
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DISCUSSION
The inflight volume changes found in the
11 subjects from the Shuttle program
demonstrated a mean volume change of 1026ml
or 11.6% with a range from 1790ml or 16.9% to
685ml or 8.3%. The majority of the subjects had
a 10% to 12% volume change. This compares
with the 12.2% from Skylab and 10.0% from
ASTP. The source of this leg volume change is a
relatively rapid shift of blood followed by
interstitial fluid and probably intercellular fluid,
with some tissue loss secondary to muscle
atrophy. It should be noted that one
crewmember (Subject F, J) had a significantly
larger volume change on his first flight (1790ml,
16.9%) than the mean, and also the volume
change of his second flight was considerably
smaller than the first (1164ml, 11.4%). There is
no good explanation for these findings. No
procedural or experimental error was identified,
and the same stocking plethysmograph was
used on both flights. The crewmember did
experience Space Motion Sickness symptoms on
both missions. He related that he believed his
level of hydration was the same for both flights;
however, there was noted a greater weight loss
on his first flight (11 Ibs. versus 7 Ibs. for the
second flight). The three crewmembers from
whom data were obtained shortly after launch
and throughout MD1 provided valuable
information concerning the dynamics of the
fluid shift. The actual fluid shift is complicated
by the prelaunch position of lying on one's back
in the spacecraft with the legs elevated for up to
2 hours prior to liftoff. The crewmembers
universally commented that they believed this
position is a stimulus to shifting of fluid prior to
launch because of noted bladder distension and
the common need to urinate while still on the
launch pad. Another environmental stimulus to
the fluid shift is the increase in G forces
encountered during the launch profile. As
stated, the crewmember is positioned on his
back at T-zero; then, as the Space Shuttle
rotates to an inverted position shortly after
clearing the launch tower, the crewmember is
also rotated to an inverted position. While in
this position throughout the launch and entry
profile, +G forces are exerted and reach a
maximum of 3.4 G's during the approximate 8
minutes prior to main engine cut-off, orbit
insertion and weightlessness. Taking into
account these factors, the total volume curves
show a logarithmic decrement for
approximately the first 6 to 10 hours on orbit,
after which there appears to be a plateauing
with slight downward slope, with some
variability in the daily measurements. The
variability may be related to circadian rhythm
variations. This is not consistent with the ASTP
data, where a subject showed only a 260 ml
change from his launch minus 1 day volume at
an MET of 0600 hours, reflecting only a 30%
shift of his mean total inflight volume reduction
of 900 ml. The repeated measurents of these
three crewmembers at the various time intervals
on the two missions gives one more assurance of
accuracy. Of great interest is the source of shift.
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The reduction in leg volume is notevenly
distributed,with the mid-thigh losing more
than 12%of its volumeversus9.4%from the
lowerleg. Whenthemuchlargervolumeof the
thighisconsidered,the importance of the upper
leg can be appreciated; e.g., more than twice
the volume was removed from the thigh versus
lower leg (619 versus 278ml- see Table S).
Possibly of more interest than this removal is the
replacement of fluid upon return to earth and
the gravity environment. Landing and
postflight data from Table 1 shows the inflight
reduction in leg volume was not totally restored
following landing and postflight. However, it
does appear that the majority of volume return
was complete within 1.5 hours after landing.
On the Shuttle crewmembers there was a
reduction of 381ml or 4.3% 1.5 hours after
landing and 283ml or 3.2% postflight. Skylab
and ASTP had higher landing volume reductions
and similar postflight reductions. This
phenomena was previously observed and the
assumptions are that (A) fluid redistribution
under 1-G is more rapid than loss in
weightlessness (such an assumption is consistent
with the difference in driving forces), and (B)
the remaining volume deficit is lost tissue due to
atrophic changes from deconditioning. As
noted, there is considerable variation between
subjects which could reflect variations in weight
loss. No consistent and reliable prelaunch and
landing crewmember weights are recorded.
However, in personal conversations, the
crewmembers usually note a 3 to 7 pound
weight loss during the missions.
Because of medical confidentiality, it is
not indicated on Table 1 which crewmembers
experienced symptoms of Space Motion Sickness
(SMS). However, it may be reported that 7 of
the 11 subjects did experience SMS. There was
no difference in the leg volume change in those
with SMS (11.6% change) when compared to
those without SMS (11.7% change).
CONCLUSIONS
This was a study of the inflight and
postflight leg volume changes associated with
spaceflight. The results of this study show that
there typically is an inflight volume change of 2
liters in the lower extremities, 1 liter from each
leg. The vast majority of this change appears to
be a shift in body fluids, both intravascular and
extravascular. The fluid shift occurs rapidly on
Mission Day 1 (MD-1), being essentially
complete by 6 to 10 hours. The regional origin
of shift and leg volume change shows that a far
greater absolute volume and percentage of the
total change comes from the thigh as compared
to the lower leg. Postflight, the return of fluid
to the lower extremities occurs rapidly with the
majority of volume return complete within 1.5
hours postlanding. There is a residual postflight
volume decrement that is probably due to tissue
loss secondary to atrophic deconditioning and
weight loss.
.
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INFLIGHT HOLTER MONITORING
Investigators: Michael W. Bungo, M.D., and John B. ChaHes, Ph.D.
INTRODUCTION
The incidence of cardiac rhythm abnor-
malities during Space Shuttle Extravehicular
Activities (EVAs) is about 40% in individuals who
do not exhibit such abnormalities during
equivalent preflight stresses. It was
hypothesized that some aspect of the space
flight EVA environment was the instigating
factor. Potential candidates included: a
physiological response to microgravity
(including fluid volume loss due to diuresis
and/or vomiting; uncorrected electrolyte
imbalance due to diuresis and/or vomiting)
which is detected only during EVA due to the
lack of ECG information during other flight
phases; a response to the EVA workload; a
response to the EVA environment of pure
oxygen at 4.3 p.s.i.; a response to other
environmental factors, such as low humidity.
Strenuous activities during previous U.S.
manned space flights did not produce
equivalent frequencies of arrhythmias, for
reasons that are unknown. Therefore, efforts to
document the current phenomenon are
considered of operational importance.
PROCEDURES
Baseline responses to treadmill stress
testing were recorded during the physical
exams. In addition, the subject wore a Holter
recorder for 24 hours at some time during the
preflight period.
Training included maintenance and use
of a Holter recorder, familiarization with the
5TS onboard treadmill and its accessories, and
familiarization with the Operational Bioinstru-
mentation System ECG harness assembly.
As planned preflight, the proposed test
procedures were to be as follows: During the
last 24 hours inflight, the subject was to
instrument himself with ECG electrodes, attach
and activate the Holter recorder, and go about
his normal activities. During this period, he was
to don the Operational Bioinstrumentation
System (OBS) harness, mount the treadmill, don
the bungee restraint cords, and "stand" quietly
on the treadmill for 5 minutes. He was then to
exercise at 70-85% of his maximum heart rate
for a period of about 30 minutes. Following the
exercise period, he was to remove the OB5
harness, stow the treadmill, replace any ECG
electrodes loosened by sweat, and resume his
normal daily activities.
The subject was to continue wearing the
Holter recorder through deorbit preparations,
landing, seat egress, and arrival at the medical
facility for post-flight testing.
FLIGHT EVENTS
The subject attempted to perform the
experimental protocol exactly according to the
Medical Check List; however, because of real-
time changes in the flight timeline and minor
equipment malfunctions, the events are
summarized as follows.
The Holter Monitor was placed as
appropriate on the morning of the treadmill
run. The treadmill test was begun according to
established procedure. At the end of a twenty
minute treadmill run, it was noted that the
Treadmill Data Recorder was not functioning,
and the recorder was recycled and began
functioning correctly. Thirteen additional
minutes of exercise were performed. Treadmill
speed was approximately 2.5 m.p.h, during the
duration of the run. After 9-10 minutes of
exercise (a heart rate of 130-135 b.p.m.) it was
noted that the pulse meter was not tracking
well and the subject voluntarily increased his
work load to 150-155 bp.m. for the remainder
of the thirteen minute exercise period. At the
end of that flight day it was noted that the
Holter Monitor had jammed and most of the
data had been lost. A backup Monitor was
donned and worn for the remainder of the
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particular environmental conditions unique t o  
EVA. Further investigations are suggested. 
Figure 7 .  Subject performs an inflight treadmill 
stress test. 
flight (shut off for a period of time because of a 
delay in landing) which included the entry 
profi le. In all, 22 hrs. o f  recording were 
obtained on the inflight Holter Monitor and an 
additional exercise period as above recorded on 
the Treadmill Data Recorder. Two 24 hr. 
preflight Holter records were made as baseline 
data. A l l  hardware discrepancies were  
investigated and corrected. 
RESULTS 
Preflight monitoring revealed a rare 
Ventricular Premature Beat (VPB) and rare Atrial 
Premature Beat. The inflight recording revealed 
four isolated VPBs during the recording period, 
and none during exercise nor entry. 
CONCLUSIONS 
There was no increase in ectopic activity 
in this crewmember during space flight and/or 
exercise in contrast to increased dysrhythmias 
seen during previous Shuttle EVA activities. This 
may be due to the natural variability between 
subjects or may relate more specifically to  the 
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NONINVASIVE ESTIMATION OF CENTRAL VENOUS 
PRESSURE USING A COMPACT DOPPLER ULTRASOUND 
SYSTEM 
Investigators: John B. Charles, Ph. D., and Michael W. Bungo, M. D. 
INTRODUCTION 
The headward fluid shift encountered 
during space flight involves the redistribution of 
body fluids from the legs and abdomen into the 
thorax and head. This fluid shift is believed to 
in i t ia te  the cardiovascular read aptat ion 
syndrome (CRAS) of respokes to  space flight by 
stimulating arter ia l  and cardiopulmonary 
sensors. The physiological responses to this 
stimulation may include reduction i n  plasma 
volume and resetting of cardiovascular reflexes 
controlling vascular volume and tone. These 
adaptive changes are appropriate for space 
flight, but inappropriate for life on earth after 
the space flight. The ability t o  counter those 
changes which are deleterious requires a 
complete understanding o f  t he  changes 
involved in  CRAS, starting w i t h  a thorough 
documentation of the fluid shift and its effects. 
One means of tracking the f lu id shift i s  by 
observing i t s  effects on  the central venous 
pressure (CVP), which i s  the f,illing pressure of 
the hear t .  A technique f o r  t h e  rapid,  
convenient and noninvasive estimation of CVP 
in  space fl ight crewmembers would provide 
important insights into the reflex control of the 
cardiovascular system both in space flight and 
on earth. 
METHODS 
The method of Durr e t  al. ( 1 )  was used. 
Briefly, a small uni-directional vascular doppler 
flow detector was used to  monitor the jugular 
venous blood f l ow  whi le  end-expiratory 
intrathoracic pressure was increased by partially 
occluded expiration. The intrathoracic pressure 
(mouth pressure, as indicated by a digital 
display on an electronic manometer) which 
transiently interrupted jugular blood flow was 
taken as an estimate of central venous pressure 
One crewmember was the subject for this 
exper iment  (Fig. 1 )  P re f l igh t  con t ro l  
measurements were made i n  the supine 
position at 34, 33, 31 ,  and 10 days before 
launch. lnflight measurements were made a t  
regular intervals during the first, second, third, 
fourth, and sixth days. 
Figure 1 .  Subject performing an infl ight CVP 
estimation. 
RESULTS 
The averaged values from each flight day 
are shown in Figure 2 [wi th the Spacelab 1 
values from Kirsch e t  al. (2) for comparison]. 
The averaged values for each in f l ight  data 
collection session are shown in Figure 3 (NE: the 
pressure ax is  i s  not corrected t o  cm. HzO).  
Preflight supine values averaged about 4 2 cm. 
HzO. Inflight values were always lower than the 
69 
ORIGINAL PAGE rs 
OF N O R  QUALITY 
preflight average, and decreased over the first
three flight days to their minimum, where they
remained for the duration of the flight.
Measurements during the first two flight days
indicate an increase in CVP over the awake
period; measurements from flight days 3-5
suggest a small increase followed by a
pronounced decrease in CVP over the awake
period.
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Figure 2. Estimated CVP during space flight.
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Figure 3. Jugular venous stop flow pressure.
DISCUSSION
The noninvasive estimates of CVP
reported here for one subject parallel the
average of the invasive measurements from 4
subjects during the Spacelab 1 flight, suggesting
that the method has application for monitoring
the time course of changes in CVP during space
flight. The noninvasive data are of a smaller
absolute magnitude than the invasive data,
suggesting that the noninvasive technique is
7O
actually measuring a parameter directly related
to CVP rather than CVP itself. However, the
data of one of the Spacelab subjects are similar
in magnitude, indicating that individual
variability may expnaan...... the ooluurencu............... _u_. an
"offset" has not been detected in
measurements on earth (1), but may exist
during space flight. This hypothesis may be
tested in a future space flight by comparing
estimated CVP using the noninvasive method
with CVP measured simultaneously using a right
atrial catheter.
The applicability of this technique to
repeated measurements will allow the testing
of hypotheses regarding the acute and chronic
redistribution of body fluids during space flight.
For example, this flight data set suggests diurnal
variations in CVP. A hypothesis (3) based on
Skylab data is that inflight tolerance of lower
body negative pressure (LBNP, which causes
blood volume redistributions similar to standing
upright) is higher in the morning than in the
afternoon because the frequent use of the legs
during the day for station keeping and
propulsion causes a headward distribution of
blood, prompting an acute decrease in leg
interstitial fluid. LBNP stress during the
afternoon sequesters some of the circulating
volume in the "dehydrated" interstitium,
decreasing the blood volume available for
cerebral perfusion and reducing orthostatic
tolerance. This hypothesis may be tested quickly
and easily by the noninvasive estimation of CVP
periodically throughout the waking hours.
Similarly, the acute redistribution of fluid by
exercise can be tracked by CVP measurements
before and after treadmill exercise.
Another application is the determination
of the influence of space motion sickness (SMS)
on fluid volume adjustment. From the limited
evidence to date, SMS may be associated with
high levels of circulating antidiuretic hormone.
Thus, afflicted individuals will retain fluid until
they have adapted to space flight, while the
unafflicted should begin diuresis soon after
reaching orbit. These differences may be
discernible in the time course of changes in CVP.
Confirmation of this hypothesis could lead to
new treatments for some of the effects of SMS.
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Equipment Testing and Experiment Verification 
I 
ne important function of the DSO program is evaluation of 
hardware prior to its use for a complex experiment. These 
photographs show the Animal Enclosure Module, a self-contained 
habitat for small laboratory animals that was tested as a DSO. The 
AEM fits into a standard Shuttle middeck locker (right). 
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ANIMAL ENCLOSURE MODULE INFLIGHT TEST
Investigators: Malcom C Smith, Jr., D. V.M., Philip C Johnson, M.D., and Adrian LeBlanc, Ph.D.
INTRODUCTION
"Verification of the Mid-deck Animal
Enclosure Module (AEM)" was flown as a DSO to
test the efficacy of the AEM in supporting
healthy animals without compromising crew
safety and comfort. This study represents the
first attempt to fly animals in the crew
compartment of a United States space vehicle,
and ground testing was accordingly rigorous.
Ground testing and logistical support
procedures for the DSO are described in two
reports: JSC #18858, dated March 21, 1983,
"Test and Implementation Plan for Verification
of the Mid-deck Animal Enclosure Module for
STS DSO-0421" and JSC #19204, dated July 15,
1983, "Logistical and Operational Support
Requirements for D50-0421"
DESCRIPTION
FLIGHT HARDWARE
The AEM was originally built to support a
Shuttle Student Involvement Project (SSIP)
experiment entitled, "Effects of Weightlessness
on Arthritis." Modifications to the AEM for
flight qualification and to improve its operation
included:
1. Microbial filter material on the exhaust
side of the cage was glued to the metal housing
to overcome leaks which occurred as a result of
stitching.
2. Improved the seal of the filter housing to
the cage to prevent channeling and leakage
around the housing.
3. Installed a microbial filter on the inlet
side of the cage to prevent back flow of
unfiltered air into the cabin.
4. Provided an air-tight seal of the Lexan
covers of the filter areas and the animal
habitation area.
The AEM was installed in a mid-deck
locker in the Shuttle Orbiter. Operation of the
AEM required a 28 v DC power supply to
operate air intake/exhaust fans and interior
lights. Otherwise, it was a self-contained system
designed to maintain 6 adult rats (250-300 g
each) for seven days.
Exhaust air filtration in the AEM was
accomplished by a 4-layer filter system. Layers
consisted of Fiberglass (H3PO 4 treated),
Activated Carbon (H3PO 4 treated), Fiberglass
(H3PO 4 treated), and a microbial filter (0.3-.5 _)
held between two 6 mm wire grids. Make-up air
was pulled into the AEM from the Orbiter mid-
deck environment by four axial flow fans. Food
for the full 7-day mission was provided by a solid
bar of nutrients (Teklad autoclaveable rat diet).
Water was provided from raw potatoes. The
AEM was tested at JSC with 6 live rats, a
combination of 2 live and 4 dead rats, and 6
dead rats. In each instance there were no
objectionable odors detected by a panel of
"smellers" in the exhaust gases after periods of
6 to 10 days of operation.
Testing to assure that the crewmembers
would not be exposed to obnoxious or noxious
odors and pathogenic microorganisms was
accomplished. Inflight crew involvement in the
experiment was limited to activating lights to
maintain nominal circadian rhythms, a 10-
minute video tape on days 2 and S, and daily
observation of animal behavior At no time did
the crew handle the animals outside of the
AEM.
TEST ANIMALS
Six Specific Pathogen Free (SPF) male albino
rats (Lewis Wistar strain), age 56 days and
weighing approximately 275 g at launch were
to be used for flight. A group of 6 controls and
6 flight back-ups were required. However, the
animal supplier could not guarantee that the
rats would be free of one of the microorganisms
on the restricted list, Klebsiella pneumoniae.
Therefore, it was determined that germfree
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(cesarian derived and isolator reared) rats would
be required in order to meet all of the
microbiological requirements. These germ-free
rats were stabilized with a "cocktail" of
I =rtnh_rill#l¢ cnn /I qt._vc nrinr tn chinm,_nt from
the vendor's facility to the Life Science Support
Facility (LSSF) at Kennedy Space Center (KSC).
Only 15 of the germ-free rats were available,
and these were subsequently divided into one
group of 6 flight animals, one group of 6 back-
up flight animals, and one group of 3 controls.
FACILITIES AND PROCEDURES
Housing facilities preflight were provided
by the KSC LSSF in Hanger L. Procedures for
handling and maintaining germ-free animals at
this facility are as specified by the Association
for Laboratory Animal Science. Procedures and
equipment at the KSC LSSF were consistently
within specification and animal comfort and
exposure to microbial contamination was not
compromised.
Animals were received in the LSSF on 18
August 1983 (F-12 days). Physical exams and
microbiological analyses were accomplished
upon receipt, at F-5 days, and at F-18 hours.
RESULTS
Average pre- and postflight body weight
changes in the flight animals and in the various
controls, Table I, are not remarkable if taken as
a whole. Flight animals lost an average of 11 g
(3.7%) in side A of the cage or gained an
average of 3 g (1.3%) in side B. Controls gained
an average of 5, 29, and 2 g (1.7%, 11%, 0.6%).
The flight rats failed to gain weight at their
expected rates and some even lost weight while
the ground based controls either gained weight
as expected or gained slightly less than
expected.
Flight rats were at a disadvantage in that
their food supply was glued to the sides of the
cage and was slightly more difficult to access
than the food in the cages of the controls.
Flight animals consumed an average of 175 g of
food whereas controls consumed 223 g. Control
group KSC-1 did not gain at the expected rate,
probably due to the fact that this group was
anesthetized for a blood sample on 8-30-83.
Control group ARC-5 did not gain at their
expected rate due to the fact that this group
was disturbed by transfer from KSC to ARC, and
they had no food supply for about 24 hours.
Gnotobiotic rats were used in this test for
reasons previously mentioned. These animals
were isolator reared and had not been handled
since birth. Birth dates varied from 6-10-83 to 7-
5-83 which resulted in a group of animals
varying in age of from 46 to 81 days at the time
of launch. Selection of the flight animals
resulted in a "small" group of 3 weighing an
average of 228 g each and a "large" group of 3
weighing an average of 293 g each.
Postflight examination of the flight
animals revealed that they were in good
physical condition. They were alert and were
actively grooming themselves and each other.
Their supply of water in the raw potatoes was
exhausted on Side A and nearly exhausted on
Side B. Their hair coat was slightly discolored
and stained which was probably due to their
inadvertent rubbing against the food bars in
microgravity. Postflight examination of the
cage and inflight video tapes indicated that the
air flow through the cage was not great enough
to quickly pull urine, feces, and debris out of the
cage area and onto the exhaust filter grid.
Therefore, coprophagy was not prevented.
Microbiological analyses of the flight
animals, food supply, water supply (raw
potatoes), and AEM were accomplished by
microbiology laboratories at KSC and JSC.
Complete results of these tests are contained in
separate reports but there was good general
agreement between the laboratories.
Preflight microbial testing of the animals
yielded Lactobacillus spp as expected, but no
organism on the exclusion list was found.
Testing of the raw potatoes revealed a variety
of organisms in spite of using ionizing radiation
and a chlorine scrub to provide a sterile potato.
The potato-borne organisms were not on the
exclusion list.
Postflight microbial testing of the animals
yielded two organisms in the animals which had
not been recovered preflight. These were
Streptococcus vividans and Staphylococcus
aureus, and it is presumed that these organisms
were introduced by the raw potatoes and/or by
the lack of complete sterility of the AEM. These
organisms were not recovered from the exhaust
ports of the AEM, and this supports the
contention that the AEM is an effective
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microbial isolator and does not result in
contamination of the external environment.
CONCLUSIONS
The AEM successfully maintained 6
healthy rats for the duration of the mission (6
days). Improvements in the water supply (to
provide a margin of safety of at least 20%) and
an increase in the rate of air flow through the
AEM are highly desirable. The AEM can be used
for a variety of flight experiments using small
laboratory animals without impairing crew
time, crew safety, and crew comfort.
Table I - Animal Enclosure Module (AEM)
Average Body Weight Change
Preflight(g) Postflight(g) Food Potatoes
Flight (8-29-83) n=3 (9-5-83) n=3 (O) (%) Consumed(q) Consumed(q)
Side A 293 282 -11 3.7 186 1170
Side B 228 231 +3 1.3 165 1182
Controls
KSC-1 278 283 +5 1.7 216 1054
*KSC-4 264 293 +29 1t.0 252 1059
ARC-5 292 294 +2 0.6 202 1155
* KSC-4 were true controls. KSC-I gave a blood sample on launch day and ARC-5 were transported
to NASA-ARC on launch day.
Table II - CBC Data
Control Animals Flight Animals
Pre Flight 2 Hours 10 Days
Post Flight Post Flight
Mean SE Mean SE Mean SE
WBC 9.8 O.l 15.2 2.4 10.5 0.4
RBC 8.7 0.2 9.8* 0.2 9.1 0.1
Hgb 17.6 0.2 19.6" 0.4 16.7 0.2
Hct 45.8 1.0 54.6 = 1.5 48.3 0.4
MCV 52.2 0.3 55.9" 0.5 52.8 0.5
MCH 20.1 0.1 20.0 0.2 18.3* 0.2
MCHC 38.5" 0.4 35.8 0.3 34.6 0.4
Plt 539 59 752 42 600
Retics 1.2 0.4 1.3 0.2
* Significantly different from the two other means at the .01 level as
determined by Analysis of Variance and Multiple Range Test
77
PROTOCOL/HARDWARE VERIFICATION OF THE
SPACELAB-3 AUTOGENIC FEEDBACK TEST
EXPERIMENT #3AFT23
Investigator: Patricia S. Cowings, Ph.D.
INTRODUCTION
A "pilot study" of the Spacelab-3
experiment, "A Preventive Treatment for Zero-
Gravity Sickness" (#3AFT23), was flown as a
DSO to examine the efficacy of inflight
procedures planned for the subsequent formal
experiment. There were three opportunities to
speak to the one subject post-flight: a private,
2-hour debrief between the crewman and two
of the investigators; a 2-hour public debrief,
which was held by Johnson Space Center SBRI
personnel; and a telephone conversation. A
number of unforeseen problems arose inflight
and were corrected for the subsequent flight
after discussion of possible solutions with the
crewman. The information obtained from this
mission that was relevant to proposed changes
in inflight procedures for the SL-3 mission is
outlined below.
PROCEDURES I RESULTS
PREFLIGHT DONNING OF AFT
HARDWARE AND EQUIPMENT
CHECKOUT
The preflight donning procedures book
developed for SL-3 was used. No modifications
were recommended. Preflight donning of the
Autogenic Feedback Test (AFT) hardware and
STS garments took approximately 30 minutes
for the one crewman. Participants in this study
should perform this task while the flight crew
receives their weather briefing. A maximum of
45 minutes to one hour may be needed for 4
crewmen as only two Ground Support
Equipment units are available for "check-out."
_,_F,£ED_G: P-_G_- F,L_,_iK NOT FILiMEO
PR]_CRr_i_TG PAC,8 BLANK NOT FI_,Mr]_D
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URINE COLLECTION DEVICE (UCD)
MODIFICATION TO THE AFT
GARMENT
It was recommended that all
crewmembers participating in this study allow a
UCD modification for the AFT garments used
during launch. The material of the flap may
"bunch-up" in the crewman's back causing
discomfort while seated in the launch chair.
Further, the snaps on this flap prevent the
garment from "riding-up" while the crewman
sits in launch configuration. Lastly, this
modification would save time post-insertion in
that the crewman will not have to snap the flap
into place while in zero-g (again, to prevent the
garment from riding up).
AUTOGENIC FEEDBACK SYSTEM
(AFS) ACTIVATION PRELAUNCH
The feedback display was carried to the
Orbiter by close-out crew and handed to the
crewman after seat ingress. The close-out crew
turned the powerswitch of the AFS on before
exiting the orbiter. It is recommended that at
this time, the crewman follow the AFS
activation cue card (mounted before each seat).
However, after the unit is in "check-out mode"
(refer to flight data file book, NOM-2, AFS
activation) only one additional button push is
required to start the tape recorder. It was
strongly recommended that this final button
push not occur until the L-10 minute hold.
Because each tape operates for 7 hours, if all
crewmen activated the recorder at the same
time (i.e., L-10 minutes), it would then be
possible to accurately time-line the cassette
change on the first mission day (refer to Flight
PAG_tNTENTIONALLY BLANK
DataFileBook[FDFB],NOM-S).After this final
button press, the crewmen should remove the
display from their wrists and place them in FDFB
pouches mounted on the sides of each launch
_.,,a,,. _,,iS ,v_.ouv,, was ,.,,v_,_n for _ts
convenience and because the high vibration
environment of launch might make the display
fall off the wrist mount.
POST-INSERTION PROCEDURES
FEEDBA CK DISPLA Y
It was recommended that upon orbital
insertion all crewmembers participating in this
study remove the feedback display from the
FDFB pouch on their launch chairs. Treatment
subjects should re-attach the display to their
cable harnesses at this time. Controls may place
the display in a pocket. It became apparent that
crewmembers should keep this display with
them at all times while on shift. The display
must be available for Treatment Subjects (i.e.,
feedback) and is used by all crewmen to input
"events" to the recorder, (i.e., indicating the
onset of symptom episodes if and when they
occur). This display may also be kept in the AFS
pouch pocket used for holding the belt.
MIDDECK PROCEDURES
Most of the following post-insertion
procedures were practiced during a class held in
the 1-g trainer. Input from the crew was
welcomed, especially from those crewmen who
had flown before. After consultation among
the investigators, it was determined to be
imperative to obtain continuous in-flight
physiological monitoring. The first mission day
was particularly important in this regard.
Therefore, the requirement for reconnecting
the AFS to the crewmember's cable harness
within one hour post-insertion was maintained.
The crewman indicated that tugging the under-
seat pouches (containing the AFS) may produce
unnecessary head movements. He recom-
mended that these may be avoided by
unbolting the launch chairs from the deck,
leaving them in the air (or velcroing them to the
wall), and then removing the pouches. This
procedure could also save time in reconfigura-
tion activities performed post insertion.
Further, if this procedure were done one chair
at a time with crewmembers assisting one
another, it .............. e
AFT FLIGHT DECK PROCEDURES
This procedure must be considerably
modified to accommodate MS-l, located on the
flight deck. Because this crewman is responsible
for payload activation and must perform many
of his tasks in the confined area of the flight
deck, it may not be possible for him to attach his
AFS unit for up to 5 hours post insertion. This
would result in a significant loss of critical data
to this experiment. Nominally, MS-1 remains in
his launch seat until the completion of OMS-2
(approximately 42 minutes). Instead, it was
recommended that he brace himself in the
hatch to the right of his seat such that his head
is level with the underseat pouches, remove the
AFS from the pouch, and connect it to his cable
harness during this time. Because of his
location, this activity should not disturb other
critical flight tasks underway. Further, the
recommended changes to the AFS pouch/belt
assembly (see below, E.1.) should facilitate his
attachment of the AFS and enable his
unimpeded performance of mission-related
activities in the flight deck.
INFLIGHT OPERATION OF TIME-
LINED AND SYMPTOM-
CONTINGENT PROCEDURES
MODIFICATION TO AFS POUCHIBEL T
ASSEMBL Y
There was no Spacelab flown on this
mission and the subject crewmember was
required to make numerous translations from
the middeck to the flight deck. Because the
hatch connecting the two decks was signifi-
cantly narrower than the "tunnel" leading to
Spacelab, the AFS unit tended to "hang-up" on
obstructions. This necessitated his making
twisting and turning motions - again unneces-
sary head movements. After discussion of this
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matter with the crewman post-flight, it was
agreed that this problem could be avoided by
making the AFS pouch detachable from the belt
while remaining connected to the cable harness.
In this way, the AFS could be held above the
crewman's head (or between his legs) during
translation. If working in confined spaces, the
unit could be attached to the bulkhead with
velcro, while the crewman remained tethered.
The crewman recommended that the shoulder
strap be used in-flight because it stabilized the
AFS unit. The size of the AFS unit did not
impede his movement or performance of
mission related activities while he was in a
relatively open volume of space (middeck and
flight deck), as he was able to slide the unit (on
the belt) to his back, side, or front, if needed. It
was also recommended that a square of velcro
be placed on the AFS unit itself to facilitate
battery change-out procedures (refer to FDFB,
NOM-6).
EVALUATION OF THE "RING"
TRA NS D U CER
The crewman did not have any difficulty
using his fingers and hands to perform mission-
related activities. The ring transducer did not
get in his way. It was recommended that SL-3
crewmen keep a roll of elastoplast tape in the
Spacelab should it be necessary to re-attach the
ring transducer for any reason. This type of tape
did hold the transducer firmly in place.
USE OF WRITTEN PROCEDURES - FLIGHT
DATA FILE BOOK AND CUE CARDS
Explicit detail is required in the FDFB and
on cue cards. No matter how well trained, an
individual may "forget" a critical step in one or
more of the flight procedures. Examples of this
are discussed below under Section G., Paragraph
1. "U se of Foot Restrai nts;" and Section H., "De-
Orbit Prep."
USE OF DIAGNOSTIC LOG BOOK OR
VOICE CASSETTE RECORDER
It was essential to the science of this
investigation that crewmembers provide a
subjective report of their malaise levels during
time-lined and symptom-contingent episodes
inflight. The crewman used a voice
microcassette recorder to perform these tasks.
He did use the diagnostic book as a "cue card"
so that his reports used the standardized
terminology of the diagnostic scale. It is
recommended that the use of a written log or
taped report be made a crew option. It was
observed that one crewman (during an early
SL-3 simulation), attached his voice recorder
with velcro to his flight suit (left side of chest) so
that it would be convenient for verbal reports.
PRE-SLEEP DOFFING PROCEDURES
Removal and stowage of the AFS
hardware and garment proceeded within
timeline allowances (less than 10 minutes). This
crewman further reduced the necessary time by
leaving his cable harness attached while
removing the garment.
POST-SLEEP DONNING
PROCEDURES
USE OF FOOT RESTRAINTS
Post-sleep donning required 45 minutes.
This was largely due to: a. difficulty with the
Basal Skin Resistance (BSR) cable snap lead (see
below, paragraph 2, "Modification of BSR
electrode snap leads"); and b. failure to use foot
restraints during donning. Although this
crewman (and two from SL-3) participated in a
class on the KC-135 zero-g flights which
documented the fact that use of foot restraints
shortened donning time from 45 to 15 minutes,
this procedure was not performed inflight. It
was strongly recommended that foot restraints
be placed permanently in the vicinity of the
stowage lockers for SL-3, and that instructions
to use these restraints be written into the flight
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datafile book.Further,useof restraintsreduces
unnecessaryheadmovementswhich might be
madewhile "floating as you dress".
MODIFICATION OF BSR ELECTRODE
SNAP LEADS
The snaps on the disposable BSR
electrodes worn on the crewman's wrist tended
to tear off the electrodes and remain mated to
the cable harness. This tended to slow down
donning procedures as the crewman had to find
an implement (i.e., screw driver) to remove the
snaps. For SL-3, these BSR snap leads were
replaced on the harness so that this would not
occur.
know if this was unique to himself or if others
were likely to also feel discomfort caused by the
garment. A possible solution to prevent the
recurrence of the problem on SL-3 was to
modify the AFT garment by inserting a second
zipper on the right side (alternatively, the
existing zipper could be modified to open from
the bottom, rather than the top). This would
loosen the fabric around the abdominal region
and result in the loss of the abdominal
respiration signal and relative respiratory tidal
volume. However, the chest respiration gauge
will remain intact and respiration rate will still
be available as feedback to the treatment group
crewmember. The experimenters would still be
able to assess the effects of respiration rate on
cardiovascular measures.
PRE-STRINGING THE CABLE HARNESS
The crewman discovered that donning
time could be reduced by attaching the cable
harness to the AFT garment before putting it
on. Appropriate changes to the FDFB were
made.
PROPOSED MODIFICATION TO AFS
GARMENT
On the second mission day, the crewman
noted that the garment felt uncomfortably
tight, particularly in the abdominal region. He
emphasized in his debriefing that he did not
DE-ORBIT PREP PROCEDURES
It was strongly recommended that a de-
orbit prep check-list be written and followed
carefully. The crewman took great care in his
preparations for re-entry. This essentially
amounted to performing post-insertion
procedures in reverse (i.e., mounting the AFS
under the middeck seat, and performing AFS
activation). However, it was discovered that
although the AFS worked as is should, no re-
entry tape was made. It is believed that the
crewman inadvertently failed to make the final
button press (which starts the tape running)
before he removed his wrist display.
In summary, the results of this mission
were extremely valuable to the SL-3 experiment.
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Section Four 
Microbiology C” BOOR QUALIT% 
wo DSOs were successful in demonstrating the attachment of T cells to microcarrier beads in zero gravity, as is evident in this 
scanning electron photomicrograph. These findings have exciting 
implications for bioprocessing in space. 
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CELL ATTACHMENT IN MICROGRAVITY 
Investigators: Dennis R. Morrison, Ph. D., and Marian L. Lewis, Ph. D. 
INTRODUCTION 
Before cells can be cultured in space for 
electrophoretic separation or as mini-factories 
for producing selected natural cell products 
such as urokinase, studies must be done t o  
assess growth characteristics o f  cells in the 
microgravity environment. Human kidney cells 
survive and proliferate in culture only when 
attached t o  growth surfaces such as flasks or 
microcarrier beads. On STS-7, a very simple 
study was conducted w i th  the objective t o  
determine i f  cells could attach to  microcarrier 
beads in microgravity. The experiment was 
conducted at ambient cabin temperature rather 
than at optimal conditions in a 37" C incubator 
since an incubator was not available for STS-7. 
The study was designed t o  simply demonstrate 
feasibility of seeding cultures in microgravity. A 
subsequent experiment in an incubator was 
performed as a DSO on 515-8 t o  investigate 
attachment and proliferation at 37" C. 
FIX AND RECORD INITIATE 
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Figure 7 .  Cell attachment procedure. 
PROCEDURES 
Human kidney cells were maintained in 
four different syringe packs during launch. 
Early in the  first day of  orbit, beads were 
transferred into the syringes containing the 
cells. At 12 hour intervals, thereafter, fixative 
was added t o  a syringe according t o  t h e  
schematic procedure shown in Figure 1. 
Figure 2a shows one of four cell bead 
packs. The pack consisted of an aluminum tray 
with a three-way valve attached to the tray and 
to three 5 mi syringes. One syringe contained 
the bead suspension, one contained cells, and 
TABLE 1. MATERIALS 
CELLS 
GROWTH MEDIUM: 
HUMAN EMBRYONIC KIDNEY (HEK)-(M A BIOPRODUCTS. USA) 
1 1 1 - MEM ALPHA, DULBECCOS MEM. AND M-199 (GIBCO. USA) 
PLUS 1 W  FETAL CALF SERUM IBIOLABS. USA) AND OTHER CELL 
G R O W H  SUPPLEMENTS 
MICROCARRIER BEADS: CYTODEX 3 .  COLLAGEN COATED - IPHARMACIA. SWEDEN1 
TRYPSIN.EDTA (GIBCO) 0 05% EACH IN Ca" Mg*' FREE PBS 
GLUTARALDEHYDE: (TOUSIMAS USA) DILUTED TO 2 5% IN DULBECCOS PBS 
G E N E R A L  METHODS 
CULTURES CELL SUSPENSION MENT CELLIBEAD 
MEDIUM 
MEDIUM 
SYRINGES 
GLUTARALDEHYDE 
1. LOAD FIXATIVE 
OBJECTIVE - TO DETERMINE IF CELLS ATTACH TO 
1. MICROCARRIER BEADS IN MICROGRAVITY za 
CECLiBEAD PACK 
2 b CONDITIONS 
* ~ CELLS 28 C IN (AMBIENT 4 SYRI GES 
CABIN TEMP) 
CELLSBYRINGE (IN 2 
ml VOL MEDIUM) 
0 40 mg BEADS IN 2 m i  
2 x  lo5 
VOL OF MEDIUM 
(INJECTED INTO CELL 
SYRINGE ON ORBIT 
0 FIXATIVE (0 8 
mllSYRINGE) 
INJECTED AT TIMES 
12.24.33 and 48 
HOURS AFTER MIXING 
CELLS + BEADS 
CONCLUSIONS 
CELLS ATTACHED TO 
BEADS IN 
MICROGRAVITY 
TEMPERATURE CELLS 
AT AMBIENT CABIN 
a) DID NOT 
FLATTEN 
b) DID NOT 
PROLIFERATE 
CLUMPING 
OCCURRED 
S I M I L A R  R E S U L T S  
GROUND 
EXPERIMENTS UNDER 
4TTACHMENT AT I2 HOURS SIMILAR CONDITIONS 
Figure 2. STS-7 celllbead packs. 
the third had glutaraldehyde as a fixative. The
whole tray assembly was sealed in a plastic bag.
Materials and methods are described in
Table 1 for each pack. The experimental
conditions are listed in FinlJr_ )h
RESULTS
Figure 2c shows attachment of single cells
and a large clump of cells for a sample fixed 12
hours after mixing of cells and beads on orbit.
At ambient temperature the attached cells did
not flatten or grow on bead surfaces. To
evaluate the number of beads with cells
attached, beads were arbitrarily divided into
three categories; 1) beads with no cells, 2) beads
with 1-10 cells and, 3) beads with clumps of cells
attached. Each of the bead packs was divided
into two aliquots for counting. Table 2 shows
results of bead counts.
TABLE 2. CELL ATTACHMENT TO BEADS UNDER
MICROGRAVITY CONDITIONS
CELL (Hrs) NO. MEAN _ OF TOTAL
FIXED BEADS W[TH
BEAD AT O CELl S
;% --
I ICOUNT±SD
1 A 12 55 84 ± 6
B 117
2 A 24 102 70 _ 14
B 91
3 A 33 114 6O t O
O !lOg
4 A 48
B
BEADS WITH
1-10 CELLS
IlEAl# _ OF TOTAL
COUNT i SD
14 16 ) 6
15
47 20 i 11
L4
42 25 ± 4
4O
18:1:0
BEADS WITH
CELL AGGREGATES
ND NO 69
NO 133
21 20 ± 11 170
9 114
34 25 _ 4 190
3O I 179
18 i O 229188
TOTAL
NUMBER
DF BEADS
COUNTED
By 12 hours after mixing cells and beads
on orbit, 84% of beads counted had no cells and
16% of beads already had 1-10 cells. As time
increased up to 33 hours, the number of beads
with no cells decreased as the number with 1-10
cells and clumps of cells increased. No mixing
was performed after the initial procedure at
time zero. This confirmed that cells attach to
growth surfaces while free floating in
suspension under microgravity conditions By
48 hours under less than optimal conditions of
temperature, no statistical increase in cells
attached to beads was apparent. Ground based
experiments showed similar results
CONCLUSIONS
Clearly, epithelial human kidney cells can
attach to microcarrier beads under microgravity
conditions even though the opportuniLies are
based on initial mixing and thereafter to
random collisions due to Brownian motion of
the cells during the experiment period.
In ground based simulations, cells which
were incubated at 37 ° C attached to beads,
flattened on the bead surfaces, and began to
grow. This indicated that the cells used in this
experiment were viable and grew normally
under optimal conditions. The aggregation of
cells to cells was not an artifact of the
glutaraldehyde fixative. In ground based
experiments fixed at 24 and 72 hours after
mixing cells and beads hardly any clumping was
observed. This finding suggests that clumping
may be due to a microgravity effect or to cell-
cell interaction in the syringes during launch
and orbit insertion prior to mixing cells with
beads on orbit. It was apparent that the cells
attach to each other if beads were not available.
It was also obvious that considerable
attachment occurred in the first 24 hours of this
experiment. Under qormal incubator
temperatures cell metabolism would be greater,
therefore, cell attachment may be even more
pronounced.
This DSO was successful in that it met the
objective of the experiment. Cells were shown
to attach to growth surfaces in microgravity.
Recommendations for the next flight DSO
experiment included: (1) optimizing cell
survival conditions by mixing cells and beads in
culture chambers in a 370 C cell culture
incubator, (2) designing the experiment to
quantitate the relative attachment which occurs
in the first 24 hours after mixing cells and beads
on orbit, (3) counting larger numbers of cells
and beads for statistical analyses post flight, and
(4) evaluating the way in which cells are
attached to beads by scanning electron
microscopy.
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ORIGrnTPiL 
INCUBATOR CELL ATTACHMENT TEST (ICAT) 
POOR Q U W  
Investigators: Dennis R. Morrison, Ph.D., Marian L. Lewis, Ph. D., A. Tschopp, Ph. D., 
and A. Cogoli, Ph. D. 
INTRODUCTION 
The microgravity environment of space 
provides unique advantages for the production 
and purification of pharmaceutical type natural 
cell products. Because of the potential of space 
bioprocessing, there is a new requirement to 
assess the behavior of cells in microgravity. 
Eventually, cells wi l l  be cultured in  space in 
bioreactors and the desirable cell products will 
be harvested, purified and returned t o  Earth. 
Many of the target products, such as urokinase, 
are produced by cells which survive and grow 
only when attached to a substratum. 
The attachment of cells t o  g rowth  
surfaces on Earth is normally affected by the 
settling of cells onto surfaces of flasks or other 
culture vessels. The experiments reported 
herein were designed simply to answer the 
fundamental questions: Do cells a) attach to 
and b) proliferate on growth surfaces as well in 
microgravity as on Earth. 
Feasibility of cell-to-bead attachment a t  
ambient temperature was shown on STS-7. The 
STS-8 Incubator Cell Attachment Test (ICAT) 
represented a cooperative effort between NASA 
and European Space Agency scientists. The test 
was initially designed to  check out the Carry-on 
Incubator, developed and manufactured at  the 
E. T. H. - Zentrum Zurich, Switzerland, before it 
was used for a lymphocyte experiment on 
Spacelab-1 and t o  assess cell attachment 
efficiencies at normal culture temperatures. On 
STS-8, kidney cells and microcarrier beads were 
incubated at 37" C in the carry-on incubator 
The attachment of the kidney cells to  beads is 
the subject of this report. 
PROCEDURES 
INCUBATOR 
The apparatus, described i n  detai l  
elsewhere (Cogoli and Tschopp, 1982), consisted 
of  a carry-on box capable of maintaining a 
temperature of 37" C either with batteries or 
with on-board power, and which could be fixed 
to  a front panel installed in the Space Shuttle's 
flight deck (Figure 1) or in a rack of the Spacelab 
module. The incubator contained four ce l l  
culture chambers sealed with a mobile piston, 
four syringes loaded with the microcarrier beads 
and four syringes w i t h  glutaraldehyde as 
fixative (Figure 2 ) .  
Figure 1. 
deck. 
Incubator in place - Orbiter flight 
OBJECTIVES - a) CONFIRM STS-7 ATTACHMENT RESULTS 
AS WELL IN MICROGRAVITY AS IN 1 x g 
b) DETERMINE WHETHER CELLS PROLIFERATE 
CONDITIONS 
CELL CULTIfRF 
Figure 2. STS-8 KAT. 
. _ _  - . . -
CHAMBERS 
AT 37°C (4 
CHAMBERS) 
3x106 CELLS/ 
CHAMBER 
(IN 6 ml VOL 
MEDIUM) 
90 mg BEADS IN 
3 ml VOL OF 
MEDIUM 
(INJECTED INTO 
CELL 
SUSPENSION IN 
CHAMBERS ON 
ORBIT) 
FIXATIVE (lml/ 
CHAMBER 
INJECTED 
AT TIMES 5 MIN, 
2.5. 13.5 AND 24.5 
HOURS AFTER 
MIXING CELLS 
AND BEADS 
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CELLS AND MEDIUM GROUND PROCEDURES
Frozen suspensions of human embryonic
kidney cells were purchased from M. A.
D_r_ll_+e _Al'_lb_re,,;ll_ RAt_ TI_ _^,1, were
grown in medium consisting of one part each of
Medium 199, MEM alpha, and Dutbecco's
Modified Eagle Medium (Gibco Laboratories,
Grand Island, NY) supplemented with 1.2 g/L of
bactopeptone (Difco Laboratories, Detroit, MI),
0.02 g/L of folic acid, 0.72 g/L of i-inositol, 0.1 g/L
of nicotinic acid, 16.2 g/L of NaHCO (Sigma
Chemical Co., St. Louis, MO), 10% fetal bovine
serum (Biolabs, Northbrook, IL), 20 mM HEPES
(Research Organics Inc., Cleveland, OH) and 100
units/ml of penicillin and 100 mg/ml of
streptomycin sulfate (Gibco Laboratories).
BUFFER AND ENZYME SOLUTIONS
Calcium and magnesium-free phosphate-
buffered saline (CMF-PBS) consisted of 2.65 mM
KCL (Pfaltz and Bauer Inc., Stamford, CN), 1.46
mM KH2HPO 4 (Mallinckrodt Chemical Works,
St. Louis, MO), 136.9 mM NaCl and 8.0 mM
Na2HPO4 (J. T. Baker Chemical Co., Phillipsburg,
N J). Trypsin (Gibco Laboratories) and EDTA
(Sigma Chemical Co.) were combined at 0.05%
each in CMF-PBS.
GLUTARALDEHYDE FIXATIVE
A 50% aqueous ultra-pure TEM grade
solution of glutaraldehyde (Tousimas Research
Corporation, Rockville, MA) was further diluted
with Dulbecco's PBS' to a concentration of 2.5%.
One ml was loaded into each syringe.
MICROCARRIERS
Cytodex 3 microcarriers (Pharmacia Fine
Chemicals, Uppsala, Sweden) were prepared for
use according to the manufacturer's instructions
by swelling and hydrating in CMF-PBS. The
microcarriers were sterilized in 70% ethanol
overnight. Prior to use, beads were washed
three times in CMF-PBS and once in culture
medium. The microcamers were suspended in
culture medium at a concentration of 30 mg/ml
and loaded into the syringes
Preflight operations were performed in
the Life Sciences Payloads Facility at NASA
Kennedy Space Center. rol,, 4÷ _ ,, ,
..... _L passage ,e,e,
one were used for the experiment. The cells,
previously grown in primary culture and stored
frozen, were thawed, suspended in culture
medium and planted in 75 cm2 growth surface
flasks (Corning 25110) five days prior to the
scheduled time of stowage on the Shuttle. At
launch time T-14 hrs, cells were approximately
90% confluent and were removed from flask
surfaces with trypsin-EDTA. The cells were
suspended in culture medium at a concentration
of 464,000 cetls/ml, and 6 ml of the cell
suspension were then pipetted into each of the
four cell culture chambers. Ground-based
control cells were prepared in the same manner
as for flight. The ground control experiment
was run at NASA Johnson Space Center,
Houston, TX.
FLIGHT PROCEDURES
The incubator with cultures and syringes
was installed on board 14 hrs before launch and
kept at ambient temperature. Four hrs after
launch the incubator was switched on and 3.5
hrs later the experiment was started by injection
of the beads into the cell chambers. Samples 1-4
were fixed by injection of glutaraldehyde 5 min,
3 hrs, 13.5 hrs and 24.5 hrs after addition of the
beads espectively. Finally the incubator was
switched off and the samples remained stored
within the incubator until the end of the
mission 6 days later. They were returned to the
investigators 6 hrs after landing of the Shuttle
and transported to the Bioprocessing
Laboratory at the Johnson Space Center in
Houston.
RESULTS
After return of the incubator to the
laboratory, the cell/bead suspensions were
removed from the growth chamber. An aliquot
was taken from each suspension for scanning
electron microscopy and the remaining
suspension was evaluated for cell to bead
attachment, cell-cell aggregation and individual
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floating cell counts. For cell and bead counts, 
four slides were prepared for each sample fixed 
at each of the four times after mixing cells and 
beads on orbit or in the ground control Figure 
3 shows the ratio and percent of single (not 
clumped) cells counted which were attached to 
beads a t  each time Significantly more single 
cells attached a t  each fixation time in the flight 
experiment than i n  the ground control  
Statistical analyses of the cell counts were done 
by the non-parametric procedure of Cochran 
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OF COCHRAN) 
THIS DATA SUPPORTED BY BEAD EVALUATIONS 
Figure 3. Attached single cell counts 
The number o f  cells per c lump in 
aggregates which were not attached to  beads is 
shown in Figure 4. In the ground control, by 2.5 
hours only eight unattached clumps of cells 
were counted in the four prepared slides. In the 
flight samples, there were approximately three 
times more unattached clumps and there 
appeared to  be more cells per clump In l-G the 
clumped cells tended to  settle rapidly and had 
an opportunity t o  adhere t o  beads; whereas, in 
microgravity clumps free-floated until coming 
into contact with a bead. I t  appeared that cell- 
to-cell clumping occurred more frequently in 
flight than on the ground a t  the 2.5 hour time. 
GROUND 
CONTROL MEAN 4.11 2.88’ 6 
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STANDARD DEV. 2.45 6.23 3.46 1.49 * 
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STICKY FLIGHT CELLS ATTACHIN 
Figure 4. Number of cells/clump (unattached). 
There was no significant difference in  t h e  
number of cells attached to beads per clump of 
aggregates in flight versus control. However, 
statistically the average number of attached 
cells per clump in both the flight and ground 
control increased with time, indicating normal 
growth once the cells were attached (Figure 5). 
NUMBER OF CELLSICLUMP ATTACHED - N O  SIGNIFICANT DIFFERENCE 
AVERAGE LOG OF NUMBER OF CELLSICLUMP ATTACHED INCREASED WITH 
FLIGHT VS CONTROL 
TIME . INDICATES SOME CELL GROWTH FLIGHT AND CONTROL 
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Figure 5. 
microgravi ty. 
Estimation of*cel l  clumping in 
As another approach to evaluating cell 
attachment to  beads in flight compared to the 
ground control, 300 beads from each fixation 
time were scanned on each o f  four slide 
preparations. Beads were categorized as having 
no cells, 1-5 cells, 6-10 cells, or greater than 10 
cells per bead for each of  the four slides. 
Multivariate analysis of variance was applied to 
statistically determine the mean and standard 
deviation in the bead count categories. Figure 6 
shows evaluations of beads with no cells and 1-5 
cells per bead. The f l ight  experiment had 
significantly more beads with 1-5 cells than the 
ground control. The number of beads with no 
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cells decreased with time as those with 1-5 cells 
increased. For categories of 6-10 and greater 
than 10 cells per bead there were very few 
beads; thus, there were large standard 
deviations for counts o i  ihe four repiicate $;ides 
(Figure 7). The trend of the mean counts 
indicates an increase in the number of cells per 
bead w i th  time. There was no significant 
difference between flight and control in the 
greater than 5 cells per bead categories To 
determine i f  there were morphological  
differences in the way cells attached between 
flight and ground samples, scanning electron 
micrographs were examined. Figure 8 reveals 
no discernible differences between flight and 
ground samples. In both cases, the cells 
attached, flattened and increased in number as 
shown by the almost confluent state of some 
beads. 
A TOTAL OF 300 BEADS WERE SCANNED PER SLIDE AND CLASSIFIED AS 
HAVING 0,l-5.6-10 OR ,, 10 CELLWEEAD. (MEAN AND STANDARD 
DEVIATION OF FOUR SLIDES) (STATISTICS - MULTIVARIATE ANALYSIS OF 
VARIANCE. 
100 , I 
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Bo ~ \ \ \ .  
BEADS WITH 1-5 CELLS h1T)LCHED 
, 
0 I I 
0 5 $0 IS 20 25 
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b--d CONTROL 
0 FLIGHT - SIGNIFICANTLY MORE BEADS WITH 1-5 CELLS/BEAD THAN 
GROUND CONTROL ~ CONSTANT AT ALL SAMPLING TIMES 
BEADS WITH N O  CELLS DECREASED AS NUMBER OF BEADS WITH 1-5 
CELLS/BEAD INCREASED 
Figure 6. Evaluation o f  beads, 5 5  cells 
attached. 
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Figure 7. Evaluation o f  beads, 2 6  cells 
attached. 
Figure 8. Scanning electron micrographs o f  
celltbead attachment fixed 24.5 hours after 
mixing cells and beads. 
DISCUSSION I ANAL YSIS 
One concern was that cell attachment 
would be less in  microgravity since the only 
opportunity for contacts between cells and 
beads would be based on random collisions 
while floating free in the culture chambers 
These results show very clearly that considerable 
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attachment occurs quite quickly when cells and
beads are mixed together in microgravity. At
37° C the number of attached cells was higher in
the flight samples than in the ground control.
This was possibly due to greater surface area
availability at low-g, since all surface area of the
beads would be available to cells, while on Earth
only the top hemisphere of settled beads is
available. Most of the cell adhesion occurred
within the first 3 hr, and cell growth and
replication appeared normal after cells had
attached to microcarriers. Unspecific adhesion
of cells by covalent attachment through an
activation of the Cytodex carriers by
glutaraldehyde can be excluded. If the
attachment were nonspecific there would not
be a difference between counts at the different
times. In the flight experiment, there also
appeared to be more cells per unattached
aggregate than in the ground control. This
could be due to cell to cell collisions rather than
cell to bead collisions, resulting in cell clumping.
There were no problems with the
incubator and no malfunctions occurred in this
DSO.
samples are waiting for return to Earth-based
laboratories for culture and analyses.
Recommendations for further study
include flying other DSOs to investigate effects
of long term culture of cells on beads in
microgravity, secretion of target products,
effects of microgravity habitation on the
cytoskeleton, and secretion of attachment
proteins.
PUBLICATIONS BASED ON THIS
DSO
. Cogoli, A. and Tschopp, A. (1982).
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Advances in Biomedical Engineering
(Fiechter, A., ed), Vol. 22, pp. 1-50
Springer - Verlag, Berlin.
. Tschopp, A., Cogoli, A., Lewis, M.L., and
Morrison, D.R. (1984). Bioprocessing in
Space: Human cells attach to beads in
microgravity. Jour. Biotechnology (1984)
287-293.
CONCLUSIONS
Results of this DSO show clearly that
anchorage-dependent human kidney cells
attach to beads as well, or better, in
microgravity than on Earth. Fifty percent more
single cells had attached by 2.5 hours than in the
ground control. There were no apparent
differences in cell spreading and proliferation
on the beads and no discernable differences in
the manner of attachment observable by
scanning electron microscopy.
These findings are extremely significant
to the future of bioprocessing in space. They
show that cells may be seeded on beads and
initiated in microgravity for culture in a
bioreactor or that cells may be grown in
microgravity for electrophoretic separations.
The selected subpopulations of high product-
secreting cells may be seeded on beads for
production of target pharmaceuticals. Cells
separated by continuous flow electrophoresis
may now be collected in receptacles containing
microcarrier beads, thereby allowing
attachment and better survival while the
. Lewis, M.L., Cogoli, A., Morrison, D.R.,
and Tschopp, A. Anchorage dependent
cells attach to microcarrier beads in
microgravity. Abstract #263 - presented
at the 8 International Biophysics
Congress, Bristol, U K., 1984.
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Investigator: Duane L. Pierson, Ph. D. 
INTRODUCTION 
Microb ia l  c o n t a m i n a t i o n  dur ing  
spaceflight presents a variety of health hazards 
t o  the crew and deterioration o f  essential 
materials. The level o f  airborne microbial 
contaminants has been established as an 
important factor i n  the  dissemination of 
infectious diseases. The Shuttle/Spacelab serves 
as a small closed environmental system with a 
limited ability for the removal o f  airborne 
microbes. Microbially laden droplets and 
particulates generated by coughs, sneezes, and 
crew activities are removed from t h e  air in 
minutes at one g; however, these droplets can 
remain suspended for hours in microgravity. 
The JSC M i c r o b i o l o g y  Laboratory 
implemented a Microbial Contamination 
Control Plan at the onset of the STS missions. 
One facet of the plan was the quantitation and 
iden t i f i ca t i on  o f  a i r b o r n e  microbia l  
contaminants. The cabin air was evaluated 
preflight and postflight to assess the efficacy of 
the environmental control system in removing 
such contaminants. The presence of an open 
hatch and the activities of various ground 
support personnel during sample collection 
jeopardizes the scientific validity of such studies. 
lnflight monitoring was the only scientifically 
sound method for assessing the levels and types 
of airborne microbial contaminants during a 
mission. The impact of the length of mission, 
number of crewmembers, and the inclusion of 
animals and other biological specimens upon 
the microbial load of the Orbiter's air can be 
assessed only by the evaluation of inflight air 
samples. 
PROCEDURES 
Evaluat ion o f  t h e  airborne 
microorganisms was achieved by the use of the 
Reuter Centrifugal Air Sampler (RCS). Two- 
minute air samples were taken with the  RCS 
using trypticase soy agar strips or rose bengal 
agar strips Samples were taken during the 
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preflight, inflight, and postflight phases of the 
missions. The sample sites were located on both 
the  mid-deck and the  f l i gh t  deck. The 
microorganisms collected on all air strips were 
quantitated and identified. 
Figure 7 .  The Reuter Centrifugal Air Sampler. 
The R C S  is a completely por tab le  
instrument which can be hand-held and 
requires relatively little maintenance. The body 
consists of a metal tube 336 5 cm in length and 
3.8 cm in  diameter with an open end drum on 
one end, a power pack attached to the side, and 
a screw cap for access t o  the batteries on the 
end opposite the drum (Figure 1) .  The power 
pack is 3.5 cm X 13.9 cm X 1.3 cm and has an 
indicator light, main power ("ON-OFF") switch, 
time settings, and a start button. The indicator 
light detects weak or nonfunctioning batteries 
when the "ON-OFF" switch is i n  the "ON"  
position. The time setting selectors determine 
the length of time the sampler will run and the 
volume of air that will be sampled. The open 
end drum assembly is 7 cm in diameter and 3.2 
cm deep and houses a removable ten blade 
impeller (Figure 2). The impeller blade assembly 
is removed for cleaning and/or sterilization as 
required by gently pulling on the knob attached 
to  the center of the blade assembly; the drum 
can then be unscrewed from the instrument. 
The inside of the drum is grooved to  hold the 
agar strip in place. 
Figure 2. RCS impeller. 
The RCS employs the principle of  air 
centrifugation, whereby the air is drawn in by 
the action of the impeller blades. The microbial 
particles present in the air are impacted onto 
the surface of the agar in the strip. The air flow 
is shown in Figure 3. The operating speed of the 
RCS i s  4092 rpm and i t  draws 40 liters of air per 
minute. The flow rate remains constant by 
means of a n  electronic control which counts 
impulses reflecting from the rotating blades. 
+I 
Figure 3. A i r  flow schematic. 
Media Strips: Two types of agar strips 
were used. One contained nutrient agar for 
growth of bacteria. The other contained rose 
94 
bengal agar for growth of fungi. Except for the 
agar, the strips were identical. 
The agar strip used in the centri fuga1 air 
sampler was specially designed t o  give a surface 
area of 34 cmi (2  rows of 17 wells measuring 1 
cm*). This design allowed the strip t o  bend 
without cracking the agar as i t  was inserted into 
the open end drum, and also aided in  the  
counting of the colonies. The agar strip was 
21.2 cm X 2.5 cm X 0.3 cm and was packaged in a 
clear rigid plastic wrapper 23.5 cm X 3.2 cm X 0.9 
cm with a seal on the cover (Figure 4). The agar 
strip was positioned in its wrapper so that the 
agar surface was facing away from the top of 
the wrapper. The agar strip may be stored a t  
4°C for a t  least three months or a t  room 
temperature for one month. 
Figure 4. Agar strip. 
Sample Procedures: The cabin air was 
monitored on both the middeck and flight deck. 
Sampleswere taken a t  the following times: 
Preflight 24 hours before flight 
lnflight #1 2nd day of mission 
#2 mid-mission day 
#3 next to last day 
Postflight 6 hours after landing 
The agar strips used inflight were stowed 
in  the  equipment area unt i l  postlanding 
destowage. The strips were packaged in wet ice 
and returned t o  the  JSC M i c r o b i o l o g y  
Laboratory where they were analyzed both 
quantitatively and qualitatively. 
RESULTS 
The results obtained from the microbial 
monitoring of the Orbiter air environment from 
STS missions 1-9 and mission 1 1  are given in 
Figures 5-8. Pre- and postflight sample analysis 
are shown for all the missions. lnflight sample 
analyses are shown for STS missions 6, 7, and 11. 
lnflight samples were also taken during another 
STS mission; however, the samples were 
compromised due t o  destowage and 
transportation conditions. The agar strips were
not destowed at the designated time and were
subsequently exposed to temperatures
incompatible with microbial recovery.
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Figure 5. Airborne bacteria, mid deck.
A qualitative analysis of each strip was
also performed. This consisted of isolating and
identifying each type of microorganism on the
strip. A number of potential pathogens were
isolated and are shown in Figure 9.
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Postflight microbial levels were generally
20-80% higher titan preflight levels. However,
the inflight measurements were more useful in
evaluating the microbial levels of crew exposure
during the mission. Four slight dropsin the
microbial load were experienced during the first
part of the mission, but this was followed by a
rapid increase as the mission proceeded. The
last inflight levels increased as much as 200-400
percent over the first inflight levels.
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Figure 8. Airborne fungi, flight deck.
DISCUSSION
Inflight monitoring of the air proved to
be a useful means of quantitating microbial
changes that occurred during missions. A slight
drop in the level of microorganisms in the air
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was commonduring the early stages of the
missions. This would indicate that the filtration
system was adequate to clean the air at that
time. However, as the mission progressed, the
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air; the levels of contamination increased as the
mission proceeded. This may have been due to
the clogging of the filters with debris. It is
logical to assume that longer missions and
larger crews would increase the levels of
contamination even more.
FUNGI
Alternaria a/ternata
Aspergillus amstelodami
Aspergillus f/avus var co/umnaris
Aspergi//us niger
Aspergil/us sydowi
Aspergi//us versicolor
Curvu/aria senega/ensis
Drechs/era hawaiiensis
Geotrichurn candidum
Rhodotoru/a rubra
Trichosporon pu/lu/ans
BACTERIA
Acinetobacter calcoaceticus
Acinetobacter ca/coaceticus (/woffi)
Figure 9. Microorganisms identified.
A number of potentially pathogenic fungi
were isolated The fungi have become
increasingly important with the advent of the
reusable spacecraft. Although the fungi are
relatively slow growers, they are also very
resistant to adverse conditions and remain
viable for long periods of time. They remain
dormant under adverse conditions but resume
growth when conditions become more
favorable. They pose a threat to the health of
the crewmembers as 1) agents of infection, 2)
allergens, and 3) producers of toxic metabolites.
In addition, they are able to synthesize a vast
array of enzymes enabling them to deteriorate
practically every organic compound known.
CONCLUSIONS
The importance of the microbial
monitoring of the air environment of the
Shuttle missions, and eventually the Space
Station, cannot be over emphasized. This
monitoring serves 1) to evaluate cleaning
procedures used between flights, 2) to evaluate
microbial build-up in the orbiter during flight,
and 3) to obtain data on contamination due to
introduction of plants, animals and
microorganisms.
A continual build-up of airborne
contaminants was demonstrated by sequential
sampling during several missions. While
postflight monitoring of the air has always
shown an increase in the microbial level, it does
not truly reflect the levels of airborne
microorganisms during the flight.
It is highly recommended that inflight
monitoring of the airborne microbial
contaminants be continued until a clear trend
emerges. It is essential to evaluate the ability of
the Orbiter's environmental control system to
maintain acceptable levels of airborne microbes
prior to the establishment of the Space Station.
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MICROBIOLOGY REPORT IN SUPPORT OF THE
SPACELAB 3 MISSION
Investigators: O. Pierson, Ph.D., and K. Gaiser
INTRODUCTION
The Spacelab 3 mission was unique for
several reasons. The flight represented the first
use of the Spacelab as an animal facility for
biomedical investigation. The mission also
served as the Flight Verification Test of the
Research Animal Holding Facility (RAHF). The
DSO, "Microbial Monitoring of the Spacelab 3
Mission," was developed and implemented to
evaluate the impact of the animals in the
Spacelab environment and to determine the
ability of the RAHF to contain microorganisms.
Microbiological testing conducted on
previous Space Shuttle flights has shown that
some microbial buildup occurs in the closed
crew environment during the course of the
mission (1-2). The inclusion of animals in the
crew environment represents a potential source
of microbial contamination that may result in
cross-contamination between the animals and
crewmembers.
The first flight utilizing the RAHF
required a more extensive microbial sampling
protocol to monitor the microbial flora of the
spacecraft and the crewmembers and to assess
the containment capabilities of the RAHF. The
microbiology effort for this mission was
comprehensive and involved the Ames Research
Center, Kennedy Space Center and the Johnson
Space Center. This report describes the JSC
effort. Included are the sample sites, methods,
and the laboratory results obtained from the
microbiological investigations conducted during
the flight of Spacelab 3.
MATERIALS AND METHODS
SAMPLING PROTOCOL
Table 1 summarizes the sample sites,
times, and types collected during the pre-, in-,
and postflight phases of the Spacelab 3 mission.
All samples described in this study were
analyzed in the Microbiology Laboratory at JSC.
SAMPLE COLLECTION
CREWMEMBER
Samples from the crewmembers' ears,
nose, throat, and hands were collected by the
Culturette System during all sampling periods.
With the exception of the throat cultures, all
other samples were obtained after moistening
the Culturette swab with 0.8 mM sterile
phosphate buffer. After sampling, the
Culturettes were stored at ambient temperature
until processi ng.
Sputum and fecal specimens were
collected in appropriate sterile containers and
stored at 5° C until processing.
A 10 ml blood sample was collected from
each crewmember for the determination of
antibody titers to specific viral agents such as
Hepatitis A and B, Epstein-Barr, and Herpeswrus
saimiri, etc. A throat swab was collected from
each crewmember for isolation of any viral
agents that may have been present. The throat
swab was placed in Veal Infusion Broth for
stabilization and maintained at 5 ° C until
processing.
S URFA CE SA MPL ES
Preflight and postflight surface samples
from the Orbiter, Spacelab, and RAHF were
collected using two sterile calcium alginate
swabs moistened with 0.8 mM sterile phosphate
buffer for each site. One swab was placed in
trypticase soy broth for bacterial analysis; the
other swab was placed in yeast malt broth for
fungal analysis. All swabs were stabilized at 5° C
until processing
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Inflight surface samples of the RAHF and
crewmembers' gloves were collected using the
Culturette system. One Culturette per site was
used. The Culturette was moistened with 0.8
mM sterile phosphate buffer before sampling.
The samples were stored at ambient
temperature until processing.
AIR SAMPLES
Air samples were collected in the Orbiter,
Spacelab, Life Sciences Support Facilities (LSSF),
and the JSC and KSC Crew Quarters using a
Reuter Centrifugal Air Sampler. Two strips were
taken at each site. One strip contained
trypticase soy agar for bacterial analysis and the
other contained rose bengal agar for fungal
analysis. Additionally, particulate samples were
taken inflight using the same air sampler with a
modified Biotest sampling strip. All samples
were maintained at ambient temperature until
processing. Particulates were enumerated by
light microscopy and further analyzed by
scanning electron microscopy.
ANIMAL FECAL SAMPLES
Fecal samples were collected at the LSSF
from the rats and squirrel monkeys. Samples
were stabilized at 5° C and delivered to JSC for
processing.
SAMPLE PROCESSING AND
ANALYSIS
Specific details of sample processing and
analysis techniques for all types of samples
collected are outlined in Spacelab 3 Microbial
Contamination Control Plan In Support of DSO
0437.
RESULTS
CREWMEMBERS
PREFLIGHT
As part of the routine F-10 preflight
physical exam, samples were collected from the
ears, nose, and throat of each crewmember. In
addition to the routine samples, fecal and serum
samples were collected from each crewmember.
The fecal samples were analyzed for the
presence of ova and parasites and pathogenic
bacteria and fungi. The serum sample was
assayed for antibody titers to specific viral
agents. A sputum sample was received from
one crewmember. Additional throat cultures
were taken at F-0 on all crewmembers.
There were no microorganisms of medical
concern recovered preflight from any of the
crewmembers' specimens (Tables 2-5). The
predominant microbial genus recovered
immediately preflight from the throat cultures
in six of the seven crewmembers was
Streptococcus.
Air samples were taken preflight at F-30
(KSC) and F-10 (JSC) to assess the microbial load
in the Crew Quarters prior to crew occupancy of
these facilities. Overall, the microbial levels
obtained at KSC (Table 6) and JSC (Table 7) were
consistent with those observed from preflight
sampling for previous missions. Three types of
potentially pathogenic fungi were isolated from
the Crew Quarters (Tables 6 and 8). These
organisms are common fungal atmospheric
contaminants, and no action was taken.
INFLIGHT
Throat and hand cultures were collected
from selected crewmembers on MD1, MD2,
MD4, and MD6. Table 9 shows the
microorganisms recovered from the inflight
throat samples. With the exception of the
Bacillus sp. and Saccharomyces cerewsiae, all
other microorganisms were isolated from the
crewmembers preflight throat samples. Neither
of these microbial species are considered to be
fecal contaminants or of probable animal
origin.
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Table 10 illustrates the microorganisms
isolated from the hand swab samples. In some
cases, samples were collected after the hands
had been cleaned with alcohol wipes. This
sampling method may explain the apparent lack
of growth in some of the cultures. The only
microorganism of interest was Streptococcus
faecalis which was isolated on MD2 from the
hands of crewmember 7. This microorganism
was recovered from preflight rat and squirrel
monkey fecal samples collected at F-30. This
species is also a common isolate of human feces.
A waste tray changeout occurred immediately
preceding the hand sampling procedure and
may have been the source of the microbe. This
microorganism was not isolated at any later
time from any crewmembers' hands.
POS TFLIGHT
Ear, nose, throat, and sputum cultures
were collected at L+ O and again at I. + 3 with
the exception of the sputum samples.
Microflora recovered from these samples was
similar to preflight findings. Postflight samples
do not indicate any cross-contamination
between the animals and the crewmembers.
Pseudomonas aeruginosa, Pseudomonas
fluorescens (Table 2) and Penicillium sp. (Table
3) were isolated at L + 3 and are not considered
to be of flight origin.
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Figure 1. Bacterial and fungal counts, mid deck.
v
1.5
1.4 "-_
1.3-
1.2 -_
1.1 t
t.O
0.0
0.8
0.7 t
O.I
O.S t
0.4
:::tIL
f.)o f-o 1 2 $ 4 $ •
tdk_don
Fllare z
SPACECRAFT
Figure 2. Bacterial and fungal counts, flight
deck.
PREFLIGHT
Orbiter
the same as seen in preflight sampling periods
from previous missions. The particulate strips
were not collected preflight.
Surface swabs were collected at F-30 after
alcohol cleaning and again at F-0 just prior to
crew entry. Analysis of these samples did not
demonstrate any unusual microbial levels (Table
11). However, a small number of samples
collected from the Waste Management System
(WMS) at F-0 showed very high levels of non-
pathogens. This was attributed to improper
temperature control of the samples prior to
processing at JSC. The microorganisms of
significance are listed in Table 12.
Bacterial and fungal air samples were
collected at F-30 and F-0 for baseline data (Figs.
1,2). The microbial levels were approximately
Spacelab
Surface swabs were collected from six
locations in the Spacelab module at F-30 after
the wipedown and during the landing
simulation exercises. The module was closed
out upon completion of the exercises. No
bacteria were isolated from any of the sites.
Only 10 fungal colonies were recovered from
the workbench handrail and were not of
medical or epidemiological interest (Table 13).
A duplicate set of surface swabs was
collected from twenty-two locations on the
interior and exterior surfaces of the primate and
rodent RAHFs. These samples were collected to
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evaluate the cleaning procedures and to
establish the baseline microbial levels for the
RAHFs. Analysis of these samples showed low to
moderate levels of microbial contamination
(Table 14). Only two species of potentially
pathogenic fungi were isolated from the
primate RAHF (Table 15). Both are common
environmental fungal species and represented
no significant problem.
Bacterial, fungal, and particulate air strips
were collected at F-30 during the landing
simulation exercises prior to the final closeout
(Fig. 3). Microbial levels were comparable to
data obtained from Orbiter samples taken
during previous missions. The particulate strips
were not stored properly and, consequently,
could not be processed.
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Figure 3. Bacterial and fungal counts, Spacelab.
INFLIGHT
Orbiter
No surface samples were collected from
the Orbiter inflight. Bacterial, fungal, and
particulate air sampling strips were collected on
MD1, MD3, and MD7 on both the Mid Deck and
the Flight Deck. Figures 1 through 3 illustrate
the quantitation of the microorganisms and
particulates recovered at each sampling period.
Bacterial levels were markedly elevated on the
Mid Deck on MD1 and decreased steadily
throughout the mission (Fig. 1). Conversely,
bacteria on the Flight Deck increased tenfold
during the course of the flight (Fig. 2). No
significant changes were observed in fungal
levels during the flight. The majority of
potential pathogens were fungi of the
Aspergillus genus. Staphylococcus aureus was
the only pathogenic bacterial species isolated
(Table 17). No microorganisms of probable
animal origin were isolated from the Orbiter
infliqht samples. Particulates on the Mid Deck
decreased during the flight (only 2 samples) in
much the same manner as the bacterial levels
(Fig. 4). However, Flight Deck particulate values
were high throughout the mission (Fig. S). The
elevated values for bacteria and particulates on
the Flight Deck may be a result of the
directional airflow from the Spacelab to the
Flight Deck.
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Figure 4. Particle counts, mid deck.
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Spacelab
No samples from the Spacelab surfaces
were collected inflight. Air samples were
collected daily in conjunction with the waste
tray changeout procedure. Bacterial, fungal,
and particulate levels remained nearly constant
tO0
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throughout the flight. An increase in particulate
counts was noted during and following the
waste tray changeout on MD4 (Fig. 6).
Aspergillus sp. was the only potentially
pathogenic microorganism isolated during the
inflight sampling period (Table 16).
Five swab samples from the rodent RAHF
and two swab samples from the primate RAHF
were taken immediately following waste tray
changeout on MD2, MD4, and MD6. All sample
sites were external surfaces of the RAHFs.
Additional samples were taken from
crewmembers' gloves. Table 17 lists the
microorganisms isolated from these sites. No
fecal coliforms, indicative of fecal
contamination, were isolated.
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Figure 6. Particle counts, $pacelab.
POSTFLIGHT
Orbiter
Bacterial and fungal swab samples were
collected at L + 0 at twenty-one sample sites. An
approximate ten-fold increase from the
preflight counts was seen in the number of
bacteria in 11 of the 22 sites (Table 11). The
number of fungal organisms did not increase
significantly during the mission. Only two
microbial species of interest, Escherichia coil and
Klebsiella pneurnoniae, were detected. E. coli, a
fecal contaminant, was recovered from the air
inlet ring and the slide valve which are two
interior components of the Orbiter Waste
Management System. This microbial species has
been routinely recovered from these sites on
previous flights K. pneurnoniae was isolated
from the air return of the Aft Flight Deck. The
origin of this contaminant is uncertain; K.
pneumoniae was isolated immediately preflight
from flight squirrel monkey #384-80 (sampling
and analysis conducted by KSC). Bacterial and
fungal air samples were collected at L+O.
Postflight data correlates with the bacterial and
fungal levels observed preflight (Figs. 1, 2). The
particulate strips were not collected postflight.
Spacelab
Surface swabs were collected at L+O
from the same six locations that were sampled
preflight. Increases in bacterial growth were
observed on five of the six locations (Table 13).
No fungal growth was detected. Staphylococcus
aureus was the only potential pathogen
isolated.
Bacterial, fungal, and particulate air strips
were collected at L+0 immediately following
the opening and ventilation of the Spacelab
module. Bacterial and fungal levels were similar
to preflight values (Fig. 3). The postflight
particulate strip could not be enumerated due
to the presence of numerous fine particles,
presumably dust, which contaminated the
5pacelab module during the ventilation
procedure.
Postflight sampling of the RAHFs
followed the preflight sampling protocol. Swab
samples were collected from the twenty-two
sites taken preflight. These samples were taken
immediately after animal cage removal. A slight
overall increase in bacterial growth was
observed in samples from L + O (Table 14). The
only organisms of significance were the fecal
markers, E. coli and S. faecalis, and
Staphylococcus aureus. All three species were
isolated only from interior RAHF surface
samples (Table 15). No appreciable change was
observed in the number of fungal organisms.
ANIMAL MONITORING
At F-30 fecal samples were taken from
selected rats and squirrel monkeys. Air samples
were collected from the KSC LSSF during the
same sampling period.
Table 18 lists all the microorganisms
recovered from rat fecal samples. No
microorganisms on the exclusion lists (Table 20
and 21) as defined by the JSC Human Research
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Policy & Procedures Committee were isolated.
Table 19 lists all the microorganisms recovered
from the squirrel monkey fecal samples. Only
one species on the exclusion list, K.
pneumoniae, was isolated from monkey #3495.
This animal was not selected for flight.
However, immediately preflight K. pneumoniae
was cultured from flight squirrel monkey #384-
80 (sampling and analysis conducted by KSC-
designated laboratories).
The air sample data collected from LSSF is
shown in Table 22. The microbial levels were
low and consistent with previous sampling data.
Only common fungal environmental
contaminants were isolated.
DISCUSSION
A total of 175 preflight, 81 inflight, and
98 postflight samples (354 total) were collected
for quantitation and identification of the
microbial flora present in the crew environment
during the Spacelab 3 mission. The sampling
protocol included samples from the air, various
environmental surfaces, animals, and
crewmembers.
Crewmember reports clearly documented
the RAHF containment problems experienced
during the flight. Comprehensive
microbiological testing of the crewmembers
and their environment during the SL-3 mission
revealed no unusual microbial accumulations
during the course of the mission. Levels of
airborne microorganisms in the Spacelab were
low compared to values obtained from the
Orbiter during previous missions.
Fecal microorganisms, such as E. coli and
S. faecalis were used as marker microorganisms
for indication of fecal contamination. E. coli
was detected only in the Orbiter Waste
Management System and was probably of crew
origin. E. coil and S. faecalis were also isolated
from the interior surfaces of the RAHF
postflight. In only two instances were microbial
species of possible animal origin isolated
external to the RAHF. 5. faecalis, a fecal marker
organism, was isolated on mission day 2 from a
crewmember's hand immediately following
waste tray changeout. K. pneumoniae was
isolated postflight from an air return screen on
the Orbiter Flight Deck. Unequivocal
determination of origin, crewmember or
experimental animal, was not possible.
The anomalies experienced during the SL-
3 mission clearly demonstrated the value for
redundancy in issues pertaining to the health of
the crew. The use of Specific Pathogen Free
animals (SPF) assured the safety of the crew
when the RAHFs' containment system
malfunctioned. It is strongly recommended that
strict adherence to the SPF list be followed for
all flights utilizing any biological specimens.
.
.
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Table 1. Microbial Samples Collected
Sample Sites
Crew
Ear
Nose
Throat
Feces
Sputum
Hands
Plasma
Spacecraft
Surface
Air
Spacel ab
Surface
Air
RAHF
Surface
Preflight
F-IO
F-IO
F-IO, F-O
F-IO
F-7
F-10
F-30
F-30
F-30
Sampling Times a
Inflight
MD1, MD2, MD4, MD6
MD1, MD2, MD4, MD6
MD1, MD7
MD2, MD3, MD4, MD5, MD6
MD2, MD6
Postfl ight
L+O, L+3
L+O, L+3
L+O, L+3
L+O
L+60
L+O
L+O
L+O
L+O
L+O
Crew quarters
KSC
JSC
LSSF
Air
Animal s
Feces
F-30
F-IO
F-30
F-30
aF refers to days prior to flight, e.g., F-IO is 10 days preflight
L refers to days after landing, e.g., L+3 is 3 days post landing
MD refers to mission day
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Table 2. Medically Important Microorganisms Isolated From Cre_r's Throat
Preflight Postf light
F-IO F-O L_O L+3
CREWMEMBER 1 2 3 4 5 6 7 1 2 3 4 5 6 7 l 2 3 4 5 6 7 1 2 3 4 5 6 7
NSBACTERIA
"--A-cT'n'etobactercalcoati-
cus bio anitrau-'¥E_s--
Bran-_IT_---Tl_alis
Citrobacter sp.
Cor_nebacterium sp.
Enterobacter_
Enterobacter cloacae
Haemophilus ap--_lus
Haemophilus sp. not
influenzae
Haemophilus para-
haemol_ticus
Haemophilus para-
influenzae
Ha_para-
influenzae
rF6T_
Haemophilus para-
influenzae
_T6T_
Haemophilus para-
influenzae
K1uyve_asp.
Micrococcus sp.
Neisseria sp.
lactamicus
_-_aT
Pseudomonas T)uorescens
Serratia rubidaea
_cu S aureus
OCCUS_-
midls
Al_emolytic
Streptococcus
Gamma-hemol_ic
Streptococcus
Streptococcus eu_
Streptococcus moriD11-
lorium
_mitis
5treptococcus_
Streptococcus sal_var_us
Streptococcus san_
FUNGI
-'-_er_illus flavus group
Candlda albicans
iL'¥6-dTJ_opicalis
IIF_b-d'6_orularubra
X X X X
X
X X
X X X X X X X
x x x x
x x x x x x x
x x x
x x
x PO PO PO PO x PO
PO x x x x PO x
x x
x
X
x PO
X
X x
X X X
X
X
X X X
X X X
X
X X X
POX
X
PO
X
X
PO X X X PO PO X
X PO X
PO
PO x x
x x
x
PO PO PO PO
x X X x
x
x
x x X
x
x x
PO x
x
x
X
x x
x x
x
x
x x
x
PO PO
x
PO PO
x X
X
PO
x
x
x x
x
x x
PO
x x X
PO = Predominant organism
NS = No sample taken
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Table 3. Medically Important Microorganisms Isolated From Crevlaembers' Nose
Preflight
BACTERIA
Citrobacter sp.
Corynebacteriom sp.
Enterobacter_
Enterobacter cloacae
Micrococcus sp.
Proteus mirabilis
Staphylococcus aureus
Staphylococcus epidermidis
Postflight
F-IO L+O L+3
CREWMEMBER 1 2 3 4 5 6 7 I 2 3 4 5 6 7 I 2 3 4 5 6 7
NS
PO X X PO PO X
X X
X
X
X PO X PO
X X PO X X X PO
PO
PO X PO
X PO PO X PO
X X X X X X PO
X
X X PO
X X
X
X
PO PO PO
X X X PO X
X
X
FUNGI
Candida albicans
Penicillium sp. 1
Penicillium sp. 2
Scopulariopsis brevicaulis
PO
PO = Predominant organism
NS = No samp]e taken
Table 4. Medically Important Microorganisms Isolated From Crewmembers' Ears
CREWMEMBER
BACTERIA
Bacillus sp.
Corynebacterium sp.
Enterobacter aeroqenes
Enterobacter cloacae
Lactobacillus sp.
Micrococcus sp.
Staphylococcus sp.
Staphylococcus aureus
Staphylococcus epidermidis
FUNGI
Aspergillus sp.
Candida parapsilosis
Fusarium sp.
Penicillium sp.
Preflight Postflight
F-IO L+O L+3
1 2 3 4 5 G 7 I 2 3 4 5 6 7 1 2 3 4 5 6 7
X
X
PO PO X
PO X PO X X X"
PO X X X PO PO
X
X
X
X
X X X
PO PO
PO PO PO PO PO X X
PO PO X X PO
X
NS
X X PO PO X PO
X X
PO = Predominant organism
NS = No sample taken
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Table S. Microbiological Analysis of Sputum
from Cre_e_embers
!
MICROORGANISMS
PREFLIGHT POSTFLIGMI
NS
NS
Alpha-hemolytic Streptococcus (PO)
Gamma-hemolytic. Streptococcus
Neisseria sp.
!_rium Sp.
iHaemophilus _ not influenzae
NS
NS
Alpha-hemolytlc Streptococcus (PO)
Neisseria sp.
_lytic Streptococcus
rium sp.
s-GT.
_e sp"
nza
Candida albicans
Alpha-hemolytic Streptococcus (PO)
Neisseria sp.
_lytic Streptococcus
aureus
_tapnylococcus e_.p'TB'e'rmidis
Alpha-hemolytic Streptococcus (PO)
Neisseria sp.
_lytic Streptococcus
Nicrococcus sp.
_rium sp. (PO)
'mcrococcus
_ue sp°
nza
Candida albicans
sp. (Po)
ainfluenzae,-
StaphLlococcus e_pidermidis
NS = No samples taken
Table 6. Quantitation of Airborne Microorganisms in the Kennedy Space
Center (KSC) Crew Quarters at F-30
AREA
BEDROOM 1B
BEDROOM 2B
BEDROOM 3B
BATHROOM B
BEDROOM 1C
BEDROOM 2C
BEDROOM 3C
BATHROOM A
GYM
DINING ROOM
LIVING ROOM
KITCHEN
CONFERENCE ROOM
LIVING ROOM A
CFU/m3 OF AIRa
BACTERIA FUNGI
38 438
SO 238
50 363
100 175
138 100
38 113
75 163
88 88
S0 75
12 88
38 50
12 188
12 150
0 5O
aColony forming units per cubic meter of air
I06
POTENTIAL
PATHOGEN
Orechslera
_sis
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Table 7. Quantitatlon of Air Borne Microorganisms Isolated
from the Johnson Space Center (JSC) Crew Quarters at F-IO
TRAILER # LOCATION
Bedroom #1
Bathroom
Kitchen
Living Room
Bedroom #2
Hall
Bedroom #3
Bedroom #4
Bedroom #1
Bathroom #1
Kitchen
Living Room
Bedroom #2
Hall
Bathroom #2
Bedroom #3
BACTERIA
1000
2050
500
300
50
550
100
150
500
6O0
150
5OO
150
2OO
150
5O
CFUIm 3 of Air
FUNGI
3500
3750
1500
1200
40O
900
2O0
750
1350
1600
8OO
1250
200
500
3OO
25O
Outside Bathroom 450 600
Trailer Area between Trailer 1&2 50 300
3 Food Storage Room
Bathroom
Hall
Living Room
Dining Room
Kitchen
Bedroom #I
Bathroom #1
Kitchen
Living Room
Bedroom #2
Hall
Bathroom #2
Bedroom #3
3OO
200
3OO
65O
8O0
150
550
80O
3O0
700
5O0
0
150
900
2OO
1250
5OO
1400
6O0
95O
1850
2150
1300
1750
400
550
950
450
Table 8. Potential Pathogens Isolated from Johnson Space Center
(JSC) Crew Quarters at F-IO
Potential Pathogen Location
Aspergillus sp.
Aspergillus flavus
Drechslera hawaiiensis
Trailer 1, Bedroom #2
Trailer 2, Bedroom #2
Trailer 2, Hall
Trailer 3, Bathroom
Trailer 4, Kitchen
Trailer 4, Bathroom #2
Trailer 1, Living Room
Trailer 1, Hall
Trailer 1, Bedroom #1
Trailer 1, Bathroom #1
Trailer 1, Bedroom #2
Trailer 2, Bedroom #1
Trailer 2, Bathroom #1
Bathroom between Trailers I & 2
Trailer 4, Bedroom 1
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Nedlcally Important Microorganisms Isolated From Crewmembers' Throat (Inflight)
Inflight
MDI ND2 MD4 MD6
CREWMEMBER 1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7
BACTERIA
Bacillus sp.
Cor_nebacterium sp.
Haemophilus sp. not
Influenzae
Micrococcus sp.
Neisseria sp.
Staph_lococcus aureus
Staph_1ococcus epidermidis
Alpha hemolytic
Streptococcus
Gamma hemolytic
Streptococcus
Streptococcus salivarius
FUNGI
Asper_illus flavus group
Candida albicans
Saccharom_ces cerevisiae
PO = Predominant organism
NS = No sample taken
NS NS NS NS NS
X PO
PO
X
X
HS NS NS HS NS
PO
x
x PO
X
NS NS
PO PO
POx X PO
X
PO
x x x
x
XXX XX
X
XXXXX X
X X
XXXXXXX
PO PO PO X PO X PO
X X X PO PO
x
x x x x
x
Table I0. Medlcally Important Microorganisms Isolated from Crewmembers' Hands (Inflight)
Cre_nember MDI MD2 MD4 MD6
3 NS No growth
NS
No growth
NS
HS
No growth
NS
Aspergillus flavus group
Streptococcus faecalis
Aspergillus flavus
group
Aspergillus flavus
group
No growth
Aspergillus flavus
group
No growth
Staph_lococcus
e_pidermidis
Staphylococcus
epidermidis
Aspergillus flavus
group
Cr_ptococcus albidus
var albidus
Penicillium sp.
No growth
NS = NO samples taken
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Table 11. Quantitation of Microorganisms Isolated from Orbiter Surface
SAMPLE SITE
Urine collection device
Air Inlet Ring
Slide valve
WCS handle
WMS Trash Bag (MF43H)
Air supply vent, Mid Deck
Wall above hatch
Water dispenser needle
Personal hygiene nozzle
Food locker (MF14E)
Food trays (MF23H)
Food warmer (MF23H)
Sleep restraint (2)
Air supply vent, sleep station
Wet trash
CO2 Absorber (B) latch handle
Window 8 gasket
Air supply vent, flight deck
Control stick, Commander
Control stick, Pilot
Data file case
Air return, Aft flight deck
SAMPLE PERIODa
Bacterial Fungal
F-30 F-O L+O F-30 F-O L+O
1.5X101 2.4X103b 3.8X102
1.5X101 1.0X104b 1.0X103
5.2X102 2.4X104b 1.3X103
7.5X100 4.gXlO2b 2.3X102
NS 2.0X104b 4.1X102
4.5X101 1.7XlO4b 7.7X102
2.3X101 4.5X101 7.5X101
0 9.0X100 3.8X101
3.0XI01 9.0XlO0 NS
NS 0 5.3XI02
NS g.OXIO0 1.2XI02
0 9.0X100 3.0X101
NS 9.0XI00 1.1X102
1.1X102 9.0XI00 9.6X101
2.3X102 7.5X101 8.3X101
NS 0 NS
1.7X102 3.8XI01 4.9X102
1.5X101 9.0XI00 3.8XI02
2.3X101 g.OXIO0 7.5XI00
9.8X101 9.0X100 2.9XI02
7.5X101 9.0X100 1.4XI02
NS 9.0X100 1.2X103
O 0 0
0 1.0XI01 0
0 0 1.0X101
0 2.1XI01 1.0X101
NS 1.0X101 0
5.0XI00 6.3XI01 9.4XI01
0 0 0
0 0 6.3XI01
1.5XI01 0 NS
NS 0 0
NS 0 1.0XI01
0 0 1.0X101
NS 0 1.2X102
3.5X101 1.0X101 3.2X101
0 1.0X101 0
NS 0 NS
5;OXIO0 0 0
2.0XI01 1.0XI01 1.0XI01
0 0 0
0 0 0
5.0XI00 0 0
NS 3.0XI02 2.1X102
aQuantitation given in colony forming units per cm2
bSample not refrigerated after collection
NS=No Sample taken
Table 12. Potential Pathogens Isolated from Orbiter Surface - STS 51-B
SAMPLE PERIOD POTENTIAL PATHOGENS ORBITER LOCATION
F-30 ASPERGILLUS SP. AIR SUPPLY VENT - SLEEP STATION
AIR SUPPLY VENT - FLIGHT DECK
ASPERGILLUS FLAVUS AIR SUPPLY VENT - SLEEP STATION
CURVULARIA LUNATA DATA FILE CASE
PENICILLIUM SP. AIR SUPPLY VENT - SLEEP STATION
F-0
L+0
ACINETOBACTER CALCOAETICUS
ALTERNARIA SP.
ASPERGILLUS SP.
ASPERGILLUS FLA VUS
ASPERGILLUS NIGER GROUP
GRAM NEGATIVE ROD CDC GROUP VE-2
STAPHYLOCOCCUS AUREUS
ACREMONIUM SP.
ASPERGILLUS SP.
ASPERGILLUS NIGER GROUP
ENTEROBACTER AEROGENES
ESCHERICHIA COLI
KLEBSIELLA PNEUMONIAE PENICILLIUM SP.
STAPHYLOCOCCUS AUREUS
WMS TRASH BAG (MF43H)
WCS HANDLE
AIR SUPPLY VENT - MID DECK
AIR SUPPLY VENT - FLIGHT DECK
AIR RETURN - AFT FLIGHT DECK
WET TRASH
WCS HANDLE
AIR SUPPLY VENT - MID DECK
WMS TRASH BAG (MF43H)
AIR SUPLY VENT - MID DECK
SLEEP RESTRAINTS
WCS HANDLE
AIR SUPPLY VENT - SLEEP STATION
AIR RETURN - AFT FLIGHT DECK (2 SPECIES)
AIR SUPPLY VENT - MID DECK
WATER DISPENSER NEEDLE
SLEEP RESTRAINT (2)
WINDOW 8 GASKET
AIR RETURN - AFT FLIGHT DECK
AIR INLET RING - WMS
SLIDE VALVE - WMS
AIR RETURN - AFT FLIGHT DECK SLIDE VALUE
AIR RETURN - AFT FLIGHT DECK
FOOD TRAYS (MF23H)
109
Table 13. Ouantltation of Microorganisms Isolated from the Spacelab Surface
Sampl_ Site
Air Vent
Workbench Handrall
Utility Box Latch
CO2 Absorber Latch
Workbench Surface - Center
Trash Container (2 loops)
Sample Perioda
F-30
Bacterial
L+O
9.0xlOOb
5.3x101
4.0x101
3.0x101
0
1.4x102
F-30
0
1.0x101c
0
0
0
0
Fungal
aOuantltation in colony forming units/cm 2
bpotentlal pathogen Staphylococcus aureus, isolated
CPotentlal pathogen Penicilllum sp._ated
L+O
Table 14. Ouantltation of Nicroorganisms Isolated from the RAHF Surface
Sample Site
Primate RAHF
Quick disconnect, lixlt, slot 1
Inner door, inner surface slot I
Quick disconnect, llxit, slot 2
Inner door, inner surface, slot 3
Case alr inlet plenum, slot 2
Case air outlet plenum, slot 2
Outer door, outer surface, slot 2
Outer door, outer surface, slot 4
Bleed air outlet port
Bleed air inlet port
Rodent RAHF
Ltxit, front, slot 4
Lixtt, rear, slot 6
Inner door,inner surface, slot 6
Ltxtt, front, slot 8
Lixtt, rear, slot 10
Case air inlet plenum, slot 10
Case air outlet plenum, slot 10
Inner door, inner surface, slot 10
Outer door, outer surface, slot 1
Outer door, outer surface, slot 3
Bleed air outlet port
Bleed air inlet port
aQuantltatlon given in colony formin
Sample Perloda
Bacterial Fungal
F-30A F-308 F-30B L+O
1.0x102
0
0
1.0x102
0
0
1.0x102
0
0
3.0x101
1.0x102
2.1x103
0
0
2.3x101
0
1.4x101
0
0
1.0x102
1.0x102
1.0x102
units/cm2
0
7.5x101
0
0
0
7.5x101
0
7.5x101
0
0
0
0
0
0
0
0
0
7.5x101
0
0
0
7.5x101
L+0 F-30A
0 0
1.9x102 0
0 2.0x101
8.3x101 0
2.4x103 0
g.8x101 0
9.0x100 0
0 0
4.5x102 S.OxlO0
1.3x105 0
1.gx102 0
2.5x103 0
0 0
2.8x103 0
9.0x100 0
9.0x100 0
9.0x100 0
9.0x100 0
9.0x100 0
0 0
0 0
1.0x103 5.0x100
0
0
0
0
5.0x100
2.5x101
S.OxlO 0
0
0
0
0
0
0
0
0
0
0
0
0
0
1.4x102
0
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Table15. Potential PathogensI olated fromthe PrimateandRodent
ResearchAnimalHoldingFacilities (RAHF)
DuringPre-andPostflight
SamplePeriod Potential Pathogens RAHFLocation
F-30
L+O
Aspergillus sp.
Penicillium sp.
Escherichia coli
Penicillium sp.
Pseudomonas acidovorans
Staphylococcus aureus
.Streptococcus faecalis
Bleed air outlet port - primate
Quick disconnect, lixit,
slot 2 - primate
Lixit, rear, slot 6 - rodent
Lixit, front, slot 8 - rodent
Bleed air outlet port - primate
Inner door, inner surface,
slot 3 - primate
Case air inlet plenum, slot 2 -
primate
Lixit, rear, slot 10 - rodent
Bleed air inlet port - rodent
Inner door, inner surface,
slot 1 - primate
Lixit, rear, slot 6 - rodent
Case air inlet plenum, slot 10 -
rodent
Case air outlet plenum,
slot 10 - rodent
Inner door, inner surface,
slot 10 - rodent
Table 16. Potential Pathogens Isolated from Spacecraft Air
Sample Period
F-30
F-O
MD1
MD2
MD3
MD4
MD5
MD7
Potential Pathogens
None Isolated
Aspergillus sp. (2)
Aspergillus glaucus
Aspergillus sp.
Aspergillus flavus group
Aspergillus flavus group
Aspergillus sp.
Aspergillus flavus group
Aspergillus sp.
Aspergillus sp.
Aspergillus flavus group
Aspergillus sp.
Sta___lococcus aureus
Orbiter Location
Flight Deck
Mid Deck
Spacelab
Spacelab
Spacelab
Spacelab
Spacelab
Flight Deck
L+O Aspergillus sp. (2) Flight Deck
( ) number of species isolated
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Table 17. Infllght Surface Samples
Rodent RAHF
HD2 1404 MD6
Cage 531 i
No growth
No growth
No growth
NO growth
No growth
Aspergillus flavus group
Aspergiiius fiavus group
No growth
Staphylococcus epidermidis
Outlet Port No growth No growth Staphylococcus epidermidis,
Gram-negative rod CDC VE-2
Slot 6/8 No growth Aspergillus flavusgroup Staph_1ococcus epidermidis
Aspergillus flavus group
Primate RAHF
MD2 MD4 MD6
Cage 1 NS NS NS
4 NS NS NS
Outlet Port Staphylococcus aureus Staphylococcus epidermidis
Slot 1/2
Asper_illus flavus group
Dematlaceous_s"
Bacillus sp.
_eous fungus
No growth Bacillus sp.
Gloves
MD6MD2
Staphylococcus epidermidis,
Micrococcus sp.
Aspergillus flavus group
*MD5 - Gloves Aspergillus flavus group
MD4
Staphylococcus epidermidis Staphylococcus epidermidis
NS = No samples taken
Rat ID Number
Bacteria
Citrobacter
amalonaticus
Enterobacter cloacae
Escherichia coli
Proteus mirabilis
Streptococcus avium
Streptococcus
faecalis
Moniliaceous fungi
(no conidia)
Penicillium sp.
Ova & Parasites
None Observed
Table 18. Microbiology and Parasitology Analysis of
Rat Feces (F-30)
1 2 4 6 7 14 17 32 34 40 42 61 63 64 95 111 112
X X
X
X X X X X X X X X X X X X X
X X
X X X X X X
X
X X X X X
X X
X
X X X X X X X X X X X X X X X X X
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Table 19. Microbiology and Parasitology Analysts of Squirrel
Monkey Feces (F-30)
Monkey ID Number 3165" 3483 3495 384-80"
Bacteria
Escherichia coli
Klebsiella pneumoniae
Proteus mirabilis
Staph@lococcus aureus
Streptococcus faecalis
Ova and Parasites
None Observed
*Flight animals
Table 20. SPF Criteria for Rats
MICROORGANISM
BACTERIA:
Streptobacillus Moniliformis
Spirillum Minor
Streptococcus Pneumoniae
Streptococcus, Beta Hemol_tic
Pseudomonas Aeruginosa
Salmonella sp.
Leptospira sp.
Klebsiella Pneumoniae
KlebsiellaO_xytoca
CampTlobacter sp.
VIRUSES:
L_mphoc_tic Choriomeningitis Virus
Sendal Virus
FUNGI
All Dermatophytes
ECTO PARASITES
ENDO PARASITES
CULTURE SITE/MATERIAL
OR
IDENTIFICATION TEST
Oral
Oral
Oral, Nasal
Oral, Nasal
Oral, Fecal
Fecal
Urine
Fecal, Oral, Nasal
Fecal, Oral, Nasal
Fecal
Blood
Blood
Skin
Skin, Hair
Feces, Caecal Contents
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Table 21. SPF Criteria for Squirrel Monkeys
MICROORGANISM
BACTERIA:
_s_E.
Salmonella s_p_.
Streptococcus pneumoniae
Klebsiella pneumoniae
Mycobacterium tuberculosis
Pasteurella multocida
Campylobacter sp.
Leptospira sp.
Streptococcus, Beta Hemolytic
(Group A)
VIRUSES:
Lymphocytic choriomeningitis
virus
Herpesvirus tamarinus
Herpesvirus saimiri
ENDOPARASITES:
Trichomonas
Acanthocephlans
Strongyloides
Entamoeba histol_tica
Hemoprotozoa
FUNGI:
All Dematophytes
CULTURE SITE/MATERIAL
OR
IDENTIFICATION TEST
Fecal
I Fecal
Oral, Fecal
Oral, Fecal
Skin Test, X-Ray
Nasal, Fecal
Fecal
Urine
Oral, Nasal
i
I
Blood (Serology)
I Blood (Serology)
I
!
Oral
Feces
Feces
Feces
Blood
I
I Skin
Table 22. Quantitation of Airborne Microorganisms
Life Sciences Support Facility (LSSF) at F-30
Sample Site
Hall
X-Ray
Cental Supply
AHR 2
AHR 5
AHR 6
AHR 7
Bacteria
0
0
0
1.5X102
CFU/m3 of Air
Fungi
1.5X102
1.1XI02
8.8X101
7.5X101
1.9X102
2.7X102
0
Potential Pathogens
Aspergillus sp. (3)
Aspergillus sp. (2)
Aspergillus flavus
Asper_illussp.-'_T-[_)
Aspergillus sp. (2)
Aspergillus sp.
Aspergillus sp. (4)
) number of different species isolated.
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n understanding of vestibular and somatosensory roles in A adaptation to microgravity may hold the key to prevention and 
treatment of Space Motion Sickness. This crewmember is using a 
device designed to measure ocular counterrolling in microgravity 
conditions. The neck brace is to “decouple” somatosensory 
receptors in the neck. -OR)(;flNAL PAGE 
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A CURRENT STATUS OF SMS EXPERIENCE IN SHUTTLE
CREWMEMBERS
Investigators: James M. Vanderploeg, M.D., Donald F. Stewart, M.D., and Jeffrey R. Davis, M.D.
INTRODUCTION
Space motion sickness (SMS) is a problem
that has been associated with space travel for
over twenty years and is the most clinically
significant medical phenomenon during the
first four days of spaceflight. Upon entry into
micro-gravity, the body begins to adapt to this
novel environment. The sensory-motor system,
among others, must learn to function
appropriately for the new conditions.
Adaptation of the vestibular system and, more
generally, the sensory-motor system is of
particular importance in the development and
resolution of symptoms of SMS.
Throughout the United States space
program information concerning SMS has been
collected by the NASA flight surgeons
examining and debriefing the crewmembers
postflight. Information collected during the
Space Shuttle program makes up the substance
of this paper.
INCIDENCE
During the United States manned
spaceflight programs SMS has been reported by
crewmembers during Apollo, Skylab, and
Shuttle flights. The reason astronauts did not
experience and report SMS symptoms during
the Mercury and Gemini flights is felt to be
largely due to the marked limitation of motion
of the crewmembers in these small space
capsules. As mobility increased in the larger
Apollo, Skylab, and Shuttle spacecraft,
susceptible crewmembers experienced one or
more of the motion sickness symptoms listed in
Table 1.
The incidence of SMS symptoms across
the United States manned spaceflight programs,
through the first 19 Shuttle flights, is given in
Table 2. The percent incidence shown in Table 2
is total incidence for each program and includes
cases of SMS ranging from mild through severe.
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As is shown, the incidence of SMS during the
Shuttle flights has been 53 percent.
TABLE 1. SMS SYMPTOMS
HEADACHE
MALAISE
LETHARGY/APATHY
DROWSINESS
DISEQUILIBRIUM
ANOREXIA
STOMACH AWARENESS
NAUSEA
VOMITING
CENTRAL NERVOUSSYSTEM
GASTRO-INTESTINAL SYSTEM
TABLE 2. SMS INCIDENCE
• MOST CLINICALLY SIGNIFICANT MEDICAL PHENOMENON
DURING THE FIRST SEVERAL DAYS OF SPACEFLIGHT
• UNITED STATES INCIDENCE
MERCURY 0%
GEMINI 0%
APOLLO 35%
SKYLAB 60%
APOLLO-SOYUZ 0%
SHUTTLE 53%
This high incidence is of increased
significance in the Shuttle program for two
reasons. First, because Shuttle flights generally
are only 5 to 7 days in duration, SMS symptoms
are present during one-third to one-half of the
flight and are a nuisance to crewmembers both
in terms of personal comfort and in decreased
work efficiency. Second, since the Shuttle is
flown back to Earth like an airplane and
requires crewmember control, an emergency
requiring an early landing could result in a sick
astronaut having to pilot the spacecraft.
CLINICAL CHARACTERISTICS
In order to apply a uniform assessment of
SMS symptoms and severity across all Shuttle
_o;_,+. _ _'_--:_;_*"^_ ^_ ..... *"" severity was
developed by Homick and coworkers (1). Four
categories of SMS severity were identified based
on type, duration and severity of individual
symptoms. Using information provided by the
crewmembers during their medical debriefings
after each mission, the interviewing flight
surgeon assigned each crewmember into one of
the four categories: none, mild, moderate, or
severe space motion sickness. The description of
each of these categories of SMS can be found in
Table 3.
TABLE 3. SMS CATEGORIZATION
NONE (0):
MILD (1):
MODERATE (2):
SEVERE (3):
NO SIGNS OR SYMPTOMS REPORTED WITH EXCEPTION OF
MILD TRANSIENT HEADACHE OR MILD DECREASED APPETITE
ONE TO SEVERAL SYMPTOMS OF A MILD NATURE; MAY BE
TRANSIENT AND ONLY BROUGHT ON AS THE RESULT OF
HEAD MOVEMENTS; NO OPERATIONAL IMPACT; MAY INCLUDE
SINGLE EPISODE OF RETCHING OR VOMITING; ALL
SYMPTOMS RESOLVED IN 38-48 HOURS
SEVERAL SYMPTOMS OF A RELATIVELY PERSISTENT NATURE
WHICH MAY WAX AND WANE; LOSS OF APPETITE; GENERAL
MALAISE, LETHARGY AND EPIGASTRIC DISCOMFORT MAY BE
MOST DOMINANT SYMPTOMS; INCLUDES NO MORE THAN
TWO EPISOOES OF VOMITING; MINIMAL OPERATIONAL
IMPACT, ALL SYMPTOMS RESOLVED IN 72 HOURS
SEVERAL SYMPTOMS OF A RELATIVELY PERSISTENT NATURE
THAT MAY WAX AND WANE; IN ADDITION TO LOSS OF
APPETITE AND STOMACH DISCOMFORT MALAISE AND/OR
LETHARGY ARE PRONOUNCED; STRONG DESIRE NOT TO
MOVE HEAD; INCLUDES MORE THAN TWO EPISODES OF
VOMITING; SIGNIFICANT PERFORMANCE DECREMENT MAY BE
APPARENT; SYMPTOMS MAY PERSIST BEYOND 72 HOURS
The first 19 Shuttle flights covered the
period from April 1981 through August 1985.
Seventy-one different individuals flew on these
missions. With several individuals flying more
than once, these people represent a total of 93
crewperson-flights. Symptoms of SMS were
experienced by 49 of these 93 crewpersons for a
total incidence of 53 percent. Twenty-four of
the cases were mild, constituting 49 percent of
the cases or 26 percent of the total; 18 were
moderate in severity, making up 37 percent of
the cases or 19 percent of the total; and 7 were
judged to be severe cases, representing 14
percent of the cases or 8 percent of the total
crewpersons flown. These data are summarized
in Table 4.
TABLE 4. SMS EXPERIENCE ON FIRST 19
SHUTTLE FLIGHTS
STS-1 THROUGH STS-51-F
APRIL 1981 AUGUST 1985
PERCENT PERCENT
NUMBER OF CASES OF TOTAL
TOTALCREWPERSONS 93
TOTAL CASES OFSMS 49 53%
MILD 24 49% 26%
MODERATE 18 37% 19%
SEVERE 7 14% 8%
Each of the 49 cases of SMS was evaluated
according to the specific symptoms experienced
by each crewmember. The results are
summarized in Table 5. The most commonly
experienced symptoms, taking all cases, were
loss of appetite (82 percent), vomiting (82
percent), stomach awareness (57 percent),
malaise (57 percent), headache (53 percent),
and lethargy (51 percent). Of interest is the fact
that the incidence of nausea was only 45
percent compared to an 82 percent incidence of
vomiting. Many of the crewmembers who
vomited reported that they frequently had
little, if any, nausea precedent to vomiting and
if nausea was present it often began only a few
seconds to minutes before frank vomiting
occurred. Anorexia and vomiting were found in
all of the individuals with moderate or severe
SMS while only 63 percent of the crewmembers
classified as mild cases had these symptoms. It is
also interesting to note that, whereas 63
percent of the mild cases described anorexia
and vomiting, only 38 percent experienced
malaise. This apparent discrepancy is explained
by the fact that a number of astronauts
indicated that they felt quite well before and
after vomiting and denied any sensation of
malaise. They found that the vomiting was very
sudden in onset without precedent nausea or
malaise.
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TABLE 5. INCIDENCE OF SYMPTOMS
MILD MODERATE SEVERE TOTAL
(n : 24) (n : 18) (n:7) (n :49)
HEADACHE 12 (50%) 9 (50%) 5 (71%) 26 (5,1%)
MALAISE 9 (38%) 13 (72%) 6 (86%) 28 (57%)
LETHARGY 9 (38%) 11 (61%) 5 (71%) 25 (51%)
DROWSINESS 2 (8%) 6 (33%) 4 (57%) 12 (24%)
DISEQUILIBRIUM 3 (12%) 7 (36%) I (14%) 11 (22%)
ANOREXIA 15 (63%) 18 (100%) 7 (100%) 40 (82%)
STOMACH AWARENESS 12 (50%) 11 (61%) S (71%) 28 (57%)
NAUSEA 8 (33%) 9 (SO%) S (71%) 22 (4S%)
VOMITING 15 (63%) 18 (100%) 7 (100%) 40 (82%)
In addition to the specific symptoms, the
time course of the symptoms was also of
interest. The time of onset of symptoms, the
time of peak intensity, and the time period in
which the symptoms of SM$ completely abated
were obtained during the medical debriefing.
Symptoms during the first 36 hours were
grouped in 6-hour time blocks; symptoms
occurring thereafter were grouped in 12-hour
time blocks. The majority of susceptible
crewmembers developed the onset of their
symptoms during the first 6 hours of flight. The
onset of symptoms has been seen from as early
as 15 minutes after launch to as late as the end
of the second day of a mission. The symptoms
tend to reach peak intensity either near the
middle of the first flight day or the middle of
ONSET
PEAK
RESOLUTION
I I I L I I I i I I I
6 12 18 24 30 36 48 60 72 84 96
MISSION ELAPSED TIME (HOURS)
Figure I. SMS symptom time course: all cases
the second day. In the majority of cases the
symptoms resolved by the end of the third day
of the flight. Figure 1 shows the time course of
onset, peak, and resolution of symptoms
plotted against the mission elapsed time. The
dip in the time of peak intensity at 18 to 24
hours most likely represents the abatement of
symptoms during the first sleep period when
the movements of crewmembers are minimized.
When the time course of symptoms was plotted
for each severity category, as is shown in Figures
2, 3, and 4, essentially the same patterns were
seen as in the plot for the combined grouping,
with the exception of the onset of symptoms.
All the individuals who experienced symptoms
of moderate or severe intensity had the onset of
their symptoms within the first 6 hours of flight.
ONSET l _
PEAK --_
RESOLUTION
I J I J I I I L I t I
0 S 12 18 24 30 36 48 60 72 84 96
MISSION ELAPSED TIME (HOURS)
Figure 2. SM$ symptom time course: mild cases.
ONSET
PEAK
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\
I I t I I I I I ; I I
6 12 18 24 30 36 48 60 72 84 96
MISSION ELAPSED TIME (HOURS)
Figure 3. SMS symptom time course: moderate
cases.
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Figure 4. $MS symptom time course."
severe cases.
PREDICTION
Prediction of susceptibility to SMS has
long been an elusive goal. A variety of ground
based tests and test-batteries have been
evaluated in an effort to develop the capability
to predict which crewmembers will be
susceptible to Space Motion Sickness. None of
these tests has thus far proven to be sufficiently
accurate to be useful in the operational setting.
In this study the intent was to evaluate the
effect of repeat spaceflight on the incidence
and severity of SMS. In particular it was hoped
to determine whether the occurrence of SMS on
one flight would predict its development and its
severity on subsequent flights.
percent. The severity distribution of these cases
is shown in Table 6.
Among the crewmembers of the first 19
Shuttle missions were 22 astronauts who flew in
space more than onc_e Eleven of these were
affected by SMS on their first flight. However,
on their second flight only 9 of these 11
experienced the sickness. This represents a
reduction from 50 percent to 41 percent. None
of the 11 who were not sick on their first flight
developed symptoms on any subsequent flight.
In addition to a reduction of the total number
affected by SMS on their second flights there
was also a reduction in the severity of symptoms
of some of those who were still sick on their
second flight. These data are summarized in
Table 7.
TABLE 7. SMS EXPERIENCE OF REPEAT SPACE
FLIGHT
SMS INCIDENCE
FIRST FLIGHT: 11 CASES = 50%
SECOND FLIGHT: 9CASES=41%
PATTERN: SEVERITY 1ST FLIGHT 2ND FLIGHT
NONE 11 13
MILD 3 6
MODERATE 7 3
SEVERE 1 0
TABLE 6. SHUTTLE CREWMEMBERS' SMS
EXPERIENCE ON FIRST FLIGHT*
PERCENT PERCENT
NUMBER OF CASES OFTOTAL
TOTALCREWMEMBERS 71
TOTAL CASES OF SMS 42 59%
MILD 18 43% 25%
MODERATE 17 40% 24%
SEVERE 7 17% 10%
*SIX SHUTTLE CREWMEMBERS ACTUALLY HAD THEIR FIRST FLIGHTS ON
VEHICLES OTHER THAN THE SHUTTLE. THEIR MOTION SICKNESS
EXPERIENCE WAS IDENTICAL TO THEIR FIRST SHUTTLE FLIGHT: FOUR
HAVING NO SMS AND TWO HAVING MODERATE SYMPTOMS.
On the first 19 Shuttle flights 71 different
individuals served as crewmembers. Forty-two
of these 71 people experienced SMS symptoms
on their first flight, for an incidence of 59
Table 8 shows the change in severity level
from first flight to second flight. It should be
noted that 2 of the 3 individuals who
experienced moderate symptoms on both their
first and second flights had their first spaceflight
experience 10 years prior to their Shuttle flights.
Overall, 5 individuals experienced the same type
and severity of symptoms on their second flight
while 6 had a decrease in severity. These data
suggest that previous spaceflight motion
sickness experience is a good predictor for
subsequent flights. First flight presence of SMS
correctly predicted the occurrence of SMS on a
second flight in 91 percent of the cases. This
compares quite favorably with the 64 percent
correct prediction reported by Homick and
coworkers (Ref. 1) utilizing ground based
motion sickness tests.
These data also suggest that there may be
a carryover of adaptation from one flight to the
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next. Of the9astronautswho flew twice on the
Shuttle and were sick on the first flight, 6 had a
decrease in symptoms on their second flight.
TABLE 8. SMS SEVERITY CHANGE FROM FIRST
TO SECOND FLIGHT
1ST FLIGHT 2ND FLIGHT NUMBER
NONE NON.E 11
MILD MILD 2
MODERATE MODERATE 3
MILD NONE 1
MODERATE NONE 1
MODERATE MILD 3
SEVERE MILD 1
TOTAL 22
COUNTERMEASURES
A search for effective and operationally
useful countermeasures for Space Motion
Sickness continues to be conducted by scientists
both within NASA and in the academic research
community. Three general areas of
countermeasures--Drugs, Preflight Adaptation
Training, and Autogenic Feedback Training--are
under investigation at the present time.
DRUGS
Various drugs have been tried in a
preventive or therapeutic regimen for SMS but
none has been entirely satisfactory. Of key
importance in selecting a pharmacologic
approach to deal with SMS is the need to avoid
drugs with side effects which are more
debilitating than the sickness itself. Many of the
traditional anti-motion sickness medications
have a sedative effect as well as an antiemetic
effect and consequently may be more
detrimental to the astronaut than the symptoms
themselves. Table 9 lists the various anti-motion
sickness drugs that have been tried during the
Shuttle program. Scopolamine with Dexedrine,
Scopolamine alone, Transderm SeEp, and
Metoclopramide have been used in both a
preventive mode and a therapeutic regimen.
The remaining medications have been used for
treatment of symptoms only. None of the drugs
has been tested in adequately controlled
studies. Consequently, conclusions about the
efficacy of any of the drugs are based only on
anecdotal accounts. Two lines of investigation
are currently underway at the Johnson Space
Center. One investigation is studying the
pharmacokinetics of Scopolamine and
Dexedrine inflight while the other investigation
will study, in a controlled double-blind manner,
the effect of Scopolamine and Dexedrine in
preventing SMS.
TABLE 9. SHUTTLE CREWMEMBER ANTI-
MOTION-SICKNESS DRUG USAGE SUMMARY
NUMBER OF CREWMEMBERS
DRUG NAME TOTAL WITH SMS
SCOPOLAMINE (.4 mS) * DEXEDRINE ($ rag) - ORAL 31 20 11
SCOPOLAMINE (.4 ms) - ORAL 1 1 0
PHENERGAN (25 ms) - SUPPOSITORY 3 3 0
PHENERGAN (2S r_l} ÷ EPHEDRINE (25 n_) - ORAL 1 1 0
METOCLOPRAMIDE (10 ms) - ORAL 22 19 3
COMPAZINE (10 ms) - SUPPOSITORY 3 3 0
TRANEDERM SCOP - CUTANEOUS 1 O 1
DIAZEPAM ($ ms) - ORAL 1 1 0
PREFLIG HT ADAPTATION
TRAINING
The concept of developing training
procedures by which adaptation of the sensory-
motor system can be accomplished prior to
spaceflight has arisen from experimental results
supporting the otolith tilt-translation
reinterpretation hypothesis (2 and 3). In this
countermeasure concept for SMS, a training
devise is used in which the subject is exposed to
conflicting visual-vestibular inputs which
produce the same eye movement responses that
are seen in the immediate postflight period. By
repeated exposure to this simulated situation
on the ground prior to spaceflight it is hoped
that the crewmember can adapt in such a
manner that he will be much less susceptible to
SMS. Preliminary studies, as reported by Parker
and co-workers (3), indicate that it is possible to
induce such an adaptation. Figure 5 shows
conceptually how the relationships between
otolith responses associated with the subject's
movements and the visual scene presented to
him are systematically altered. For example, in
the trainer, leftward head roll results in
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translation of the visual scene toward the left
without rotation. It remains to be seen whether
this will be an effective countermeasure for
SMS.
NORMAL
_,. _-_.\ ,_... I
Figure 5. Concept for preflight adaptation
training (PA 7").
AUTOGENIC FEEDBACK TRAINING
A third area of investigation in the
development of SMS countermeasures is the
study of autogenic feedback training. In this
technique the crewmember is taught to control
certain autonomic nervous system functions,
such as heart rate, skin temperature, and muscle
tension, with the goal that this training will
carry over into the control of motion sickness
symptoms (4 and 5). This technique has been
tried on two Shuttle flights under the direction
of Dr. Cowings of the NASA Ames Research
Center. Thus far too few subjects have been
evaluated to draw a conclusion about the
efficacy of this countermeasure.
SUMMARY
The incidence of space motion sickness
during flights of the Space Shuttle continues to
run between 50 and 60 percent. Although there
has not been a serious deleterious effect on
Shuttle mission objectives to date, the
symptoms are unpleasant and reduce crew
efficiency. The impact of SMS is potentially
greater in flights which, planned or otherwise,
are completed in less than four days.
Approximately half of the cases of SMS are mild
in nature and resolve fairly quickly. The
remainder of the cases are in the moderate to
severe categories and include multiple episodes
of vomiting, suppression of appetite, and
contribute to dehydration of the crewmembers.
Most of the crewmembers who become sick do
so within the first 6 hours after launch, reach
the peak of their symptoms in the middle of the
first or second day of flight, and feel back to
normal by the end of the third day of the
mission.
Previous spaceflight experience with SMS
is an accurate predictor of subsequent
susceptibility to the sickness. There does,
however, appear to be a partial retention of
adaptation from one flight to the next,
particularly if the time interval between space
flights is less than two years.
A search for effective and operationally
useful countermeasures continues. In order for
a countermeasure to be useful it not only must
be effective in preventing or minimizing
symptoms but must also be free of side effects
which could reduce crew performance. There is
active ongoing research in three general areas:
anti-motion sickness drugs, preflight adaptation
training, and autogenic feedback training. In all
likelihood the ultimate solution to the problem
will involve a combination of countermeasures
tailored to each individual's specific needs.
.
.
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EFFECTS OF PROLONGED WEIGHTLESSNESS ON SELF-
MOTION PERCEPTION AND EYE MOVEMENTS EVOKED
BY ROLL AND PITCH
Investigators: M. F. Reschke, Ph.D., and D. E. Parker, Ph.D.
INTRODUCTION
Responses to three types of motion were
examined before and after 5-7 days of orbital
flight. Self-motion perception and eye
movements were recorded during roll and pitch
stimulation. Postural orientation was assessed
using video tape recordings of voluntary body
movements.
The research described in this paper was
derived from the otolith tilt-translation
reinterpretation model (1,4,5). This model
suggests that on Earth the otoliths respond to
both linear motion and head tilt (pitch or roll)
with respect to gravity. In space, however, the
otoliths no longer respond to head tilt with
respect to gravity. Following adaptation to
weightlessness, otolith signals apparently are
interpreted by the brain as always indicating
linear motion.
Three research hypotheses were
examined: (i) roll or pitch stimulation would
result in translational self-motion perception
during reentry and immediately postflight; (ii)
within the first 1-2 hr after landing, roll would
elicit increased (relative to preflight) horizontal
eye movements and pitch would elicit reduced
vertical eye movements; (iii) overshoots in torso
bending would be observed when a standing
astronaut attempted to tilt (roll and pitch) 20
deg off-vertical immediately postflight.
Those parts of the first and second
hypotheses concerning effects of roll were
derived from data obtained from three
astronauts and were reported previously (1). It
was anticipated that the previous observations
would be replicated.
Hypothesized response changes
associated with pitch stimulation were based on
the otolith reinterpretation model. If otolith
signal reinterpretation persists immediately
after landing, anterior-posterior displacement
of the otoliths should be correlated with
P;  ING ,PAE¢ NOT
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translation along the astronaut's X body axis
and with ocular accommodation and
convergence changes (but not vertical eye
movements). After adaptation to
weightlessness and while still on orbit, vertical
eye movements during pitch head motion
should be driven entirely by the semicircular
canals. Immediately after landing, otolith
signals associated with pitch head motion
should stabilize the eye and oppose the vertical
eye movement signal generated by semicircular
canal stimulation; therefore, the gain of the
vertical eye movement evoked by pitch should
be reduced.
The third hypothesis was derived from
anecdotal observations and the otolith
reinterpretation model. Vestibular, propriocep-
tive, and visual signals normally provide
feedback as a person attempts to bend from the
waist to a particular tilt angle. If visual signals
are eliminated and if the otolith output is not
interpreted as tilt immediately postflight, the
magnitude of the feedback signal during
voluntary tilting should be reduced.
Consequently, the astronauts should bend too
far as they attempt to perform roll or pitch
movements.
PROCEDURES
SUBJECTS
Eight astronauts who participated in four
different shuttle missions contributed to the
results reported here. Data from Astronauts 1-3
have been reported previously (1). Due to last-
minute change of the landing site, postflight
eye movement data from Astronauts 7 and 8 are
incomplete.
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APPARATUS AND PROCEDURES 
The apparatus used to  passively move 
Astronauts 1-6 during self-motion perception 
and eye movement recording was the !Miami 
University Parallel Swing (1). The astronaut was 
restrained in the prone position with his head 
dorsal-flexed about 45 deg. A cloth shroud 
enclosed the head-end of  the cylinder and 
eliminated motion cues from air currents and 
light. 
For rol l  stimulation, t h e  aluminum 
cylinder was oscillated a t  0.26 Hz around the 
subject's Z body axis ( X  head axis). Roll 
amplitude was ? 5 deg from the head-upright 
position for self-motion perception and f 15 
deg for eye movement recording. 
Preflight observations from Astronauts 7 
and 8 were obtained using a newly-constructed 
pitch-and-roll device (PARD-Fig. 1) .  The 
astronauts were restrained by belts located at 
the feet, legs, hips, waist, shoulders and arms. 
The head was restrained by ear pads and a bite 
board. A Iight-tight shroud covered the entire 
body. Self-motion perception was recorded 
following stimulation at 0.2 Hz and f 5 deg 
from the head-up position. Eye movements 
were recorded during stimulation a t  0.1,0.2 and 
0.4 Hz a t  f 15 deg for the higher frequencies 
and f 30 deg at 0.1 Hz. 
Figure 7 .  Pitch and roll device. 
SELF-MOTION REPORTING 
Responses t o  three m o t i o n  st imul i  
produced by the parallel swing were obtained 
fmm a:trcnauts 1-6. The mG:ion; con5i;:ed of 
pure linear mot ion a t  100 cm/sedsec, pure roll 
a t  f 5 deg, and phase-locked combined roll and 
linear motion. Three cycles of each type of 
motion stimulus were presented. The data 
collected consisted of  drawings and verbal 
reports (recorded on a VCR) of perceived self- 
motion path. 
Self-motion and visual-surround-motion 
perception reports during pitch, roll and yaw 
voluntary head motion ( ? 15 deg, 0.25 Hz) were 
voice recorded during reentry and while the 
orbiter was stationary on the runway from 
Astronauts 7 and 8. Less formal observations 
were performed by Astronauts 5 and 6. The 
voice tapes were reviewed wi th  the subjects 
during a video-taped debriefing two days after 
landing. 
EYE MOVEMENT RECORDING 
Eye movements were recorded using an 
infra-red sensitive video camera and w i t h  
Electrooculogram (EOG) electrodes. For the 
video recordings, the camera was focused on 
the subject's left eye with the aid of extender 
rings. The light source was an array of infrared- 
emitting diodes mounted on the camera lens. 
The camera output was recorded on 3/4 inch 
tape. For EOG recording, signals from "vertical" 
and "ho r i zon ta l "  e lectrode pairs were  
preamplified and recorded using an LSI-11/23 
computer system. 
VOLUNTARY TILT 
The astronauts were placed adjacent to  a 
wall on which a 20 deg off-vertical line was 
located. They were required t o  t i l t  from the 
waist until their torso was aligned with the line. 
Video tape records were obtained while the 
subjects rolled to  their left or pitched forward 
first with their eyes open and then closed 
(Astronauts 4-6) or only with their eyes closed 
(Astronauts 7 and 8) .  
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RESULTS
PERCEIVED SELF-MOTION
PARALLEL SWING OBSERVATIONS
Drawings indicating perceived self-
motion path during roll from Astronauts 1-6 are
illustrated in Fig. 2. Preflight, all reported that
cylinder roll produced primarily roll self-motion
perception. Immediately postflight, they
reported increased horizontal displacement
during the roll stimulation.
PREFLIGHT POSTFLIGHT
ASTRONAUT 1
ASTRONAUT 2
ASTRONAUT 3
ASTRONAUTS _,_,.,,_,..e_.,,
ROLL-SLIOE TRANSLATE-STOP-ROLL
ASTRONAUT II
ROCKING GENTLE SIDE-TO-
NO TRANSLATION SIDE WITH A
DIP
Figure 2. Drawings of self-motion perception
during roll from Astronauts 1-6. The postflight
reports were obtained within 2.5 hours after
landing.
backward translation. This perception was
reported as unexpected. Subsequently during
reentry, pitch and roll elicited translational self-
motion perception in the same direction as the
head movement.
Astronaut 7 reported strong sensations of
self- and surround-motion associated with pitch
and yaw during reentry and after the orbiter
had stopped on the runway. No unexpected
sensations were associated with roll head
movement. As previously reported by
Astronaut 6, the translation component of the
self-motion was perceived to be in the direction
of the tilt. Astronaut 8 reported that head
motions during reentry and subsequently on the
ground made him dizzy and elicited motion
sickness symptoms.
EYE MOVEMENTS
Data suitable for Fourier analysis were
recorded from Astronauts 4-6 postflight and
from Astronauts 7 and 8 preflight. Following
digital filtering and cosine tapering, the
digitized eye movement and roll stimulus
records were analyzed employing Fourier
transforms. Stimulus power, ocular response
power, transfer function gain, phase and
coherence at the stimulus frequency were
determined.
Figure 3 illustrates horizontal eye
movements recorded during roll stimulation
from Astronaut 6 two hours (Fig. 3-A) and three
days (Fig. 3-B) after landing. On the day of
landing (R + 0), the horizontal eye position trace
led the roll position signal by 33 deg; three days
after landing (R + 3) the eye position trace led
the roll signal by 165 deg.
REENTRY OBSER VA TIONS
Astronaut 6 reported self-motion
perception associated with pitch, roll and yaw
head motion during reentry Forward pitch
motion initially resulted in the perception of
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ASTRONAUT 6
A R-0 PHASEANGLE = 33 ° L
ROLL- Z AXIS _ t
HOR EYE POSN
ROLL'Z AXISHOR EYE POSN
TIME S}NCE START OF RUN (SEC)
m R-3 PHASE ANGLE = 165 ° L
ROLL-Z AXIS _ J_
HOR EYE POSN •
,L
ROLLoZ AXIS
HOR EYE POSN
ROLL-Z AXIS
HOR EYE POSN
TiME _NCE START OF RUN (SEC)
Figure 3. Eye movement records from Astronaut
6 during roll stimu/ation at 0.25 Hz 2 hr (R + O)
and 3 days (R + 3) after landing. Note that the
phase relationship between horizontal eye
movements and head roll changed.
Eye movement phase angle and
coherence data from Astronauts 4-6 are plotted
in Fig. 4. The EOG records from Astronaut 6
indicate a 132 deg phase shift during roll
stimulation immediately postflight relative to
later postflight observations. Leftward roll was
associated with leftward horizontal eye
movement for Astronauts 4 and 5 across all
recordings and for Astronaut 6 three days after
landing.
ASTRONAUT DATE
4 R+I5 R+0
_ 5 R+I5 R+2
(_ 6 R+0
(_) 6 R+I
(_ 6 R+3
PHASE ANGLE - dog
9O °
±180o_,. x_ :7_1 i ,/0o
\..2 .4 .6 .8 1.0
Figure 4. Phase relationships and coherence
between horizontal eye position and roll
position signals from Astronauts 4-6 postflight.
Eye movement responses elicited by
stimulation with the PARD apparatus are
illustrated in Fig. 5. Unfortunately, the shuttle
made a contingency landing at Edwards AFB,
whereas the PARD was located at Kennedy
Space Center; consequently, no postflight eye
movement data were collected from Astronauts
7 and 8.
VOL UNTA R Y TILT
Pitch and roll voluntary body tilt
immediately postflight was not different from
preflight. Astronaut 5 indicated that he relied
more than usual on waist joint receptor cues
when performing voluntary tilt with his eyes
closed. He stated also that he probably could
not have performed the task within minutes
after landing. Astronaut 6 deviated leftward
when attempting to pitch forward and reported
"digging in" his toes.
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Figure 5. Phase and gain of horizontal eye
movements during roll stimulation in a newly
constructed pitch and roll device. No postflight
data were collected due to the landing of the
shuttle in California rather than Florida.
CONCLUSIONS
PERCEIVED SELF MOTION
his perception of translational self-motion was
always in the direction of the head tilt.
Following the otolith tilt-translation
reinterpretation model, we hypothesized that
weightlessness-adapted astronauts would
report translational self motion in the direction
opposite to head pitch or roll immediately
postflight. Figure 6 summarizes a possible
resolution of the discrepancy between this
prediction and the astronauts' reports.
Resting Condition
a
Compensatory eye
movement to leftward
translation in microgravity
C
Rightward eye movement
following rightward roll
posfflight
Figure 6. Otoconia displacement and associated
compensatory horizontal eye movements
developed during adaptation to microgravity.
The data reported here confirm previous
reports of increased translational self-motion
perception during roll stimulation immediately
after extended orbital flight. The reports from
Astronaut 6 and 8 regarding perception during
reentry strongly confirm the basic observations.
Three astronauts performed slow pitch
and roll head motions during reentry or while
stationary on the runway immediately after a
mission. All three reported unusual self- or
surround-motion perception while performing
the head movements. Astronaut 6 reported
self-motion initally in the direction opposite to
the head tilt and subsequently in the same
direction as the tilt. Astronaut 8 reported that
An astronaut's eyes and the otoconia
located above the utricular maculae are
illustrated in Fig. 6-A. In microgravity, leftward
translation would be associated with rightward
displacement of the otoconia and a rightward
compensatory horizontal eye movement, as
illustrated in Fig. 6-B. When the astronaut
returns to a gravity environment, rightward
head roll would produce rightward
displacement of the otoconia. If he relies only
on the signals from the otolith organs, the
astronaut should perceive leftward translational
self motion because rightward otoconia
displacement has been associated with leftward
translation during adaptation to microgravity.
Alternatively, suppose the astronaut's eyes are
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open while he rolls his head. The rightward
compensatory horizontal eye movement
developed during adaptation to weightlessness
should persist (Fig. 6-C). This compensatory eye
movement would cause the image of the
stationary visual surround to slip across the
retina in a leftward direction. This leftward
retinal slip could be interpreted by the
astronaut as rightward self motion in the same
manner as the well-known linear and circular
vection reactions. Conversely, the retinal image
slip might be interpeted by the astronaut as
inappropriate surround motion. (As one
astronaut said, "1 tilted my head and the
middeck lockers that had been in front of me
slid off to one side.")
Given this analysis, it is not surprising that
the reports of motion during head pitch or roll
postflight are contradictory. Unless trained to
make careful observations, an astronaut may be
able to report only that his "gyros were
tumbled." Careful observations from
appropriately trained astronauts will be
requi red to resolve these issues.
Astronaut 8 was exposed to the basic
sensory rearrangement produced by a
prototype preflight adaptation trainer (2,3). He
reported that the trainer produced sensations
similar to those that he had experienced during
pitching head movements while seated in the
shuttle on the runway immediately after
landing except that the phase relation between
visual surround motion and head tilt was
incorrect by 180 deg.
EYE MOVEMENTS
The altered head movement/eye
movement phase relationship recorded from
Astronaut 6 was not found for Astronaut 5. This
may be due to the fact that the observations
were performed with Astronaut 5 about 45
minutes after those with Astronaut 6.
Consequently, he may have been more
completely readapted to the normal-gravity
environment. Alternatively, this may reflect
individual differences in adaptation or
readaptation processes.
Astronaut 5 reported erratic self
motion/head motion relationships during
reentry and that locomotion during this period
was guided solely by visual cues. He reported
strong "pitching over" sensations associated
with any off-vertical head position during the
first minutes after landing. Although he did not
report translation, the direction of the
relationship between head motion and self-
motion perception is similar to that reported by
Astronaut 6.
The failure of this investigation to obtain
predicted increases in horizontal eye movement
amplitude from Astronauts 5 and 6 may have
been due to motion apparatus and data analysis
limitations. The newly developed PARD
apparatus and associated data analysis
procedures will allow this prediction to be
assessed.
The failure of this investigation to obtain
predicted overshoots during voluntary body tilt
was also surprising, particularly in view of the
report from Astronaut 4. In the future,
voluntary body tilt will be examined with the
astronauts' ankles "decoupled" (by standing on
a foam rubber pad) or with vision stabilized.
The basic findings from this investigation,
particularly the self-motion reports during
reentry, are consistent with the otolith tilt-
translation reinterpretation model and the
concept for preflight prophylactic adaptation
training (1).
.
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GASTRO-INTESTINAL MOTILITY IN SPACE MOTION
SICKNESS
Investigators: William E. Thornton, M.D., Tom Moore, M.D., and Sam Pool, M.D.
INTRODUCTION
Motion sickness (MS) signs and symptoms
have traditionally been divided into those of
'head' and 'stomach', with nausea and vomiting
being cardinal signs. With adequate stimulus,
vomiting is the final stage of motion sickness
(14). With continued stimulus repeated
vomiting may occur, to the point of prostration
in some cases (15).
The neurological control mechanism for
emesis has been studied and discussed in detail
(2,4,19) and a simplified rendition of the
currently accepted scheme of this mechanism is
shown in Figure 1. There are connections from
the vestibular system to the vestibular nuclei
and from the nuclei to the emesis center, which
produces vomiting by way of the respiratory
and abdominal musculature plus some
gastroduodenal activity.
StGHT AND SMELL -- VISCERAL BRAIN NAUSEA
•::A_GI! :E ) VOMITING CENTER
VEST' i_ __LL ll_ R_/TC/N _
if I
BLOOD PATHWAY8 I
AFFEREN I AFTER IIORISON 14)
Figure 1. Currently accepted schema of emesis
center and its major inputs. The center itself
coordinates and directs the action of vomiting
by stimulation of the respiratory and somatic
abdominal musculature with some G.I. activity.
After Borison.
Many investigators report the nausea of
motion sickness to be accompanied by a
reduction of gastrointestinal act=vity (16).
Others have found that vestibular and other
stimulation produces strong duodenal
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antiperistalsis (1,10). Crampton reported that
vomiting in MS-susceptible cats can be
prevented by plugging the aqueduct between
the third and fourth ventricles, implying a
possible cerebral spinal fluid (CSF) carrier role
with a humoral pathway (6). Several
investigators have shown decreased GI motility
accompanied by increased endorphin levels
with caloric stimulation (17,18). Borison found
that the Chemoreceptor Trigger Zone (CTZ, area
postrema) is not necessary for vomiting from
motion sickness in cats (3).
The current theory is that as stimulus
duration/intensity increases, hypersalivation,
swallowing, nausea, and finally
retching/vomiting will occur. If the stimulus
level is maintained vomiting will be repeated.
At lower stimulus levels only salivation or
nausea may be sustained. Less frequently,
nausea and vomiting may occur suddenly with
or without any or all of the prodromal
symptoms.
Early in the Shuttle program there were
reports of sudden, brief bouts of vomiting
without prodrome (including nausea).
Considerable periods of time, usually hours,
could elapse before the event was repeated
unless food or water was ingested, in which case
vomiting typically followed in less than an hour.
Vomitus was usually clear, but occasionally bile
stained. Any food present was undigested.
There were one or two reports of vomiting
coincident with seeing the Earth "inverted" but
such cases were a small minority; it usually
occurred in ordinary circumstance and often
with lights out. Nausea was sometimes present,
but was more often absent.
Vomiting of this nature was so different
from that of ordinary motion sickness that a
crewman who had experienced both summed
up his opinion by stating, "1 don't know what it
is but it isn't sea sickness!" This difference was
one of the major reasons for an inflight
investigation begun by the Astronaut Office
and Flight Medicine. As part of this
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investigation, an on-board physician noted that
bowel sounds were absent in those with Space
Motion Sickness (SMS) for the duration of the
syndrome but present after recovery and in
.a ...... ££_ ___J i _, , *k -* _.-|
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problem was a temporary ileus. Electronic
recording of bowel sounds and direct and
electronic ascultation performed on one flight
confirmed the earlier findings. Metoclopramide
(MCP) was taken in an attempt to reestablish
bowel activity and seemed to be effective in two
subjects.
An improved sound recording system was
devised and 18 inflight records of sounds have
been made, including 6 during SMS and 3 while
taking MCP. An electro-gastro-graphic study
was done on 1 subject, a single trial of
intravenous MCP and Naloxone was done, and
frozen plasma from 2 subjects with SMS was
obtained for analysis of possible transmitter
substances. The following results are from an
ongoing study.
PROCEDURES
Electronic stethoscopes (with a battery
life of 14 days) were incorporated into an
elastic, velcro-secured belt (Figure 2). They were
located over the right and left upper quadrants
of the abdomen. Output was recorded by a
professional quality, miniature dual channel
tape recorder typically carried in a flight suit
pocket. Frequency response of the microphones
was 30 to 500 Hz (3 db. points) in contact with
skin. They were embedded in foam to improve
the sealing of the microphone cavity to the
body. Validated frequency response of the
recorder was 40 to 15,000 Hz (3db), with 1
percent distortion and wow and flutter of less
than 0.14 percent with a speed accuracy of 0.3
percent. Cassette tapes with 45 minutes
recording time per side were used. No attempts
were made to control conditions or activities
during the recording period, including ingestion
of food, since this would have inevitably
conflicted with inflight operations and would
have further reduced recording opportunities.
Where possible, the conditions were
documented.
MIN.
CAIETTE
Y__RDER
Figure 2. Inflight recording of bowel sounds.
The recorder is small enough to be carried in a
pocket.
Data were reduced by the investigator by
monitoring both channels of the recorded
sounds with wide response earphones. Sounds
were graphically recorded by a high-frequency
(DC-15 kHz) electrostatic recorder after band
pass filtering from 400 Hz - 3 kHz (24 db/oct.
roll-off). The nominal graphic recording speed
was 1 cm./sec, so that only sound envelopes
were distinguishable. An event marker,
manually controlled by a push button, was
actuated for every sound ranging from single
brief "tinkles" through prolonged "rushes."
Figure 3 is an example of a scored record. If
several distinct sounds were present in an event
they were scored. No allowance was made for
differences in amplitude, and events were
frequently too rapid for manual counting. The
result was that a quiet bowel was overscored
and an active one underscored. Obviously, this
was semiquantitative at best. The events were
counted for each one minute epoch, summed,
and plotted for 5 minute epochs.
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Figure 3. Section of a scored bowel sound
recording m_e inflight on one mission.
Identified sol'--J_ are indicated by the marker
signals betwe,.,, channels.
The planning matrix in Figure 4 was done
to allow the comparisons shown. Twenty
recordings were also made before, during, and
after acutely induced MS on the rotating chair
using this system on ordinary subjects. A series
of recordings over extended periods during
normal activities was also made.
A
A'' O 'oI÷
MD 1-2 MD3-7
<:==_>
I
I
PRE OR POET
FLIGHT
B
AFFECTED AFTER RECOVERY
PERIOD FROM SMS
REGLAN 1 DAY 2-3 DAYS PRE-POET
TAKEN _ RECOVERY _ RECOVERY FLIGHT
Figure 4. Planned matrix for comparison of
sound activity of two hypothesized populations,
affected versus unaffected, plus another with
medication, in 3 possible circumstances. 'A'
allows comparison of affected versus unaffected
under various conditions while 'B' examines the
effect of MCP on individuals affected.
RESULTS
Nineteen individuals have made at least 1
recording inflight. Of these, 6 affected subjects,
one of whom flew 3 times, have made
recordings that met the horizontal or temporal
requirements of the study; i.e., lg baseline and
recording during and after SMS. None of these
had simultaneous inflight controls. One subject,
unaffected by SMS, made an adequate total
number of recordings. Two of the recordings
included the use of MCP. Other recordings were
randomly scattered in time.
The collected data does not allow for
significant comparisons as planned (Figure 4)
other than between the level of activity
preflight and inflight during SMS in those
affected, and between those affected and
unaffected during the same periods.
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Figure 5. Plot of means of sounds counted per
five minutes versus time during the period of
SM$ inflight and after recovery. Subject A was
unaffected while B had a typical course of SMS.
Inflight MD2 on subject A was made during the
susceptible period while inflight MD7 was made
after this period.
Typical plots of sound activity versus time
for individuals with and without SMS are shown
in Figure 5. Of particular interest was one
recording made over the period of recovery. In
Figure 6, the 5-minute means of counts are
shown over this period. The means of such
activity for all subjects versus the period in
which they were gathered are plotted in Figure
7. Normalized activity, i.e., counts during the
period of SMS divided by lg baseline counts, are
also plotted here.
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Figure 6. Record of sound activity from a subject
during recovery from SMS. The rapid resolution
and period of hyperactivity is consistent with
indirect observations of this process. MET is
mission elapsed time and MD is mission day; i.e.,
recordings on MD3 were made on the morning
of the third day.
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Figure 7. Means of counts from recordings
made of all subjects, preflight and during
periods of SMS and recovery. Affected
individuals have solid lines, while those
unaffected are dotted. Percentage of activity
during SMS versus preflight are plotted on the
right side with those affected in solid circles and
those unaffected in open circles.
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Figure 8. Mean of sound activity in 6 normal
subjects during and after off-vertical rotation.
Level of sickness reached by Graybiel criteria is
shown in the numbered circles which also show
time at which the rotation was stopped. On the
right side, the mean activity during the period
of symptoms is plotted as a percentage of pre-
stimulus activity levels.
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In addition to these data, a number of
flights have had physicians aboard who listened
to the bowel sounds of those with and without
SMS. They have confirmed a great reduction or
virtual absence of sounds in those with SMS as
compared to activity after recovery or in those
without SMS. Such reductions have been
observed in all but one case of recorded or
observed subjects to date. One subject
appeared to develop marked hyperactivity
during SMS, but medication was present. In
contrast, most who were unaffected have had
normal or hyperactivity during this period. The
change was so striking that a number of
nonmedical astronauts have monitored their
gut activity with stethoscopes. The sound
activity of normal subjects with acutely induced
MS is shown in Figure 8. In every case
monitored during off-vertical rotation, the
activity was increased or unchanged.
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Only 3 monitored studies of
metocloprarnidewere done; one on a normal
subjectand two on subjectswith SMS. There
werenostrikingchangesproducedbythisdrug
in the bowelactivityof eitherof the lattercases.
Intravenousmetoclopramide and naloxone
were each tried in one case without significant
difference.
On one subject, a naso-gastric catheter
with transducer was passed from oral cavity to
duodenum, and pressure recordings were
obtained, but this was after recovery from SMS.
It probably would not have been possible
during SMS.
There have been numerous ground-based
electrogastrogram (EGG) studies, but only one
flight study has been performed, and that was
after SMS had resolved.
CONCLUSIONS
Reasonably accurate measurement of GI
motility is difficult under laboratory conditions
on Earth. Radiographic methods or nuclear-
tagged meals are not currently possible inflight.
Radiotelemetry pills leave much to be desired
even on Earth. The multi-port perfused catheter
is technically feasible, but operationally
unacceptable. This was obvious during passage
of the naso-gastric catheter on orbit, which was
more difficult than in lg and would have been
unlikely with SMS present. It is more difficult to
relate motility to the electrogastrogram (11)
than to bowel sounds, and the recording
technique is more complex for the EGG.
There is an indirect relationship of sounds
to mechanical activity and especially to
coordinated activity (5,7,8,9,12,13,20).
Conversely, life and death decisions are still
routinely based on this technique. In short, it
was the best that could be done under the
circumstances. The methodology is robust and
reliable albeit inefficient and time-consuming,
requiring approximately two times the actual
recording time for assessment.
In addition to the limitations inherent in
estimation of motility by auscultation there is
also the wide variation that may occur with
uncontrolled sampling; for example, the large
changes in normal activity level from mealtime
to mealtime, and under other conditions.
In spite of this and with the limited
results, it seems safe to say that a significant
ileus is present in the majority of subjects during
SMS, and appears to last for the duration of
symptoms. Such a state of the bowel is also
consistent with other signs such as the vomiting
of virtually all ingested food and in most cases
any significant amounts of water. The vomiting
of true SMS is therefore probably secondary to
distension of the stomach which then stimulates
the emesis center by vagal afferents. There are
many and varied ramifications and possible
complications of this simple scheme, both in
practice and theory.
Some of the facts that must be accounted
for include: vomiting may occur within minutes
of orbital insertion, long before significant
accumulation of liquids could occur. It seems
likely, in this case, that simple motion sickness
secondary to launch stresses may be present,
although in every such case to date signs and
symptoms of SMS have followed, in rare cases
there has been bile staining of vomitus which
would indicate a relaxed pylorus or retrograde
duodenal peristalsis. In the latter case, bowel
sounds should be present at some point,
possibly prior to emesis. Much more complex is
the question of why the majority of subjects was
not nauseated. The two final questions are how
is this related to lg motion sickness and what is
the mechanism?
In both cases there is neither the
experimental, nor theoretical knowledge to
answer. If the currently accepted scheme of
vestibular (system) conflict -_ ernesis center -_
nausea/vomiting is correct, then it seems at odds
with the findings here. The question of GI
activity during lg motion sickness has not been
satisfactorily answered, for while some
investigators find reduced or absent activity,
others have reported increased sounds and
duodenal anti-peristalsis with caloric
stimulation. This limited study of sounds in
acutely induced motion sickness supports
increased gut activity which may well be
retrograde.
As to the mechanisms of this ileus, there is
no certainty. At first glance it would seem to be
simple vagal inhibition; but in view of animal
and human studies which show large changes in
endorphin levels and upper GI motility with
caloric stimulation, and the blocking of effects
of endorphins on motility in animals, it may not
be this simple. A further note of caution may
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have been raised by recent studies of Koch and
Stern (personal communication) in which
vagotomized patients had gastric responses to
motion sickness stimulation by circumvection.
The failure of MCP and Naloxone(a) was
disappointing, for if some agent could be found
to restore motility a major portion of the SMS
problem might be resolved. It appears that we
may have to await more knowledge of the GI
system itself, as well as a better understanding
of brain-gut pathways to attack the ileus
logically.
A better means of motility measurement
is needed, and while the bowel sound
methodology could obviously be improved,
there is little else of promise at this time.
Conversely, the absence or reduction in
bowel sounds is the first consistent sign, the first
reliable marker, of SMS. It promises to be an
objective means of detecting and following SMS
and also offers a research path to increased
knowledge of SMS, possibly back to its origin.
1.
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OCULAR COUNTERROLLING 
Investigators: M. E. Reschke, Ph. D., D. E. Parker, Ph. D., and N. Skinner 
The Otolith Tilt-Translation Reinterpreta- 
t i o n  (OTTR) hypothesis says in  part that 
adaptation t o  space f l ight  i s  a function of 
sensory rearrangement and that signals from 
the otol i th organs during orbital f l ight  are 
reinterpreted as linear displacements. 
An important question relating t o  this 
concept concerns t h e  maintenance or  
substi tut ion by other sensory systems of 
information io the central nervous system which 
will replace missing or altered vestibular inputs. 
Specifically, this study asks the question: "Can 
neck receptors substitute for otolith receptor 
input t o  maintain ocular torsion during space 
flight?" 
The measurement of ocular torsion is 
difficult under the best of circumstances. When 
coupled with the additional constraints imposed 
by orbital flight, very careful consideration had 
t o  be given to  the mechanism and procedures 
tha t  were t o  be used. The device and 
procedures had to  be simple enough that the 
experiment could be per formed by one 
crewperson at a time, while meeting size, 
weight, and safety requirements. 
To meet these criteria a method of 
measuring ocular torsion first used about 140 
years ago was selected. In this method an after- 
image of a target is formed on the retina. Any 
eye torsion occurring while the after-image is 
visible produces a t i l t ing of the after-image 
relative to  an objective reference target. 
Figure 1 shows the apparatus developed 
to  obtain ocular torsion with the after-i mage 
method. This device i s  a goggle arrangement 
housing an electronic flash to  place the after- 
image on the retina, and a digital read out to 
indicate angular position of the target. A small 
voice-activated tape recorder was attached to 
the goggle so that the subjects could verbally 
report the position of the target as well as their 
head position. A neck brace was used to 
eliminate proprioceptive cues from the neck as a 
control measurement during the flight. 
Figure 1 .  Ocular counterrolling measurement 
goggles, voice recorder, neck brace, and battery 
pack. 
During use, the head was held in place 
with a set of flexible rubber eye goggles that 
were fixed to  the main body of the device. A 
wide Velcro strap was used to secure the head to 
the goggles. The device was fixed to  a smooth 
wall for ground-based testing or to the forward 
bulkhead lockers during fl ight wi th a set of 
large suction cups. The interface between the 
main body of the goggle assembly and the 
suction cups was fitted with a t i l t mechanism. 
This allowed the goggles to  be t i l ted in 1 5  
degree increments from the horizontal position 
up to plus or minus 60 degrees. Each position 
had a positive engagement detent to hold the 
goggles a t  the desired angle. Each of the nine 
possible t i l t  positions was marked with a letter 
rather than the actual degree of rotation to  
l imit knowledge of head position. During 
ground baseline testing a level was used t o  
insure that the goggles in the zero tilt position 
were perpendicular to the gravity vector. 
Upon looking into the goggles, the 
subject saw a digital display indicating the 
amount of target rotation. The digital display 
provided a 2000 count output for displacements 
between plus and minus 20 degrees. This 
allowed a resolution of 1.2 minutes of rotation 
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per count. There was a small amount o f  
hysteresis in the controls used t o  move the 
reference target and in the potentiometer used 
for measurement of the angular torsion. This 
iesi;l:ed iii an absdute accuracy of IC! minutes 
of rotation. 
During the execution of this experiment 
the subject verbally reported the digital read 
out. During data reduction the values reported 
were converted t o  actual degrees of rotation. 
The target used to  place an after-image 
on the subject's right retina consisted of  an 
aluminum disk into which an inverted " T "  
reticle had been machined. Behind the target 
disk were an electronic photo flash tube and 
ready light positioned so that they were visible 
t o  the subject through the inverted "T." 
The target was rotated by a gear and belt 
driven mechanism operated by means of  a 
thumbwheel. 
Also incorporated in the apparatus was a 
low intensity light strobe that flashed at 2 hertz. 
This stroboscopic i I I u m i nation ref res hed the 
retinal after-image. 
Dur ing pre- and p o s t f l i g h t  da ta  
collection, the subject set the target t o  the 
gravitational vertical wi th the thum bwheel. 
The vertical position corresponded to a value of 
1000 on the digital display. Then, whi le  
following a checklist, the  subject tilted his head 
and the goggles to  a predetermined and 
randomized angle. Once the subject achieved 
the t i l t  angle, that position was maintained for 
approximately 30 seconds. Following the 30 
second period the electronic flash was enabled 
and triggered t o  place an after-image on the 
retina. 
With the afterimage in place, the subject 
returned the goggles to  the upright position. 
The subject shut his eyes and displaced the 
target slightly with a thumbwheel in either the 
clock wise or counterclockwise direction. Once 
the target was displaced from the vertical, the 
subject opened his eyes, set the target reticle 
with the thumbwheel so that it matched the 
angular position of the after-image, and read a 
displacement value from the LED's. The subject 
repeated this procedure in the upright position 
twice more for that angle, always displacing the 
target in the opposite direction between each 
measurement. This entire procedure was then 
repeated for each of the  remaining 8 angles of 
head tilt. 
The infl ight procedures differed only 
slightly from those used on the ground. In one 
condition the subject's feet were restrained in  
foot restraints. This condition required the 
s ~ h j e r t  n flcr his neck to obtain the t i l t  anqles 
just as he did on the ground. The control 
condition required the subject to  wear a neck 
brace and to  float freely such tha t  his whole 
body was ti l ted t o  match the angle of the 
goggle tilt. 
Measurements were obtained during one 
Shutt le f l i g h t .  I t  was hoped  t o  have 
measurements made as early inflight as two or 
three hours. Unfortunately, the goggle uni t  
failed during its early use. However, the crew 
was able to  repair it and obtain data beginning 
on the third day of the flight. 
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Figure 2. The ocu la r  c o u n t e r r o l l i n g  
measurement goggles in use during flight. 
Figure 3 shows the  pref l ight average 
response obtained from the two crewmen that 
were tested. The amount of eye torsion is 
indicated on the y-axis, and the head t i l t  
position is located on the x-axis. 
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Figure 3. Preflight average data. 
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Four preflight measurements were
obtained from one crewman and 6 from the
second crewman. Each point on the plot
represents 30 trials at that angle of head tilt.
The variance for each data point, expressed as
plus or minus one standard error of the mean,
was less than 0.2 degrees.
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Figure 4. Preflight average vs. published data.
Because the method of measuring ocular
counterrolling that was chosen is subjective in
nature, it was interesting to compare these data
with those from others who had used a more
objective approach.
Figure 4 illustrates the preflight average
data compared with data that have been
published both by Miller (1) during his time at
Pensacola and by Dr. Charles Markham (2). Note
that for the range between plus or minus 15
degrees the data are comparable. It is at the
extremes that this study shows a greater degree
of eye torsion than the more objective camera
data. However, the lack of correspondence
between these data and those of others has no
impact on the primary objective of this
experiment.
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Figure 5. Data for flight days 3 and 4.
Figure 5 shows the data obtained during
the flight. Measurements were only obtained
from one crewman on the third day of the
flight. However, both crewmen were measured
on flight day 4. Note that there is some
counterrolling present particularly to a
rightward head tilt and that there appears to be
more torsional eye movement to a head tilt
early in the flight.
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Figure 6. Neck brace average data.
Figure 6 shows the data obtained when
the neck brace was worn. Note that the data
appear random and do not exhibit a particular
trend.
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Figure 7. Inflight average minus inflight brace
data.
Because of the variability of the data
obtained with the neck brace, the absolute
difference between the inflight experimental
trials and the inflight control data was taken.
That difference is depicted in Figure 7. Note
that very little eye torsion is evident. The
amount that is present represents the variability
of this measurement inflight.
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Figure 8. Postflight data.
Figure 8 shows the torsional eye data
obtained after the flight. The eye movements
measured immediately after the flight show
some slight reduction from those obtained
preflight. By the third day postflight the
amount of counterrolling was essentially
equivalent to that seen prior to the flight. This
trend was particularly noticeable to a leftward
head tilt. It is interesting to note that the
compensatory eye movements to a left-ward tilt
inflight showed the greatest reduction.
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Based on the data obtained from a single
flight with only two subjects it appears that the
eyes show a compensatory torsional movement
to head tilt. This compensatory torsional eye
movement appears to be elicited by the neck
receptors.
These findings support a concept of
sensory substitution, in this case the substitution
of neck receptors for missing otolith
information.
If these findings are replicated on future
flights, the otolith tilt-translation reinterpreta-
tion hypothesis may be modified to incorporate
these results. As one might expect, adaptation
to space flight is a complex process that is just
beginning to be understood.
.
.
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OTOLITH TILT-TRANSLATION REINTERPRETATION
FOLLOWING PROLONGED WEIGHTLESSNESS:
IMPLICATIONS FOR PREFLIGHT TRAINING*
Investigators: D. E. Parker, Ph.D., M. F. Reschke, Ph.D., A. P. Arrott, Ph.D., J. L. Homick, Ph.D.,
and B. K. Lichtenberg, D.Sc.
_ODUC_ON
Three major points were considered in
this investigation. First, this research addressed
the problem of space motion sickness. Secondly,
this research suggested concepts that provide a
basis for understanding space motion sickness.
Thirdly, on the basis of these concepts, a
proposal for preflight prophylactic adaptation
training was presented.
This investigation assessed changes in
responses associated with otolith receptor
activity following prolonged space flight. The
results led to the development of an otolith tilt-
translation reinterpretation hypothesis which,
in conjunction with the sensory conflict
hypothesis, provides a conceptual framework
for comprehending space motion sickness.
Possible effects of weightlessness on
spatial orientation system (13) responses have
been considered by several investigators during
the past two decades (10). Some have focused
on the consequences of altered stimulation of
the otolith receptors while others have
suggested changes in the "gains" assigned by
the brain to orientation information from
visual, vestibular, and somatic receptors (9, 10,
13).
The vestibular otolith receptors respond
to linear motion and gravity. If motion cues
from visual and skin receptors were reduced or
eliminated, responses to roll and linear
translation attributable primarily to the otolith
receptors could be examined. The Miami
University parallel swing and its associated
restraint system allowed this.
This investigation examined two types of
responses associated with roll and linear
translation stimulation: perceived self-motion
*Originally printed in Aviation, Space, and
Environmental Medicine, June 1985.
path and eye movements. These responses were
examined before and after orbital flight.
Because the otoliths are gravity receptors, it was
hypothesized that adaptation to the loss of
stimulation due to gravity during flight would
alter responses to which the otoliths contribute.
Both perceptual and motor responses
associated with the vestibular receptors adapt
to rearrangements of either vestibular or visual
stimulation. This adaptation phenomenon
accounts for the observation that motion
sickness symptoms resolve during the initial 48-
72 h of orbital flight. Rearrangements that have
been investigated previously include ocean
travel, slow rotation, image reversing glasses
and weightlessness (3,7,17,23). Return to a
"normal" stimulus environment following
prolonged exposure to rearranged stimulation
is associated with a period of readaptation.
Responses seen during readaptation suggest
that mechanisms of response change during the
initial adaptation to the rearrangement.
After preliminary observations (15), the
otolith tilt-translation reinterpretation
hypothesis was proposed: on Earth,
information from the otolith receptors is
interpreted by the brain as linear motion or
head tilt with respect to gravity. Because
stimulation from gravity is absent during orbital
flight, interpretation of otolith responses as tilt
is meaningless. Therefore, the brain adapts to
weightlessness by reinterpreting all otolith
receptor output as linear motion (Fig. 1).
Immediately following return to earth and
before the brain readapts to the normal gravity
environment, this reinterpretation of otolith
responses persists.
Following the otolith tilt-translation
reinterpretation hypothesis, it was predicted
that roll stimulation would elicit roll self-motion
perception preflight but that this stimulation
would be associated primarily with linear
145
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translation self-motion perception immediately 
postf I ig ht. 
It was also predicted that roll stimulation 
wou ld  e l i c i t  increased h o r i z o n t a l  e y e  
movements and decreased ocular counterrollinq 
immediately postflight relative to  preflight and 
I ater postf I i g ht observations. Vesti bu I a r-ocu I a r 
reflexes serve to stabilize the direction of gaze 
during head motion. If the weightlessness- 
adapted brain interprets otol i th signals as 
ind icat ing translat ion, the appropr ia te 
compensatory eye movement during head roll 
would be horizontal eye deviation. 
IG - PITCH: OTOLITH DISPLACEMENT 
(TILT) 
OG - PITCH: NO OTOLITH DISPLACEMENT 
(TILT) 
0 
IG or OG - FORWARD TRANSLATION: 
OTOLITH DISPLACEMENT 
Figure I .  Diagram of vestibular otolith 
displacement. 
PROCEDURES 
PERCEIVED SELF-MOTION PATI 
S U BJ E CTS 
Three astronauts from t w o  missions 
served as the subjects in this experiment. 
APPARATUS 
The motion apparatus employed was the 
Miami University Parallel swing (Fig. 2 ) .  The 
swinq was a four-pole pendulum that produced 
"linear" (translation) oscillation a t  0.26 Hz. For 
translation, the swing was moved manually by 
the experimenter. The swing restraint system 
included an aluminum cylinder which was 
connected to a motor drive and could be rolled 
a t  amplitudes up t o  + 2 0 °  and frequencies 
between 0.1 and 0.5 Hz. Objective measures of 
translation and roll motion were provided by 
appropriate transducers. 
The subject was encased in a Styrofoam 
body mold inside of the aluminum cylinder. 
Head restraint was provided by ear pads and a 
bite board. The subject was placed in  the 
restraint in the prone position, and his head was 
dorsal-flexed about 50". A cloth shroud, which 
eliminated motion cues from l ight  and air 
currents, enclosed the head-end of the cylinder. 
* 
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Figure 2. Parallel swing. 
PROCEDURE 
Responses t o  three types of  mot ion 
stimuli were obtained. These were linear 
translation at 100 cm/s2 peak; roll a t  ? 5"; and 
phase-locked, combined ro l l  and l inear 
translation. Translation was in the direction of 
the subject's Y axis. Roll motion was around the 
subject's Z body axis (X head axis). For both 
types of motion, the oscillation frequency was 
0.26 Hz. 
Three cycles of each type of motion 
stimulus were presented. The subject 's 
responses consisted of drawings and verbal
reports of his perceived self-motion path.
EYE MOVEMENT RECORDING
SUBJECTS
Two astronauts
participated in this study.
from one mission
APPARATUS
The apparatus was the same as that used
in the self-motion path perception study with
the addition of eye movement recording
capability. Eye movements were recorded using
an experimental RCA infrared video camera.
The peak sensitivity of the camera was 890
nanometers. The camera was focused on the
subject's left eye with the aid of extender rings.
The light source was an array of twelve 100-row
infrared-emitting diodes mounted on the
camera lens. The camera output was recorded
with a video cassette recorder.
PROCEDURE
Eye movements were recorded during roll
-+ 15°) and Y axis linear translation oscillation
(200 cm/s2 peak). The oscillation frequency was
0.26 Hz. The goal was to record during five
consecutive cycles of movement. The subject's
"arousal level" was not controlled.
PREFLIGHT POSTFLIGHT
ASTRONAUT1
ASTRONAUT 2 J
A.TRO.UT3
Figure 3. Astronauts" drawings of self-motion
perception following roll stimula tion.
RESULTS
PERCEIVED SELF-MOTION PATH
Drawings indicating perception of self-
motion path during roll are shown in Figure 3.
Preflight, the three astronauts reported that
cylinder roll produced nearly pure roll self-
motion perception, which they illustrated by
drawing a "U" shape with arrows at the ends,
and that linear translation oscillation produced
nearly pure horizontal linear self motion.
Immediately postflight, roll stimulation was
perceived as translation self motion with a small
angular motion component. The verbal reports
and drawings were congruent.
EYE MOVEMENTS
Analyzable data during roll oscillation
were obtained from both subjects on days 2 and
3 after landing. Fewer usable data were
obtained during linear translation.
Because of the poor quality of the video
tape records, quantitative analysis focused on
transient horizontal eye movements.
Horizontal nystagmus during roll stimulation
was greater immediately postflight than 2 or 3
days after landing or preflight. The data
suggest depression of horizontal eye
movements during roll on day 2 after landing
and some rebound on day 3. Data obtained
during translation stimulation suggest enhance-
ment of the horizontal eye movement response
on the second and third day after landing.
Qualitatively, the recording during roll
from Astronaut 2 immediately postflight
appears different from the other recordings.
This record shows the "classic" phase reversing
horizontal nystagmus seen ordinarily during
oscillation around the Z head axis.
Eye movements were difficult to assess
immediately postflight because of the
movement of the astronaut's head in the
restraint relative to the camera, poor image
quality, and the inability of the subjects to
maintain straight-ahead gaze.
The video tape records showed a clear
ocular counterrolling for Astronaut 3 during roll
stimulation. The counterrolling was observable
150 minutes after landing as well as preflight
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andon thesecondandthirddaysafter landing.
Becauseof the poorimagequality,noattempt
was made to analyze counterrolling
quantitatively.
CONCLUSIONS
OTOLITH REINTERPRETATION
The results of this experiment support the
hypothesis that the brain adapts to prolonged
weightlessness by reinterpreting all otolith
signals as indicating linear translation. This tilt-
translation reinterpretation is reasonable in
view of the normal functions of the otolith
receptors and analysis of how these functions
must change in weightlessness. In
weightlessness, no changes in otolith signals are
associated with head tilts; only linear
translations elicit responses from these
receptors. Therefore, it is reasonable to expect
that the adaptive brain would learn to interpret
all otolith signals as indicating linear translation
and that both eye movement reflexes and self-
motion perception would be altered
accordingly.
MelvilI-Jones (9) may have been the first
to note that adaptive changes during orbital
flight could leave the brain temporarily
unresponsive to otolith stimulation by the
steady "G" vector. Young, Oman, and their
colleagues (10) suggested "otolith
reinterpretation" as one of several possible
consequences of prolonged weightlessness.
Roll stimulation immediately postflight
elicited complex self-motion reports. The self-
motion perception included both linear and
angular motion components. Also, both
horizontal . eye deviation and ocular
counterrolling were elicited by roll stimulation
within the 150-min period after landing. These
results are interpreted as follows: Upon return
to the normal-gravity environment, the brain
persisted in interpreting otolith signals as linear
motion. Therefore, the otolith signals produced
by roll (tilt) elicited horizontal eye deviation and
were perceived as linear motion. Because
oscillatory roll also stimulates the semicircular
canals, the self-motion path was perceived as a
combination of roll and translation, and ocular
counterrolling was present.
Results from five other life sciences space
experiments are congruent with those reported
here. Immediately postflight, astronauts
exhibited decreased postural stability with their
eyes closed (24), slightly decreased ocular
counterrolling during tilt (22), improved ability
to null lateral linear motion in the "closed loop
otolith nulling task" (24), and unchanged linear
oscillation detection thresholds (16, 22). One
subject noted that the "rooftop illusion,"
ordinarily experienced during translation on the
U.S. Lab Sled, was absent during the immediate
postflight period.
•These additional postflight observations
are consistent with the otolith tilt-translation
reinterpretation hypothesis for the following
reasons. Decreased postural stability and ocular
counterrolling should be associated with failure
to interpret otolith responses following roll
stimulation as head tilt. If all otolith signals are
interpreted as linear motion, performance of
the closed-loop nulling task, which requires
precise linear motion detection, should be
improved. Because motion detection would be
independent of the particular class of motion
perceived (translation or tilt), self-motion
detection thresholds during linear oscillation
should be unchanged. Finally, if all otolith
output is interpreted as linear translation, the
rooftop illusion (10,13) should be lost.
These observations led Young et al. (24)
to propose a tilt-translation reinterpretation
hypothesis that is nearly identical to the one
developed independently by this study (15,16).
A sixth observation suggests an
additional type of otolith reinterpretation.
Reschke, Anderson, and Homick (18) examined
vestibulospinal reflex and perceptual responses
elicited by "drops" before, during, and after the
Spacelab 1 mission. Pre- and postflight, the
subject was dropped over a short distance using
a quick-release helicopter cargo hook. The
subject suspended himself above the floor by
grasping a T-shaped handle. At random time
intervals after suspension, the release was
activated and the subject fell to the floor.
Because gravity was absent inflight, the drops
were produced by pulling the subject to the
Spacelab floor using calibrated bungee cords.
Modulation of the Hoffman reflex (H-reflex)
and perception of self motion were recorded.
During the early period of space flight,
sudden drops were perceived as "falls," but by
the sixth day of flight the drops were perceived
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as linear translations but not as falls. The
subjects reported that drops early in the flight
felt much as they did preflight. The H-reflex
changes associated with these drops also were
similar to those recorded preflight. Later in the
flight, the drops were perceived as sudden, fast,
and hard. The subjects were not aware of
where their legs and feet were and exhibited
difficulties in maintaining "balance" following
"landing." Late in flight, the H-reflex was not
potentiated by the drops. Postflight, the drops
were perceived just as they were by the sixth day
inflight. That is, the subjects were unaware of
where their feet were, and the drops were
perceived as unexpected and hard (19).
These observations support an otolith
reinterpretation hypothesis. Under normal-
gravity conditions, a sudden drop is perceived as
a "fall" and elicits an otolith-spinal reflex if the
body's Z axis is parallel to the gravity vector.
Ordinarily, falls are produced by gravity acting
on the body mass and the fall is in the direction
of the gravity vector. The reflex response
prepares the body for the impact deceleration
of landing following the fall.
During space flight, a fall, defined as
linear translation parallel to gravity, is
meaningless because gravity is absent. The
"drops" produced on orbit were linear
translations but were not falls. Consequently,
the adaptive brain learned to interpret all
otolith signals as linear translations but not as
falls; reflex and perceptual responses ordinarily
elicited by falls were lost.
Certainly the data from the space
experiments conducted to date are not ideal,
and firm conclusions based on observations
from only seven subjects are problematic.
Nevertheless, converging lines of evidence
appear to support an otolith reinterpretation
hypothesis.
SPACE MOTION SICKNESS
Motion sickness during the early period
of orbital flight and, to a lesser extent,
disorientation during re-entry are among the
problems associated with space flight. A
substantial body of evidence suggests that these
problems may be related to alteration of
vestibular responses following prolonged
weightlessness (4,5).
Sensory conflict appears to be the basic _
mechanism underlying space motion sickness
(5). During the initial period of exposure to
weightlessness, signals from the otolith
receptors would conflict with those from the
semicircular canals and the eyes. Following roll
or pitch head motions, movements of the visual
scene and signals from the semicircular canals
would indicate that the expected head motion
had occurred; however, an appropriate signal
from the otolith receptors would be lacking.
Many astronauts have reported that pitch head
motions during the initial period of orbital
flight evoke motion sickness symptoms (12,21).
These reports support the sensory conflict
approach to space motion sickness as well as an
otolith tilt-translation reinterpretation
hypothesis.
Alteration of otolith receptor response
during prolonged weightlessness also could be
related to disorientation following return to a
normal-gravity environment. In fact, some
crewmembers noted horizontal oscillopsia
(visual field motion) during head roll motions
while in the re-entry phase of flight.
PREFLIGHT PROPHYLA CTIC
A DAPTA TION TRAINING
Based on the otolith tilt-translation
reinterpretation hypothesis and the sensory
conflict approach to space motion sickness, it is
proposed to develop prophylactic adaptation
training (PAT) procedures and apparatus for use
by astronauts prior to flight. The proposed
training is based on the concept that the brain
can be forced to "recalibrate" relationships
between otolith and visual signals in a manner
that would be appropriate to weightlessness.
After training, eye movement reflexes, postural
muscle reflexes, and self motion experiences in
relationship to visual scene movements would
be appropriate to the weightlessness-adapted
state. It is hypothesized that the training would
afford astronauts significant relief from space
motion sickness symptoms during the early
phase of orbital flight.
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BACKGROUND
As noted previously, people adapt to
sensory rearrangements such as those produced
when ,h_,, _,_ _1_,^_ :, ,, .... i..... ;,_
_.llV.=._f f.,ll_ _,Pl_l_._sd/ III :_l*lJVVly-l_l.O¢.lll1*_ l*l_lIJlll_
(17) or wear optical devices that reverse or
invert the visual scene (7,20). Exposure to these
sensory rearrangements frequently elicits
motion sickness symptoms.
Weightlessness is a form of sensory
rearrangement (6,8,13). Because gravity is
absent, the vestibular and skin receptor signals
elicited by postural orientation and body
motion are different from those experienced on
earth. Consequently, the relationships between
orientation and motion signals from the visual
receptors are rearranged with respect to those
from the vestibular and skin receptors.
Following adaptation to visual-vestibular
sensory rearrangement, vestibular-ocular reflex
and self-motion perception response changes
indicate neural recalibration of the relationships
between visual and vestibular motion signals
(1,2,11). These response changes can be used to
assess the current state of adaptation and to
determine the adequacy of a prophylactic
adaptation training protocol.
PROPHYLACTIC ADAPTATION
TRAINER
It is proposed to alter, systematically, the
relationships between otolith response changes
associated with the subject's movements and
the visual scene presented to him (14).
Relationships between visual scene and subject
motion are illustrated in Figure 4. Normally,
when the subject's head is rolled toward his left
shoulder, the visual scene rotates around the
corneal-retinal axis in the direction opposite to
the head tilt.
HEAD ROLL
NORMAL
PAT
HEAD PITCH
Figure 4. Relationships between head
movements and visual scene during PA 7".
In the trainer, a leftward head roll would
result in a translation of the visual scene toward
the left without rotation; i.e., the vertical axis of
the scene would remain aligned with the
vertical retinal meridian. Normally, when the
subject's head is pitched backward, the visual
scene moves downward in the visual field. In
the trainer, pitch backward would be associated
with apparent flow of the visual scene toward
the subject, but the horizontal axis of the scene
would remain aligned with the horizontal
retinal meridian. The relationships between the
visual scene and head movements in the trainer
would mimic those that are experienced in
weightlessness, as revealed by the results of
inflight observations.
Several possible concepts for constructing
a prophylactic adaptation trainer are currently
being pursued.
1.
.
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PREDICTION OF SUSCEPTIBILITY TO SPACE MOTION
SICKNESS*
Investigators: J. L. Homick, Ph.D., M. FoReschke, Ph.D., and J. M. Vanderploeg, M.D.
INTRODUCTION
Space motion sickness (SMS) is
experienced by about 50% of crewmembers
during the first several days of exposure to the
microgravity space flight environment (1,2,3).
Predominant symptoms of the syndrome are
headache, depressed appetite, general malaise,
lethargy, gastrointestinal discomfort, nausea,
and vomiting. As in other forms of motion
sickness, the syndrome may reduce self-
motivation and result in decreased ability to
perform demanding tasks. The syndrome is self-
limiting. Complete recovery from major
symptomatology, in other words adaptation to
the space flight environment, occurs within two
to four days. After complete adaptation occurs,
crewmembers appear to be immune to the
development of further symptomatology.
The overall incidence to date of SMS in
the U.S. and Soviet manned space programs is
summarized in Figure 1. Available data indicates
that the frequency of occurrence of this
syndrome has been approximately equal in both
countries. An important feature of these data is
that with the advent of larger spacecraft in the
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Figure 1. SMS experience.
*Originally presented at the meeting of the
B_r_ny Society, Ann Arbor, Michigan, May
22, 1985.
U.S. program (i.e., Apollo, Skylab and Shuttle)
that permit greater mobility of crewmembers,
the incidence of SMS has increased.
In an effort to resolve the SMS or at least
minimize the operational impact of the
syndrome, NASA has significantly expanded its
research efforts in this area. As part of this
expanded effort, a systematic program of
operationally oriented motion sickness data
collection was implemented on most individuals
assigned to Shuttle flights from April 1981 to
April 1985. The primary objective of this
program was to collect preflight, inflight and
postflight data on the crewmembers in an effort
to begin validating ground based tests which
may be predictive of susceptibility to the
syndrome. The development of reliable
predictors is operationally important because
they would permit the a priori identification of
individual crewmembers for whom special
preventative measures should be taken. A
secondary objective of the program was to
acquire data which could be used to validate
countermeasures for the syndrome.
PROCEDURES
Preflight data collection involved several
different procedures. Approximately three to
six months prior to flight, each crewmember
completed a questionnaire designed to elicit
information regarding past experiences with
various types of motion environments and
responses to those environments.
Also during the three to six months
before flight each crewmember was tested at
least one time for susceptibility to
experimentally induced motion sickness. Three
different laboratory test procedures were used
to provide a ground-based data point against
which inflight susceptibility could be compared.
For the first nine Shuttle missions, which
involved 29 different crewmembers, a standard
Coriolis Sickness Susceptibility Index test (CSSI),
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originally developed by Miller and Graybiel (4)
was used. This procedure, which stimulates
primarily the semi-circular canals, requires the
performance of head movements while rotating
Prior to the start of the test the crewmember
was instructed on how to report his or her
symptoms of motion sickness to an observer
who was skilled in the recognition of signs and
symptoms of motion sickness. The signs and
symptoms were recorded and scored according
to the diagnostic categorization shown in Table
1 (4). The test was terminated when the blind-
folded crewmember reached the Malaise III
level of motion sickness or performed 150 head
movements, whichever occurred first. The
higher the score, the longer the subject
continued the test, indicating a greater
resistance to motion sickness. A majority of the
crewmembers on the first nine Shuttle missions
were tested at least one additional time with
the CSSI procedure in order to evaluate the
efficacy of an anti-motion sickness medication.
The medication most frequently evaluated was
oral scopolamine (.4 rag) plus dexedrine (5 mg).
TABLE 1. DIAGNOSTIC CATEGORIZATION OF
ACUTE MOTION SICKNESS LEVELS
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The second motion sickness susceptibility
procedure used was a modified version of an
off-vertical rotation or OVR test originally
developed by Graybiel and Miller (5). The OVR
produces a rotating linear acceleration and is
essentially an otolith stimulus. During this
procedure crewmembers were blindfolded and
restrained in the rotating chair with lap,
shoulder and leg straps. The head was also
restrained. While in the vertical position the
chair was accelerated to a velocity of 20 rpm and
rotated for 5 minutes. Following stabilization
of 0 ° tilt the angle of tilt of the chair was
increased in 5° increments at 5 minute intervals
until the crewmember reached the Malaise III
maintained at 30 ° tilt for 5 minutes. The OVR
test was performed on 29 individual astronauts
most of whom flew subsequent to the ninth
Shuttle flight.
The third procedure used was a modified
version of an eyes open sudden-stop test
developed by Graybiel and Lackner (6). This test
assessed susceptibility to a vestibulo-visual
interaction stimulus. Visual stimulation was
provided by a stationary optokinetic field which
surrounded the chair in which the crewmember
was restrained. The chair was accelerated to a
velocity of 50 rpm and held at that velocity for
30 seconds. The chair was then decelerated at
150°/see to a complete stop and maintained at
zero velocity for 30 seconds, after which the
sequence was repeated for a total of 20
clockwise and 20 counterclockwise stops or until
the Malaise III level of symptoms was reached,
whichever occurred first. Data were collected
on only six crewmembers with this procedure•
Inflight data collection was limited to the
use of a microcassette tape recorder and a
motion sickness symptom checklist. The
checklist was similar in content to the diagnostic
scale shown in Table 1 and allowed comparisons
between the pattern of symptoms that occurred
during the preflight pro vocative tests and those
that occurred inflight. The checklist also
required crewmembers to report on
preventative measures used such as anti-motion
sickness drugs and voluntary restriction of head
and body movements. Each crewmember was
required to use the recorder and checklist each
mission day to report any symptoms or
sensations that had been experienced during
that day.
Questions pertaining to SMS, vestibular
sensations, and performance were also asked of
each crewmember on the day of landing and
during postflight medical debriefings.
Both the inflight and postflight crew
debriefing data were used to categorize
crewmembers as susceptible or non-susceptible
to SMS. Those who were defined as being
susceptible were further classified into mild,
moderate and severe subgroups for subsequent
data analysis. Operational definitions for SMS
categorization are given in Table 2.
154
OF POOR QUALrTY
TABLE 2. SMS CATEGORIZATION
NONE (0):
MILD (1):
MODERATE (2):
SEVERE (3):
NO SIGNS OR SYMPTOMS REPORTED WITH EXCEPTION OF
MILD TRANSIENT HEADACHE OR MILD DECREASED APPETITE
ONE TO SEVERAL SYMPTOMS OF A MILD NATURE; MAY BE
TRANSIENT AND ONLY BROUGHT ON AS THE RESULT OF
HEAD MOVEMENTS; NO OPERATIONAL IMPACT; MAY INCLUOE
SINGLE EPISODE OF RETCHING OR VOMITING; ALL
SYMPTOMS RESOLVED IN 36-4R HOURS
SEVERAL SYMPTOMS OF A RELATIVELY PERSISTENT NATURE -
WHICH MAY WAX AND WANE; LOSS OF APPETITE; GENERAL
MALAISE, LETHARGY AND EPIGASTRIC DISCOMFORT MAY BE
MOST DOMINANT SYMPTOMS; INCLUDES NO MORE THAN
TWO EPISODES OF VOMITING; MINIMAL OPERATIONAL
iMPACT, ALL SYMPTOMS RESOLVED IN 72 HOURS
SEVERAL SYMPTOMS OF A RELATIVELY PERSISTENT NATURE
THAT MAY WAX AND WANE; IN AODITION TO LOSS OF
APPETITE AND STOMACH DISCOMFORT MALAISE AND/OR
LETHARGY ARE PRONOUNCED; STRONG DESIRE NOT TO
MOVE HEAD; INCLUDES MORE THAN TWO EPISODES OF
VOMITING: SIGNIFICANT PERFORMANCE OECREMENT MAY BE
APPARENT; SYMPTOMS MAY PERSIST BEYOND ?2 HOURS
RESULTS
Results include preflight and inflight
symptomatology data, antimotion sickness drug
data and preflight versus inflight motion
sickness susceptibility data.
As indicated in Table 3 there is a striking
difference in the pattern of symptomatology
generated inflight versus during the ground-
based tests. Subjective warmth, sweating, and
pallor, which were dominant ground-based test
symptoms, were almost nonexistent inflight. In
contrast, vomiting, anorexia, headache, malaise
and lethargy were dominant inflight symptoms.
The vomiting episodes often occurred abruptly
with little or no prodromal nausea, although a
sensation of stomach fullness or discomfort was
often present prior to vomiting. In most cases,
vomiting resulted in relief from the
uncomfortable stomach sensations, although
for some crewmembers the discomfort would
gradually return.
TABLE 3. INCIDENCE OF PREFLIGHT VS.
INFLIGHT SYMPTOMATOLOGY
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The specific nature and time course of
inflight symptomatology tends to be highly
variable. Some crewmembers reported that
symptoms appeared within the first one to two
hours of the mission. Others did not become
aware of symptoms until the second day of
flight. In general, however, symptoms began
during the first day of flight, plateaued
between 24-48 hours and gradually diminished
between approximately 48-96 hours. During
this time the symptoms usually waxed and
waned in severity. Unquestionably, head and
body movements exacerbated the
sympt0matology. Accelerometric data obtained
by Oman during the Spacelab 1 mission (STS-9),
and subsequently confirmed by verbal reports
from a number of crewmembers, indicate that
in microgravity head movements in the pitch
and roll planes are the most provocative (7,8).
Anti-motion sickness and/or anti-emetic
medication was used by 40 of the 65
crewmembers included in this study. As
indicated in Table 4 the oral scopolamine plus
dexedrine combination was the most frequently
used with 25 crewmembers taking one or more
doses during the first few days of flight. Oral
metoclopramide was used by 18 crewmembers
in an effort to restore gastric motility and
alleviate nausea and vomiting. Of the 31
crewmembers who experienced symptoms, 29
used medication during the course of their
symptomatology.
TABLE 4. SHUTTLE ANTI-MOTION-SICKNESS
DRUG USE SUMMARY
DRUG NAME
SCOPOLAMINE (.4 MG) + DEXEDRINE (5 MG) - ORAL 2S
SCOPOLAMINE (.4 MG) - ORAL 1
PHENERGAN (25 MG) - SUPPOSITORY 3
PHENERGAN (2S MG) + EPHEDRINE (25 MG) - ORAL 1
METACHLOPRAMIOE (10 MG) - ORAL 18
COMPAZlNE (10 MG) - SUPPOSITORY 1
TRANSOERM SCOP 1
Results related to a comparison of
preflight motion sickness data with SMS are by
no means unequivocal.
The motion experience questionnaire
indicated that all of the crewmembers had a
minimal history of susceptibility to terrestrial
forms of motion sickness. The questionnaire
revealed that a few had experienced some
motion sickness during past exposures to
aerobatic flight, parabolic flight, and heavy sea
conditions. The questionnaire results, however,
NUMBER OF
CREWMEMBERS
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did not correlate with the actual incidence of
SMS reported.
Table 5 provides an overall summary of
group mean differences between the SMS
susceptible and non-SMS susceptible subgroups
for each of the preflight motion sickness
susceptibility tests used. The subgroups of
astronauts who experienced SMS were slightly
more susceptible to the preflight motion
sickness tests than were the non-SMS
susceptible astronauts. However, the test score
ranges for all subgroups are large and the
difference between the means of the subgroups
for each test are not statistically significant. In a
further attempt to establish a relationship
between the ground-based tests and SMS,
correlation coefficients between the ground-
based test scores and the scores assigned for the
inflight level of severity of SMS symptoms were
computed. The correlation coefficients were
non-significant for all three ground-based tests.
TABLE 5. PREFLIGHT MOTION SICKNESS TEST
RESULTS VS. SMS
"INFLIGHT
SYMPTOM NUMBER
4-
VOMITING 26
ANOREXIA 23
HEADACHE 20
MALAISE 18
STOMACH AWARENESS 17
LETHARGY 15
NAUSEA 13
DROWSINESS S
DISEQUILIBRIUM/DIZZINESS S
SALIVATION 0
PALLOR ?
SWEATING 0
SUBJECTIVE BODY WARMTH 0
PERCENT PREFLIGHT
40 0
3S O
31 0
28 0
26 1S
23 0
2O SS
I 3
S 3
0 18
? 85
0 ?S
0 48
"BASED ON 65 INDIVIDUALS, 31 OF WHOM REPORTED SMS
As an alternative approach to
determining whether or not the preflight
susceptibility tests might have some predictive
value for SMS, the astronaut data for each test
was compared to a frequency distribution of
non-astronaut normative data. The normative
data were collected over the past several years
by the Johnson Space Center Neurophysiology
Laboratory. Figure 2 summarizes the CSSl test
data. The hatched bars are the normative data
and the closed circles are the astronaut data.
The "star" symbol indicates astronauts who
reported SMS. The astronaut mean CSSI score is
28.7 while the normative population mean CSSI
score is 14.0. Of potentially greater significance
is the finding that 67% of the astronauts whose
CSSI score was below the population mean
experienced SMS, while only 40% whose scores
were above the population mean experienced
SMS.
so
• -- ASTRONAUT DATA
• -- REPORTED $M$
iI% SELOW NORM. POPULATION X REPORTED RMS
40% ABOVE NORM POPULATION X REPORTED SMS
Figure 2. C$SI test.
Data from the OVR test are shown in a
similar fashion in Figure 3. Here there is
virtually no difference between the astronaut
and normative population data. The mean OVR
test scores are almost identical and there were
as many crewmembers above the normative
population mean who reported SMS as there
were below the mean.
IN FLIGHT
N
%
PREFLIGHT
¢8RI OVR SliT (EO)
• Side NO Side SidS NO SidS ImS NO mS
14 IS 1S 14 3 3
48 U $2 48 SO SO
= 27.4 30.11 2tl.7 27.1 1_0 111.7
RANGE 8.4-&4,S 11.2-g_0 17.0-35.0 IL0-3S.0 2-0-2tl.0 IL0-41kO
**F = .1112 .201 _48
p = ,SO ,eli .S1
• Side REPORTED
°" ONE WAY ANOVA
Figure 3. OVR test.
Figure 4 summarizes the sudden-stop test
data. The number of astronaut data points are
too few to permit drawing any meaningful
conclusions. However, it is of interest to note
that two astronauts who were very susceptible
to the preflight sudden stop test experienced
SMS.
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Figure 4. Sudden-stop test.
All of the data summarized thus far in this
report have compared SMS susceptibility to a
single preflight test. Table 6 compares a
weighted ground-based test score with SMS
susceptibility for each of 11 crewmembers on
whom data were collected on two or more of
the preflight tests. The weighted score is the
algebraic sum of the differences between the
astronaut's test scores and the normative
population means for each test. It would be
predicted that a positive weighted score (i.e.,
greater than average resistance to
experimentally induced motion sickness) should
relate to a lack of SMS and a negative weighted
score should be related to the presence of SMS.
A correct match was obtained in 64% of the
cases.
TABLE 6. WEIGHTED GROUND-BASED TEST
SCORES VS. SMS
WEIGHTED 8CORE : 'r(CREW 4'8 FROM NORM POPULATION'X)
HYPOTHEII$:
• POIITIVE WEIGHTED 8CORE SHOULD BE RELATED TO LACK OF 8ME
• NEGATIVE WEIGHTED IICORE 8HOULD RE RELATED TO PREINENCE OF lids
CREW WEIGHTED lIME
MEMBER ICORE --
1 (88T : 4) ÷ (OVR : ÷3) : 4 1
3 (liST : -I) ÷ (OVR : -T) : -1S 1
:1 (SIT = ÷IO) + (OVR z ÷|) : ÷21 I
4 (SLIT : +$) + (OVR =-1) + (CEIl : ÷IE) = ÷21 1
S (SIT : *4) ÷ (OVR : ÷7) : +3 0
S (SIT : +30) ÷ (OVR : "4) ÷ (CEIl : ÷77) : ÷111; 0
7 (OVR=+II) ÷(CSII=+S1) = ÷SO 0
8 (OVR : -10) + (CSEI : -2) = -13 O
9 (OVR : ÷:l) +(C881 :-1) : .8 0
10 (OVR=-4) +(C881:-1,S) : -4.S 1
11 (OVR : ÷8) * (C881 : -1) : ÷e I
HITE MIEIEE
7 OUT OF 11 4 OUT OF 11
64% 38%
CONCLUSIONS
On the basis of data collected during this
study it can be generally concluded that the
prediction of SMS susceptibility on an individual
crewmember basis remains a difficult and
challenging task. Certainly the use of a single
ground-based parameter or test procedure is
inadequate. The use of a composite index or
weighted score which takes into account several
response parameters appears to have greater
predictive potential. A larger sample size of
composite scores based on the collection of
preflight CSSI, OVR and sudden-stop data on
Shuttle crewmembers would be desirable. The
data needed to derive these composite scores
do not exist, nor do plans currently exist to
collect these data.
Despite inability to identify preflight,
ground-based predictors of SMS susceptibility,
there does appear to be one reasonably
accurate predictor and that is space flight itself.
Out of 16 individuals who have flown two or
more space missions only 3 changed their
response pattern from one flight to the next.
Out of the remaining 13, 7 individuals were
symptom free on all of their flights, while the
other 6 experienced symptoms on each of their
flights. Obviously, the routine use of space
flight as the method of identifying SMS
susceptible individuals is impractical. Thus the
need to identify and validate ground-based
methods remains an important issue.
It is important to emphasize that efforts
in this area have not been abandoned. The
collection of inflight and postflight symptom
reporting data is continuing as a standard
operating procedure. Improved methods for
characterizing the exact nature and time course
of SMS are being evaluated. Also, various pre-,
in- and postflight measurements of vestibular
function are being conducted, the data from
which may be useful in our attempts to develop
predictors of SMS susceptibility.
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SPACE MOTION SICKNESS: CHARACTERIZATION AND
ETIOLOGY
Investigators: William E. Thornton, M.D., Tom Moore, M.D., and Sam Pool, M.D.
INTRODUCTION
Whenever man is placed in environments
of motion to which he is unaccustomed, either
real or simulated, a sizeable percentage of the
population will develop the characteristic
syndrome of motion sickness (23). This is a
nuisance, or worse to many individuals. It is a
significant problem to modern military forces,
and much of the study of motion sickness has
been sponsored by the military in World War I
and II (24). Dr. Graybiel's work in the U.S. Navy
is an archetype of such research (6,7,8,9). With
the development of a numerical scoring system
of signs and symptoms (12) and means with
which to rapidly induce motion sickness,
research became almost stylized. It was possible
to develop such a scoring system only because
susceptible individuals develop characteristic
signs and symptoms on continued exposure to
an environment which produces major sensory
conflict.
If such exposure is continued, vomiting
and retching may be prolonged, sometimes
with prostration (25). After varying amounts of
exposure, the majority of subjects develop
resistance to the specific stimuli (26).
Medication, habituation, and training may be
effective in prevention or treatment to varying
degrees (27). In addition to the above
symptoms, Graybiel proposed a 'sopite'
syndrome (10). This may be intertwined with
motion sickness and may occur under prolonged
mild stimuli, or as a variant of motion sickness
under strong stimuli. Features of this syndrome,
as proposed, include yawning, drowsiness,
disinclination for physical or mental work, and
lack of participation in group activities.
Prior to space flight it was predicted that
a conflict between the gravity-sensitive statolith
organs and unaffected canals would occur in
weightlessness and produce a variety of
symptoms (20). Early in the Soviet space
program, cosmonauts complained of
disorientation, illusions, malaise, nausea and
vomiting (4). Similar complaints were expressed
later by American astronauts in the Apollo
Program (15). Based upon these reported
symptoms, it was reasonable to consider this
motion sickness and treat it accordingly. By the
end of Skylab, however, there was reason to
doubt that the sickness in space was absolutely
identical to that on Earth. There was little
correlation between susceptibility on Earth and
in space; the medications effective on Earth had
questionable efficacy in space, and after a few
days of exposure to weightlessness individuals
became remarkably resistant to coriolis
stimulation, a unique non-specific adaptation
(11). After the third Space Shuttle flight, it was
obvious that the Shuttle Program also would
have to contend with the problem (13,14).
There were repeated attempts to document
signs and symptoms by means of questionnaires
and debriefings, but the first scheduled inflight
study (Spacelab 1) was still 18 months away.
An objective inflight investigation of the
problem with major emphasis on operational
concerns was necessary. This was especially so
with accumulating verbal information
describing differences between sickness inflight
and on Earth. An operationally oriented
program by the JSC Astronaut Office and Flight
Medicine was mounted on Shuttle flights 4
through 8, and astronaut physicians were added
to two of the crews. A large number of
investigations were developed and flown as
Detailed Supplementary Objectives (DSOs).
Some studies of this series have been continued
to the present under the aegis of JSC's Space
Biomedical Research Institute (SBRI). These
investigations used clinical procedures where
possible and had the major goals of:
1. Clinical characterization
2. Investigation of etiology
3. Investigation of possible treatment
A listing of studies is given in Table 1.
These investigations included personal
observations and anecdotal accounts from
Astronaut flight experience.
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TABLE I
LISTING OF INFLIGHT SMS STUDIES
Number of Subiects
Study (With SMS)
Head and Eye Motion 5 (4)
(EOG) During Launch
& Reentry (a)
Head and Eye Motion 11 (5)
(EOG) On Orbit( a )
Kinesthetic 14 (7)
Repeatability( b )
Eye-hand Tracking 12 (7)
Task( b )
Audiometry, pure 6 (3)
tone(a)
Physical Examination(a) 7 (4)
With Ophthalmoscope 7 (4)
Intraocular pressure(a) 1
Evoked Potentials: audio, 7 (4)
short and mid-latency(a)
visual I (I)
Fluid Balance(a) I (I)
Ambulatory monitoring
Heart Rate and 2 (Z)
Blood Pressure(a)
EKG(a) 2 (Z)
Heart Rate and 8
Blood Pressure on
Reentry( b)
Bowel Sound Recording( b) 12 (7)
Leg Plethysmography(b) tO (5)
Tissue Tonometry(a) 5 (2)
Serum for Causative 3 (3)
Agents( b )
Ta_--Study begun in Astronaut Office and Flight
Medicine Inflight Investigation.
(b) Study begun in Astronaut Office and Flight
Medicine Inflight Investigation and
continued under Space Biomedical Research
Institute (SBRI).
CLINICAL CHARA CTERIZA TION
SYMPTOMS
MOTION SENSITIVITY
These studies observed an amazingly
wide and variable range of symptoms in space
motion sickness (SMS). Typically, the first
indication was hypersensitivity to angular head
motion, either alone, or combined with body
motion. In many subjects this sensitivity was
predominant in the pitch plane, in others it was
in yaw; but in most cases it was also present in
all other angular axes. This hypersensitivity
became noticeable from zero to 1 to 2 hours
after exposure. It typically increased to a
plateau in several hours and remained at that
level until resolution, when it rapidly dimin-
ished. It could only be described as a thoroughly
unpleasant sensation not to be repeated if
possible. One simply wanted a quiet immobile
spot during this period of altered sensitivity.
It did not produce visual disturbance or
illusion, nor did it obviously produce stomach
symptoms as, for example, does out-of-plane
head motion in a spinning chair. If anything, it
was increased with eyes closed. The sensation
strength appeared to be related to the
magnitude of the velocity or possibly to the rate
of acceleration of movement.
Translation, even reciprocating
translation, did not produce these symptoms.
ILLUSIONS, VISUAL DISTURBANCE,
ORIENTATION
Illusion of both position and motion was
reported as a major symptom in the Russian
Program (18) and in some of the Apollo
experiences (3). Many Shuttle Astronauts have
been questioned after flight and there has been
no admission of either visual disturbance or
illusion on launch or orbit, except from one
pilot. He was not motion sick and claimed an
illusion of being in a static pitched-down
position for several hours after orbital insertion.
Great care was taken during questioning to
insure that illusions and vertigo were explained
and understood.
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Much has been made of the 'egocentric'
ability or referencing surroundings to one's own
axis; for example, the ability to place the Earth
above one's head rather than being inverted
above the earth. Some crewmembers who were
able to do this easily reported that it did not
prevent SMS. Sensitivity to scenes out of
alignment with one's own reference, such as
inverted Earth or inverted crewmen, appears to
have been disturbing to a few, but not to the
majority. A common illusion may occur in
experienced aircraft pilots observing the Earth
while strapped in the Commander or Pilot seats
with the Shuttle nose down: one feels as if it is
pitching further. This may be avoided by
releasing the seat belt. Dr. Lackner has reported
similar experience in zero-g aircraft (19).
universal. A variety of non-specific epigastric
symptoms have been reported, the most
common being a "knot in the stomach." Lower
bowel functions, as judged by flatus and
defecation, seemed normal.
SWEATING AND PALLOR
There was virtually no incidence of
sweating, and flushing was more common than
pallor. The absence of sweating cannot be
attributed to the "cool, dry environment of
Spacelab" (37), since it was the same
environment as most test labs on Earth.
0 THER SYMPTOMS
GASTROINTESTINAL
These signs and symptoms appeared from
minutes to several hours after weightlessness
and often consisted of a very brief bout of
unproductive retching, but usually of sudden
vomiting without nausea or other prodrome.
There have been several reported episodes of
vomiting, often repeated, within a few minutes
of orbital insertion. One such case was observed
and although sweating and pallor were absent,
it is suspected that the vomiting was evoked by
the launch-insertion environment (i.e., ordinary
motion sickness). However, these subjects all
had continuing symptoms of SMS.
Typically, vomiting due to SMS was
strenuous, brief, and appeared to empty the
stomach of whatever contents were present,
undigested. The contents were rarely bile-
stained. Subjective relief was commonly
claimed afterward. In the absence of eating or
drinking, these events, which produced clear
vomitus, were sometimes repeated one or more
times, usually with hours of spacing between
events. Vomiting was not prolonged; there
were no dry heaves nor frequent bouts.
Typically all significant amounts of ingested
food or drink were lost, usually within thirty
minutes to an hour or more. The majority of
subjects denied nausea, but in some this was a
major symptom or a presenting symptom. This
nausea sometimes waxed or waned but was not
necessarily related to other activity (although
some motions were avoided by SMS-affected
individuals). Loss of appetite was almost
Malaise, lack of initiative, and irritability
were nearly universal during this time.
Headache was common, usually mild, non-
specific and with various locations in different
individuals. Malaise typically increased in the
first few hours and then plateaued.
Somnolence was very common and may have
caused brief periods of sleep given the
opportunity. This was frequently a symptom
which developed early and persisted until
resolution. It may have been complicated by
lack of usual sleep.
EFFECTS OF ACTIVITIES
Demanding activities such as the
Commander's duties, the responsibility for
satellite launch, or Remote Manipulator System
(RMS) operations appeared to reduce the
perceived discomfort, if not the actual level of
SMS. Excessive movement early on orbit may
have precipitated or increased the symptoms. In
any event, cessation of activity, even sleeping,
sometimes decreased the discomfort, but did
not cure the problem.
INCIDENCE
Two interrelated questions are the
incidence of SMS and the horizontal overlap of
symptoms in those affected versus those
unaffected. The presence of symptoms from
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other causes must also be considered. Incidence 
depends upon the criteria used and the accuracy 
of reporting of symptoms; estimates vary widely 
among investigators, from 30% to as high as 
7Q?/,. Whi!e there were variations in severity 
with some mildly affected, there was a distinct 
clustering of well versus sick subjects. In some 
cases without frank SMS some features of the 
sopite syndrome were present. There was also 
ample stimulus available for ordinary motion 
sickness; e.g., vertical launch and visually 
inverted flight with up to  3.5G "eyeballs-in" 
terminating in weightlessness, plus a host of 
other new sensations. Consequently, diagnosis 
of SMS must be made with some care. 
OBJECTIVE STUDIES 
ELECTROOCULOGRAPHY (EOC) 
Because of the unique relation between 
eye motion and the greater vestibular system 
(1,16,21), electrooculography was intensively 
studied (29). 
Horizontal and vert ical EOG were 
recorded during launch on one f l ight and 
during entry on two flights, wi th 3 subjects. 
Horizontal EOG and head mot ion  were 
mnnitored doring 3 ascents and entries with a 
total of 4 subjects. 
Conventional Cali brat ion, electrode 
configurations and equipment standards were 
employed (2,34). Standardized voluntary head 
oscillations wi th  eyes open and fixed on a 
target, and w i th  vision occluded by bl ind 
goggles were made before, during, and after 
ascent and entry. Continuous recordings were 
made during launch and entry (Figure 1 ) .  No 
abnormalit ies were seen, not  even br ief  
nystagmus. 
On-orbit a more or less conventional EOG 
exam was performed (Table 2), without Hallpike 
maneuver or caloric stimulation, and w i th  
voluntary head oscillation substituted for an 
oscillating chair (Figure 2). 
TABLE 2 
ON ORBIT EOG PROTOCOL AND NUMBER OF 
PARTICIPATING SUBJECTS 
Number o f  S u b j e c t s  
Procedure  ( W i t h  SMS) 
1 7  ( 6 )  Gaze, Eyes open and 
c losed ,  H o r z o n t a l  
and V e r t i c a l  D e v i a t i o n  
Saccad ic  T r a c k i n g ,  
C a l i b r a t i o n  
Head O s c i l l a t i o n  w i t h :  
Eyes open. f i x e d  t a r g e t  1 7  ( 6 )  
Eyes c l o s e d ,  f i x e d  1 7  ( 6 )  
Eyes c l o s e d ,  s h i e l d e d ,  9 ( 4 )  
Eyes open, head 15 (6) 
t a r g e t  
F i x e d  T a r g e t  
s y n c h r o n i z e d  t a r g e t  
P u r s u i t  t r a c k i n g ,  head f i x e d  4 
O p t o k i n e t i c a l l y  i nduced  4 ( 2 )  
Head t u r n s  1 7  ( 6 )  
Head and Body R o t a t i o n  - 2 ( 2 )  
nystagmus 
s l n u s o i d a l  
s h l e l d e d  w i t h  f i x e d  t a r g e t  
Figure 1 .  Crewman instrumented for EOG and 
recording of head position prior to launch. 
D a t a  was recorded and t r a n s m i t t e d  
continuously during launch and entry. 
Eyes open, c l o s e d  and 
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Again conventional standards were 
adhered to  although the equipment had to be 
designed to  f i t  the situation. Forty-one records 
were made on orbit, 7 during SMS, with 57 
preflight and 19 postflight controls. This series 
can be summarized as clinically normal (29). 
Two isolated records contained distortion 
during the head oscillation which seemed most 
likely to  be artifactual. 
subject showed them to become remarkably 
low as the symptoms plateaued the first day 
(33). Ambulatory monitoring of  a subject 
during recovery from SMS showed a significant 
increase in basal heart rate during this period. 
BOWEL SOUNDS MONlTORlNG 
Figure 2. Crewman during EOG study with 
sinusoidal rotation on STS-8. A two axis 
gyroscope is mounted on the head. 
AUTONOMIC NERVOUS SYSTEM 
RESPONSES 
As part of these studies, an onboard 
physician observed tha t  bowel sounds were 
absent during the course of SMS. This finding 
has been subsequently c o n f i r m e d  by 
auscultation in nearly every case observed, and 
objectively studied (31). At least one case of 
hyperactive sounds during SMS with nausea and 
vomiting has been seen. It was possible that this 
hyperactivity was anti-peristaltic duodenal 
activity which has been seen with nausea. 
Objective studies consisted of recording 
sounds from the right and left upper quadrants 
of the abdomen preflight and during and after 
SMS in parallel with unaffected controls. The 
records were semiquantitatively scored by 
counting the rate of audible events by standard 
criteria. Weightlessness did not greatly alter the 
rate or quality of bowel sounds i n  those 
unaffected, although some individuals may 
have been hyperactive the first day. Conversely, 
SMS greatly depressed or virtually eliminated 
sounds during the course of the syndrome. This 
phenomenon bears a constant relation to  the 
presence of SMS. There i s  some evidence of 
rebound a c t i v i t y  for the f irst hours af ter  
recovery followed by normal activity. 
Another major effort was documenta- 
t ion  o f  autonomic changes dur ing SMS, 
inc lud ing facial  co lor ,  pup i l l a ry  size, 
temperature,. heart rate and blood pressure. 
These have proven extraordinarily difficult to 
obtain for non-technical reasons and there is 
not an adequate statistical sample t o  date; 
however, attempts continue. Objective studies 
o f  pupi l lary size were made by macro- 
photography under controlled and measured 
light conditions. Pallor/flushing studies were 
also done by photography with color control to 
be analyzed by chromatic micro-densitometry. 
Depending upon the individual, observation 
showed pallor or flushing wi th  apparently 
normal pupillary size. Ambulatory monitoring 
of the heart rate and blood pressure of one 
PERFORMANCE DURlNG SMS 
This was the most difficult evaluation to  
make. Even under normal circumstances, tests 
of performance are, a t  best, tenuously related 
to actuality. While i t  is obvious that a person is 
hors de combat during vomiting, this i s  brief. 
Conversely, trained astronauts have in  every 
case performed assigned tasks, though there 
have been t w o  precautionary delays of  
scheduled EVAs. While there was a lack of 
initiative during SMS, tasks trained for and 
scheduled were done and done well. Many of 
these required concentration as well as good 
neuromuscular and eye-hand coordination 
There have been cases of Payload Specialists, 
who have not had extensive t ra in ing and 
163 
mission simulations, being unable to  complete 
all assigned tasks. 
In an effort to study effects of SMS on 
performance, two areas have been examined: 
neuro-muscular performance and mental 
processing. The first consisted of returning 
hand or arm to a fixed linear position after 
voluntary displacement and manual tracking of 
a visual target on a linear scale which moved in 
a series of regular and aperiodic functions. A 
second study used the relat ively common 
Sternberg test. This consisted of the timed 
indication of presence or absence of  a single 
digit in a previously displayed number. Neither 
of these tests have shown any decrement in 
performance in the few cases examined to  date. 
TEMPORAL PROFILE OF 
SYMPTOMS 
As noted, with an exception which will be 
treated later, onset of symptoms occurred 
within minutes to 1 t o  2 hours of exposure to  
weightlessness (Figure 3). This  progressed in 
intensity over a period of hours t o  a plateau 
which for a given condition remained stable. 
There were typically both head and gut 
symptoms although one or the other sometimes 
predominated. In some subjects, the gut  
symptoms may have been the  only ones 
recognized, but in almost every case the gut 
remained quiet. Vomiting was often more 
frequent at the beginning. In some cases, after 
one or two episodes, i t  did not recur in  the 
absence of intake. 
The resolution of symptoms was typically 
sudden and dramatic, and most frequently 
occurred between 30 to  48 hours, but has been 
seen after only 12 hours, and possibly as long as 
72 hours. During and after resolution there was 
a marked change in  attitude, loss of malaise, 
return of stomach activity and usually appetite, 
and marked decrease in motion sensitivity. This 
typically occurred in a matter of hours or less. 
There was occasionally some residual motion 
sensitivity which decreased to normal over the 
next 2 to 3 days. With determined effort this 
sensitivity could be aggravated (37). but was not 
a problem w i t h  reasonable movement .  
Anorexia sometimes remained also, but hunger 
was more common. a t  this time or in the days 
immediately following, resistance to  all forms of 
motion sickness developed. This included the 
out-of-plane head motions in the rotating chair 
as was first demonstrated in Skylab (1 1). 
DELAYED ONSET 
There was a sub-group of 4 crewmen who 
had significantly delayed onset of symptoms, 
one for 48+ hours. This crewman was very 
active and symptom-free for the first 2 days, yet 
developed a moderate case which persisted for 
24+ hours. Common in  these four were 
lOMlN 20MIN 1 HR 10HR 1 D A Y  P D A Y S  3 4 5 6 1 WK 
TIME IN WEIGHTLESSNESS 
Figure 3. Time course of symptoms of SMS. The range of symptoms that have been recorded on 
Shuttle crewmembers i s  shown in the shaded area Note that the time scale i s  logarithmic. 
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medicat ion wi th  ScopDex and onset of 
symptoms a f t e r  d iscont inuat ion o f  the 
medication. This was the most convincing 
evidence seen to  date of the efficacy of a drug 
t o  combat SMS, but i t  represented only a small 
number o f  subjects hav ing  taken  this 
medication. I t  i s  probably significant that 
symptoms were not prevented, only delayed. 
REENTRY AND POSTFLIGHT 
In the American program, there have 
been few instances of recurring symptoms after 
landing, al though this is reported t o  be 
common in the Russian Program (18). During 
reentry and for hours thereafter head turns 
have provoked a sense of disequilibrium in some 
subjects, including those not affected by SMS, 
but  not  w i th  the sense of  unpleasantness 
experienced by those with SMS inflight (Figure 
4). One subject w i t h o u t  S M S  reported 
developing mot ion sickness symptoms on 
reentry while making head motions as part of 
an investigation. A few subjects have noted an 
illusion of translation during head turns hours 
after return to  lg. This phenomenon could not 
be elicited in flight from any subject including 
one who experienced it briefly on return. 
lnflight detection of  motion, both angular and 
linear, was correct and had a nominal threshold 
as judged by manual movement of blindfolded 
crewmen without tactile stimulation. 
Several changes in sensation were 
transiently present postflight. One of  these 
postflight changes is an apparently delayed 
resistance t o  all forms of  motion sickness or 
even disequil ibrium. This has no t  been 
adequately studied. There have been anecdotal 
reports of such increased postflight resistance to  
unpleasant motion sensations and mo t ion  
sickness, especially in aircraft, even from those 
who did not experience space motion sickness. 
One crewman repetitively tried every maneuver 
possible in the T-38 for 19 days after his first 
flight, and could elicit nothing. Two crewmen 
also rode the Coriolis chair with head motions 
postflight, without any effect, although on the 
day of landing one had been hypersensitive t o  
it. This lack of sensitivity appeared to last for 
I DOWN 
10 
TIME, RETURN FROM WEIGHTLESSNESS 
Figure 4. Time course of symptoms during neurological readaptation upon return to Earth. 
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weeks,but is one of many questions which need
quantitative answers.
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The question of acquired resistance to
SMS has not been adequately documented. At
one time it was considered part of flight
readiness to have gone through informal but
vigorous acclimatization by repetitive, violent
maneuvers in the T-38 and in some cases
prolonged sessions in the spinning chair. Some
of the subjects most resistant to motion sickness
during such maneuvers suffered most from SMS.
Conversely, there is increasing evidence,
largely undocumented, that prior spaceflight
produces resistance to SMS. This is supported by
several gastrointestinal motility studies done on
individuals who have flown more than once.
Previous flight appears to have no effect after a
period of 10 years or more. For those who have
flown within 2 to 3 years there was wide
individual variation with some showing
relatively small effects, even with flights as
recent as 7 months, while one crewman was
symptom-free on his second flight after a delay
of 2 + years. In some there was no reduction in
symptoms, but a reduction in duration, while in
others there was a significant reduction in
severity of symptoms.
It seems very significant that in no case in
the American program has there been a failure
to adapt to weightlessness, nor has there been
redevelopment of symptoms once resolved.
Significant differences between SMS
symptoms and those of classic motion sickness
have been seen. There are other factors to
consider in SMS, such as the large and rapid
weightlessness (22,30,32). Taking into account
the symptoms of malaise, lethargy, headache,
sudden vomiting and reports of illusions, one
could not reasonably exclude the possibility of
malfunctioning end organs, nor even of
increased intracranial pressure. At the time the
inflight investigation was started a number of
possible causes had to be considered and
investigated (Table 3). They were based on
clinical experience and a word of explanation
may be in order for each.
Table 3
POSSIBLE ETIOLOGIES OF SMS
DISCORDED FUNCTION
Vestibular Hydrops
Increased intracranial
pressure
Cervical Vertigo
ANOMALOUS SIGNALS
Visual
Vestibular
Semicircular
Canals
Statolith
Organs
Somatosensory
Visceral
POSSIBLE CAUSES
ETIOLOG Y OF SPA CE MO TION
SICKNESS
There is insufficient space to review
theories of etiology of motion sickness on Earth
except to say that the sensory conflict theory
currently best fits our existing knowledge. We
can find a number of situations involving major
sensory modalities: vision, somatosensory and
vestibular, which in continued conflict will
produce the classic symptom complex of motion
sickness. The mechanism whereby the
conflicting temporal profiles of neurological
impulses are translated into the symptoms
remains unknown.
DISCORDED FUNCTION
Vestibular hydrops or in this case pseudo
Meniere's disease could result from a sudden
shift of labyrinthine fluid pressure or
composition (36). In the same way, chanqes in
intracranial pressure or composition were also
possible. It was known that in the absence of
hydrostatic pressure several liters of fluid are
shifted from legs alone and that part of the
fluid was retained as edema in facial tissue and
in mucous membranes (30). Under these
circumstances intracranial changes could not be
overlooked.
Cervical vertiqo is a variously described
but apparently real syndrome usually resulting
from trauma to the neck's somatic sensors. This
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may produce vertigo, nausea and other motion
sickness symptoms (5). It is known that
significant expansion of the intervertebral discs
occurs in weightlessness, usually beyond that
seen in bed rest on Earth (28,30). There is also a
change in the carrying angle of the head in
weightlessness (30). These two factors could
conceivably produce distortion in cervical
sensors and their signals.
ANOMALOUS SIGNALS
Weightlessness can, indeed must,
produce anomalous signals in some of our
normal Earth-based sensory systems. There was
little reason to think that it would directly affect
the visual system. In many ways the visual
image should remain the standard of
comparison. Conversely, many correct scenes in
space are inconsistent with previous experience
and might well produce symptoms. For
example, rapid angular maneuvers or positions
incongruent with local orientation which are
not possible on Earth will not have been
previously experienced.
There is an inherent conflict between
canal and statolith organs in weightlessness, for
the dynamic angular responses of each overlap
and weightlessness will grossly distort the
statolith organ's signal. While the static
component of this signal is correct, it wilt
conflict with previous experience and with
visual and possibly other sensory signals.
Many of the somatosensory signals a
crewman encounters when weightless have
never been experienced before. Relatively little
is known of visceral signals beyond the fact that
they occasionally reach consciousness during
motion, particularly vertical accelerations, and
that they are capable of producing a variety of
upsets.
INFLIGHT INVESTIGATIONS
An investigational program was designed
to study as many potential etiologies as possible
with minimum resources. For example, EOG
may provide information on several of the
above categories. Because of its nature,
determination of etiology was not possible w_th
techniques currently available; rather, it was
feasible to reasonably exclude most of the
possibilites and focus on the most probable
cause. There is not space to give the usual
details of procedures or detailed results, so only
summaries are offered, treating each of the
potential causes listed previously.
DISCORDED CNS FUNCTION
Vestibular Hydrops
Illusions and visual field disturbances
were denied; clinical neurological exam was
normal; EOG exam was normal (13); there was
no difference in audio threshold sensitivity or
audio-evoked potentials between those
affected and unaffected (13); and no significant
difference was seen in volume of fluid shifted
from legs in those with and without SMS.
Increased CNS Pressure
Illusions and other neurological
disturbances were denied; clinical neurological
exam was normal; there were no changes in
fundus; EOG was normal (13); one intraocular
pressure was normal; audio evoked potentials
including midlatency studies were normal (13);
eye-hand tracking was normal; one visual
evoked potential was normal; and no difference
was seen in fluid volume shifted from legs in
those with and without SMS (22).
Cervical Vertigo
Illusions and other neurological
disturbances were denied; clinical neurological
exam was normal; EOG was normal; there was
no difference in height increases in those with
and without SMS; and cervical loading was
without affect in one subject. In summary,
there was not positive evidence for altered
sensory or CNS function.
ANOMALOUS SIGNALS
When potential roles of various sensory
inputs are examined there is less hard evidence,
and subjective symptoms are open to many
interpretations. Looking at sensory modalities
for effects of weightlessness:
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Visual Visceral Inputs
Visual disturbances were denied, and
visual acuity and extraocular motion were
normal, as were reflexes to light and
accommodation. The visual tracking function
for saccadic, pursuit and nystagmoid motion
was normal, as was optokinetic nystagmus; i.e.,
the purely visual inputs were normal. The
absence in this study of oscillopsia, or
pathological nystagmus, and the ability to
normally track a head-synchronized target
during SMS argue against other sensory
modalities disturbing visual function; i.e., the
visual information should be valid.
Vestibular Function
Canal function appeared to be normal,
for while there were changes in VOR gain as
could be determined from eyes occluded head
oscillation, the differences appeared random in
time and between subjects. The strongest
evidences for the role of vestibular inputs were
the overwhelming conscious sensations that
occurred during motions. In many, the pitch
plane was most sensitive while in others it was
yaw, but in any event it was a potent sensation.
Stopping all motion sometimes caused some
improvement in feeling, but it did not cure SMS,
and there is evidence from gastrointestinal
studies to support this. Stopping motion
probably only removed the unpleasant
sensations from motion and had little objective
effect on the underlying process. An example of
this is one subject who simply clung to a
supporting structure with eyes closed for two
nights and a day without improvement.
Somatosensory Inputs
The only direct studies of this system were
the kinesthetic position sense and eye-hand
tracking. These did not look at senses which
would most likely be involved in gravity
produced signals, hence it could be argued they
are irrelevant. The number of studies during
SMS are small and not statistically significant to
date, but no significant changes have been seen
in performance during or after SMS. One subject
was loaded to the equivalent of his own weight
by the treadmill harness and stood quietly for a
prolonged period without improvement in
symptoms.
No means were available to study this.
Other than the gastric symptoms noted, visceral
sensation did not reach consciousness.
In summary, this study showed no
evidence for the role of altered or disturbed
sensory or neurological systems and
considerable evidence against such. At the
same time there is strong theoretical argument
for a sensory conflict between the canal and
statolith organ signals. This argument is
consistent with the phenomena observed.
Visual signals are not altered and should be
consistent with canal signals, both of which
conflict with dynamic statolith signals. Visual
scenes may produce conflicts with stored
information from previous experience or
possibly with static information from statoliths
or somatosensory signals. The role of
somatosensory or visceral inputs is unknown.
Neuroanatomy also seems to be
consistent with a major role for vestibular
conflict since there are known pathways,
through nuclei, connecting the end organs to
the one area which is consistently affected by
SMS, the upper gastrointestinal tract (28,32). It
may be significant that the vestibular nuclei, the
nuclei which control the digestive tract, the
chemoreceptor trigger zone, and the emesis
center are in very close proximity around and
under the 4th ventricle.
CONCLUSION
COMMENT
The current problem is ignorance of basic
mechanisms. The pathways and the nature of
the signals that cause the ileus of the upper
gastrointestinal tract and the head symptoms
are unknown. There are two basic possibilities:
neurological transmission and/or humoral
transmission. This remains an open question.
While it is felt that the neurological pathway is
more likely, nevertheless serum has been
collected in a search for strange agents. One
subject received an injection of naloxone, an
opioid blocker, during SMS without effect.
The question of whether or not cerebral
spinal fluid might be a pathway has been raised
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by one set of experiments. This certainly
deserves consideration.
An important aspect of these investigations
was the demonstration that useful, objective
data can be gathered quickly and with
minimum resources during operational
missions.
SUMMARY
Space Motion Sickness is a probable
variant of lg motion sickness with major
differences in many aspects. It has not been
incapacitating to trained individuals, who have
still performed demanding tasks with it. It has
been universally self limiting in the American
experience, usually clearing within 36 hours. It
has not recurred on continued exposure, and
appears to be moderated by repeated
experience. It appears to have produced an
upper gastrointestinal ileus in almost all of
those affected and vomiting has been secondary
to this ileus, not a primary event. Restriction of
food and drink has helped to minimize
vomiting.
At this time it appears that an intra-
vestibular conflict is the primary cause with
unknown contributions from other modalities.
Current knowledge of the neuronal mechanisms
in volved is inadequate for understanding the
process. Some breakthrough, some drug, or
some method of stimulating the conflict on
Earth might be found, but until then SMS must
be studied in the only place it occurs - space.
.
.
.
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Section Six 
Vision 
his crewman is performing a DSO to test for changes in near- T vision acuity. An understanding of visual function changes due 
to microgravity is important for on-orbit operations. 
EFFECTS OF SHORT-TERM SPACE FLIGHT ON SEVERAL
VISUAL FUNCTIONS
Investigators: H. Lee Task, Ph.D., and Col. Louis V. Genco
INTRODUCTION
Since the early days of the Gemini space
program there has been an interest in the
possible effects of the space environment on
visual capability. During the Gemini program
S.Q. Duntley headed an effort to determine the
effects of space on visual acuity at two different
contrast levels. His approach was to develop a
portable, compact vision tester to fly aboard the
Gemini capsule and compare these results with
the astronauts' ability to see similar target
patterns constructed on the ground. These
methods provided limited visual acuity data on
a total of 4 astronauts.
Duntley originally planned to measure a
number of visual functions, but due to various
limitations only the visual acuity under two
contrast conditions was measured. Very little
quantitative work on vision in space has been
done since that time.
In order to explore the area of vision in
space, a series of visual function testers (VFT)
was developed to measure several visual
functions. The first of these (VFT-1) measured
visual acuity, stereopsis, torsional phoria, lateral
and vertical phoria, critical fusion frequency and
eye dominance. VFT-2 was designed to measure
contrast thresholds for several types of optical
patterns.
These first two VFTs were flown on
several shuttle flights. A total of 16 astronauts
have been tested on VFT-1 and 5 have been
tested on VFT-2.
PROCEDURES I RESULTS
VFT-2: MEASUREMENT OF
CONTRAST SENSITIVITY
VFT-2 was designed to measure visual
contrast threshold for several test patterns. The
P;_D¢_ _PAGE BLANK NOT
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amount of contrast required to see a pattern or
to extract specific information concerning the
pattern (e.g. orientation) increases as the size of
the pattern (or information detail) becomes
smaller. A standard method of presenting this
data is to take the reciprocal of the contrast
(designated contrast sensitivity) and graph it
against the reciprocal of size (spatial frequency).
The observer was instructed to increase
the contrast of the pattern until the specified
detail was detected. At this point, readings of
the luminance values of the target pattern and
background were taken with internal light
sensors. This insured accurate calibration of the
instrument.
Four types of test patterns were
employed. Six upper squares each contained a
square-wave pattern of a single spatial
frequency (light & dark bars per degree of visual
angle). The six spatial frequencies tested were:
4, 8, 12, 16, 22 and 30 cycles per degree. The
lower left square contained an array of tri-bar
targets with 8 spatial frequencies represented
(the 8 rows) and 8 tri-bars at each spatial
frequency in random orientations (vertical or
horizontal). The lower center square was a
continuous resolution fan test pattern ranging
from 10 to 70 cycles per degree and the lower
right square contained Blackwell disks of six
different sizes (six rows).
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SQUARE- WAVE CONTRAST SENSITIVITY
RESULTS
Figures 1, 2, and 3 show the square-wave
contrast sensitivity for the three astronauts who
participated in the use of the VFT-2. Subjects
S-12 and S-15 tended to show a decrease in
square-wave contrast sensitivity during flight
compared to pre-flight tests while S-13 showed
a minor improvement in contrast sensitivity
during flight compared to pre-flight. As a
group, there was no statistically significant
change in contrast sensitivity during spaceflight
compared to the pre-flight baseline. Further
investigation is required to determine if the
individual changes are significant and
repeatable.
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BLA CKWELL DISK CONTRAST
SENSITIWTY RESUL TS
The Blackwell disk contrast sensitivity
graphs (Figures 4, 5, and 6) for the same three
subjects show results that are very similar to the
square-wave contrast sensitivity. Again S-12
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had a lower contrast sensitivity during flight
than pre-flight. S-15 showed essentially no
difference between the two conditions. The
overall group results indicate that there is no
significant group effect due to space flight.
Again, further research is required to determine
if the individual changes are repeatable.
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TRI-BAR CONTRAST SENSITIVITY
RESULTS
The tri-bar results are highly similar to the
Blackwell disk and square wave contrast
sensitivity results as can be seen from the graphs
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(Figures 7, 8, and 9). One significant finding
from this study so far is that the results from the
different test pattern types are so close that
future study in this area need only use one of
the pattern types to investigate changes in
contrast sensitivity. Since the Blackwell disks or
tri-bars require much less space than the square-
wave patterns and yield the same results, it is
most probable that future efforts will
concentrate on one of these two pattern types.
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VFT-2 COMPARISON WITH OTHER
CONTRAST SENSITIVITY
MEASUREMENT METHODS
Figures 10 and 11 show a comparison
between contrast sensitivity measured using the
square-wave test patterns of VFT-2 and two
other methods using sine-wave test patterns.
The Optronix y/n tracking method uses a TV
display to produce a sine-wave test pattern to
which subjects respond. The other method uses
a photographically printed array of sine-wave
patterns of different contrasts and spatial
frequencies. The graphs below show a good
correspondence between the VFT-2
measurement and the photographic charts
method. The specific TV method used resulted
in somewhat higher measures of contrast
sensitivity as evidenced by the graphs below.
These graphs are part of a validation study that
was conducted to compare the VFT-2 methods
of measuring contrast sensitivity with other
methods.
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PHORIA OR EYE MUSCLE
BALANCE RESULTS
Figures 12, 13, and 14 summarize the
,¢_u,L> ui cy_ IllU_l.tf_ Udti:lrl(.e eTle(.L_ due tO
space flight for all 15 astronauts tested• There
was no significant group effect for cyclophoria,
vertical phoria or horizontal phoria.
Additionally, there did not appear to be any
evidence of individual changes in eye muscle
balance due to weightlessness.
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EYE DOMINANCE
The change in eye dominance as
measured by the VFT-1 was not statistically
significant. The changes ,,:" . ^ ._ .... k,e.,uen,, vn ,,,eu,o_,,,=
(Figures 15, 16 and 17) may have been a result of
repeated exposure to the method of testing
(essentially learning). As noted on the graphs,
data for this test was only available for six
astronauts: S-1 to S-6.
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CRITICAL FLICKER FREQUENCY
The critical flicker frequency was
measured both foveally (center of the retina)
and peripherally (about 15 degrees off center)
for all astronauts. As is obvious from the graphs
(Figures 18 and 19), there were no significant
changes in either of these parameters due to
weightlessness.
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STEREOPSIS AND ACUITY
These two visual functions are interesting
for different reasons. Initial reactions of some
of the early astronauts indicated that they felt
they could see better in space during space to
ground observations. This would mean an
improvement in their far visual acuity. From
Figure 20 it is apparent that visual acuity was
slightly (not statistically significant) worse
during flight than pre or post flight.
Stereopsis showed the largest group
change of all the parameters tested. Although
the change was not statistically significant, the
ORIGINAL PAGE IS
OF POOR QUALITY
change was particularly interesting because it
shows an apparent improvement in stereo
acuity due to space flight. There is no
explanation nor any hypothesis of a mechanism
for why this might occur.
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INDIVIDUAL EFFECTS
None of the parameters tested showed a
significant change due to space flight.
However, some of the individual data were
interesting in that there appear to be some
effects on some individuals. Figures 22, 23, and
24 are the most striking examples of possible
individual effects. Two individuals seemed to
show a significant improvement in stereopsis
during space flight and one showed an
apparent decrease in visual acuity during space
flight. There is no way to satisfactorily test the
statistical significance of these effects since
these data are post facto selected from the data
collected. However, the possibility exists that
weightlessness affects the visual system of
different individuals differently, as does space
adaptation syndrome. The best way to
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determine if the graphs are significant is to
retest these subjects on future flights if the
opportunity arises.
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CONCLUSIONS
The VFT-1 and VFT-2 tested for changes in
visual acuity, stereopsis, vertical and lateral
phoria, cyclophoria0 critical flicker frequency,
eye dominance and contrast sensitivity. None of
these visual parameters showed a statistically
significant group change due to weightlessness.
A total of 15 astronauts participated in VFT-1
experiments and 3 in the VFT-2 study.
Although there were no group changes in
these parameters, some individuals appeared to
show significant differences in acuity and
stereopsis during space flight. Without further
study it is impossible to determine if these
effects are real or simply a happenstance of the
data.
Two of the parameters studied seemed to
show some (not statistically significant) group
effect. These were a minor decrease in visual
acuity and a relatively large increase in stereo
acuity.
It should be remembered that all of these
data were collected on short duration shuttle
flights. It is quite possible that significant visual
effects may become evident during extended
space habitation stays as would occur on a space
station. This remains as an area of study for the
future.
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VISION IN SPACE: NEAR VISION ACUITY AND
CONTRAST SENSITIVITY
Investigators: Arthur P. Ginsburg, Ph.D., and James Vanderploeg, M.D.
INTRODUCTION
Both American and Soviet astronauts
have reported conflicting experiences with
visual capability in space (1). While some
astronauts report considerable increases in
visual capability, some report marked decreases Crew-
in capability, and still others report no change, member
Since weightlessness causes disruption of the 1
vestibular-ocular system and a redistribution of 2
3
fluid throughout the body which could cause
cerebral edema and changes in eyeball shape, 4
changes in visual capability would not be 5
unexpected. Studies using two different testing 6
methods, near visual acuity and contrast 7
sensitivity, were undertaken to determine the 8
effects of weightlessness on vision. Near visual 9
acuity was selected to determine changes in 10
accommodation and other possible changes 11
12
affecting vision. Contrast sensitivity testing was
selected as a more precise measure of general 13
vision loss as well as an aid in determining the 14
possible physiological location and nature of 15
vision changes. Evidence shows that significant 16
losses in contrast sensitivity can occur with little 17
or no effect on visual acuity (2-6). 18
19
20
21
22
23
PROCEDURES
Twenty-three crew members were tested
for near vision acuity. Sixteen crew members
were evaluated for contrast sensitivity. Using
the near point of accommodation, near vision
acuity was measured in diopters from a Krimsky
rule. Contrast sensitivity was measured using
five specially designed contrast sensitivity
charts. The contrast levels and orientations of
the test patches for each chart were randomized
to control for guessing and memorization. Six
spatial frequencies of 1, 2, 4, 8, 12, and 24 cycles
per degree were tested at a distance of 18
inches. Luminance differences between ground
and space testing were controlled
Measurements were taken at thirty days
preflight, ten days preflight, during flight, at
landing, and seven days postflight.
TABLE 1. NEARVISION ACUITY
Change in Diopters
(Space - Ground)
0.20
1.20*
-0.45
0.05
0.00
-0.20
0.07
-0.22
0.04 Range -2.2
-0.25 to 1.45
-0.83 Mean -0.068
-0.80 Std Dev 0.74
0.15
-2.20*
-0.10
O.20
-0.45
-0.47
1.45"
0.20
1.10"
-O.40
0.15
*Clinically Significant (> 1 Diopter Change)
RESULTS
Near vision acuity data were analyzed for
differences in the near point of accommodation
among the preflight, inflight, postflight, and
average of pre- and postflight measurements
(Table 1). Paired t-tests and analysis of variance
with repeated measurements showed that no
significant differences in diopter measurements
existed among the three phases of flight
Contrast sensitivity data were analyzed for
differences between the average preflight
contrast sensitivity data and those obtained
inflight, at landing, and postflight (Figure 1).
Statistically significant individual differences in
contrast sensitivity changes in space were
found. Crewmembers exhibited different
magnitudes of change at different spatial
frequencies•
CONCLUSIONS
No clinically significant changes in near
vision acuity in the micro-gravity environment
of space were found during space shuttle
flights• However, changes in contrast sensitivity
were seen under these conditions• Alterations
in contrast sensitivity occurring in the low and
middle but not the high spatial frequencies
cannot be readily attributed to changes in
accommodation, but reflect more central
effects. In general, the changes in contrast
sensitivity are less than a factor of two and
would not be expected to cause major visual
performance increases or decreases. The
possible physiological reasons for the changes in
contrast sensitivity during space flight will
require further research.
Figures I - 6. Changes in contrast sensitivity of
crewmembers from initial (baseline)
measurements. The data of these six
crewmembers are typical of the largest changes
found. Note that there are significant increases
and decreases in sensitivity over different spatial
frequencies for these crewrnembers. Further
research will be required to fully understand
these changes. Since these changes are
generally a factor of two or less, no major visual
gains or losses are indicated for crewmembers in
space.
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MATRIX 3
DSO Investigators
INVESTIGATOR
Dr. M.W. Bungo
Dr. J. B. Charles
Dr. N. Cintron
Dr. P. S. Cowings
It. Col. L. V. Genco
Dr. A. Ginsberg
Dr. J. L. Homick
Dr. L. D. Inners
Dr. P. C. Johnson
Dr. C. S. Leach
Dr. T. P. Moore
Dr. D. R. Morrison
Dr. D. E. Parker
Dr. D. L. Pierson
Dr. S. L. Pool
Prepared 2/19/87 by SBRI Flight Projects/MAB Page 1 of 2
ORG OSO
CODE NUMBER
SD5
SD5
SD4
ARC
USAF
USAF
SD
SD4
SD
AC
SD5
SD3
SD5
SD4
SD
402
462
463
465
460*
462
463
465
450
453
457
458*
464
442
440
408
401
460*
402
423
453
460*
441"
44_461"
451"
456
413
432
4331449*
459
409
437
425
SHORT TITLE OF DSO
Cardiovascular Deconditioning Countermeasures
Estimation of Central Venous Pressure
Inflight Treadmill Stress Test
Pre- and Postflight Echocardiography
Total Body Water
Estimation of Central Venous Pressure
Inflight Treadmill Stress Test
Pre- and Postflight Echocardiography
i Salivary Cortisol During Spaceflight
i Combined Blood Investigations
Salivary Pharmacokinetics of Scop-Dex
Salivary Acetaminophen Pharmacokinetics
Inflight Assessment of Renal Stone Risk Factor
Autogenic Feedback Training (AFT)
Crew Visual Performance Testing
Near Vision Acuity (Contrast Sensitivity)
Predictive Tests and Countermeasures for SMS
Total Body Water
Cardiovascular Deconditioning Countermeasures
Study of Inflight Fluid Changes
Combined Blood Investigations
Total Body Water
Blood Pressure Monitoring During Re-entry
Leg Plethysmography
Eye-Hand Coordination During SMS
Medical Tests and Measurements (51D P/S)
Cell Attachment in Microgravity
Carry-on Incubator/Cell Attachment in MicrooG
Pre- and Postflight Parallel Swing
Otolith Tilt-Translation Reinterpretation
Microbial Screening
Microbial Monitoring
Intraocular Pressure
A-15
DSO Investigators (Continued) Page 2 of 2
INVESTIGATOR
Dr. L. Putcha
Dr. M. Reschke
Dr. H. Schneider
Dr. E. L. Shulman
Dr. M. C. Smith
Dr. W.E. Thornton
Dr. J.M. Vanderploeg
ORG
CODE
SD4
SD5
SD4
CB
CB
SB
DSO
NUMBER
457
458*
433/449"
459
453
414
421
403
404
405
406
407
410
411
412
415
416
417
418
422
423
424
427
439*
441"
446/461"
451"
453
454/455
456
408
454/455
456
SHORT TITLE OF DSO
Salivary ....... " ............t.'narmacoKmfl_u(.b UI )(..U_-l..S_A
Salivary Acetaminophen Pharmacokinetics
Pre- and Postflight Parallel Swing
Otolith Tilt-Translation Reinterpretation
Combined Blood Investigations
Ophthalmoscopy
Animal Enclosure Module Inflight Test
Head and Eye Motion During Re-entry
On-Orbit Head and Eye Tracking Tasks
Acceleration Detection Sensitivity
Kinesthetic Ability
Photographic Documentation of Body Fluid Shift
Audiometry
Simple Mass Measurement
Treadmill Operation
Tissue Pressure Tonometry
Ambulatory Monitoring
Inflight Countermeasures for SAS
Eye-Hand Coordination
Anatomical Observation
Study of Inflight Fluid Changes
Evoked Potentials
Soft Contact Lens Application
Documentation of the Action of Metoclopramide
Blood Pressure Monitoring During Re-entry
Leg Plethysmography
Eye-Hand Coordination During SMS
Combined Blood Investigations
Clinical Characterization of SMS
Medical Tests and Measurements (51D P/S)
Near Vision Acuity (Contrast Sensitivity)
Clinical Characterization of SMS
Medical Tests and Measurements (51D P/S)
* Included as part of DSO 456.
AC, CB, SB, SD, SD3, SD4, and SD5 are NASA JSC mail codes.
ARC - NASA Ames Research Center.
USAF - United States Air Force.
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MATRIX 5
CURRENTLY ACTIVE MEDICAL DSO Prepared 02-20-87 by SBRI F11ght ProJects/MA8 Page I of 1
TITLE PRINCIPALINVESTIGATOR(S) STATUSDSO
437
450
455
Microbial Monitoring
Salivary Cortisol During
Acute Phases of Sl:_ceflight
Clinical Characterization of
SMS
457 Salivary Pharmacokinetics of
Scop-Dex
458 Salivary Acetaminophen
Pharmacokinetics
459 Otolith Tilt-Translation
Reinterpretation
460 Changes in Total Body
Water During Spaceflight
Dr. D. L. Pierson
Dr. N. Cintron
Drs. W. E. Thornton and
To be flown when animals are on board
5 additional subjects are needed to reach the
approved total.
Need additional subjects with SMS (minimum of 6
462 Noninvasive Estimation of
Central Venous Pressure
464 Inflight Assessment of Renal
Stone Risk Factor
465/466 Pre and Postflight
Echocardiography
J. Vanderploeg
Drs. N. Cintron and L. Putcha.
Drs. N. Cintron and L. Putcha
Drs. M. Reschke and D. E. Parker
Drs. C. Leach-Huntoon,
L. D. Inners, and
J. B. Charles
more)
3 additional subjects are needed to reach the
approved total.
1 additional subject _sneeded to reach the
approved total.
6 additional subjects are needed to reach the
approved total.
2 additional subjects are needed to reach the
approved total.
Drs. M. W. Bungo and
J. B. Charles
Dr. N. Cintron
Drs. M. W. Bungo and
J. 8. Charles
Initially approved only for STS-61C; additional
subjects have been requested.
Initially approved only for 5T5-61C; additional
subjects have been requested.
DSO 465 was approved for STS-61C and later
supplanted by DSO 466. 66 subjects on missions
of various durattons are needed.
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